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Zusammenfassung 
 
Die vorliegende Arbeit gibt zuerst eine Einführung in die Genetik, beleuchtet zelluläre 
Mechanismen und Systemaspekte von Gedächtnis, und gibt einen Überblick über einige 
Gene, die mit Gedächtnis in Zusammenhang gebracht werden. 
 
Im Zentrum steht ein empirischer Artikel über den Einfluss eines Polymorphismus 
(Met129Val) des Prion-Protein-Gens aufs Gedächtnis. Wir wollten Befunde unserer 
Kollaborationspartner replizieren und ergänzen, die sagen, dass homozygote Val/Val-Träger 
beim Gedächtnis von Wörtern über 24 Stunden, aber noch nicht nach fünf Minuten, einen 
Nachteil haben. Wir führten eine Studie mit funktioneller Magnetresonanztomographie (fMRI) 
durch mit 3 Gruppen von jungen, gesunden Versuchspersonen mit verschiedenen Prion-
Genotypen (Met/Met, Val/Met und Val/Val). Diese waren so gut als möglich angeglichen in 
Geschlecht, Alter, Bildung, weiteren genetischen Polymorphismen und in der 
Gedächtnisleistung. Wir behandelten Gedächtnisleistung als Kontrollvariable und die fMRI-
Aktivierung als abhängige Variable. Dies war wichtig für die Interpretation der Resultate, weil 
mehr Aktivierung ein Zeichen von erfolgreicherer Erinnerung oder von mehr Mühe beim 
Erinnern sein kann, und wir wollten beide Effekte trennen können, weswegen wir den ersten 
Faktor konstant hielten. Die Resultate waren wie erwartet: Val-Träger zeigten mehr 
Aktivierung beim Wiedererkennen der Wörter, und zwar transitiv (die Val/Val-Träger mehr als 
die Val/Met-Träger und diese mehr als die Met/Met-Träger). Ausserdem korrelierten die 
Aktivierungen innerhalb der Met/Met-Träger und Val/Met-Träger meistens positiv mit der 
Erinnerungsleistung, bei den Val/Val-Trägern hingegen vorwiegend negativ. Beide 
Beobachtungen galten gleichermassen 30 Minuten nach dem Lernen der Wörter wie 24 
Stunden nach dem Lernen. Wir interpretierten sie dahingehend, dass Val-Träger schlechtere 
Gedächnis-Fähigkeiten haben, sobald der Abruf mehr als 5 Minuten später erfolgt als die 
Lernphase. Zusätzlich fanden wir eine höhere Konzentration von grauer Materie bei Val-
Trägern als bei Met-Trägern, trotz statistisch nicht unterschiedlichen Hirngrössen. Wir wissen 
nicht woher dieser Unterschied kommt, aber er scheint die Befunde im funktionellen MRI 
nicht zu erklären, da sie qualitativ gleichbleiben, wenn man die Dichte der Grauen Materie 
als Kontrollvariable berücksichtigt.  
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Am Ende der Arbeit werden methodische Fragen der Genetikforschung und der Forschung 
über Gedächtnis mit fMRI erörtert, und es wurde versucht, den Forschungszweig kritisch zu 
bewerten.  
 
 
Summary 
 
This work first gives an introduction on genetics, on cellular and system aspects of memory 
and on genes that have been proposed to influence memory functions.  
 
The main part is an empirical paper on the influence of a polymorphism (Met129Val) of the 
prion protein gene on memory. To replicate and complement an earlier finding of our 
collaboration partners, which states that homozygous Val/Val carriers have an impaired 
episodic memory performance for words over a time lag of 24 hours, but not yet five minutes 
after learning, we conducted a functional magnetic resonance imaging (fMRI) study with 
three genetic groups of twelve young, healthy (Met/Met, Val/Met and Val/Val) subjects each, 
which were as similar as possible with respect to sex, age, education, several other genetic 
polymorphisms and memory performance. We treated task performance as a control variable 
and the activation during the task as the dependent variable. This was important for the 
interpretation of the results, because more activation can be a sign of more retrieval success, 
but also of more labor to reach a certain performance, and we wanted to be able to match 
out the first factor and evaluate only the second. Our study mainly conformed to our 
hypotheses: Val carriers showed more activity to reach the same recognition performance, in 
a transitive way: Val/Val-carriers more than Val/Met carriers and these in turn more than 
Met/Met carriers. In addition, Met/Met and Val/Met carriers showed more positive than 
negative within group correlations between memory-related fMRI activity and successful 
performance, while Val/Val carriers showed more negative correlations than positive 
correlations between activation and successful performance. Both effects held true at word 
recognition both 30 minutes after learning and 24 hours after learning. We interpreted these 
findings in term of lesser memory abilities in Val-carriers than in Met-carriers for long term 
memory over more than five minutes. An addition was a higher grey-matter concentration in 
large parts of the brain in Val-carriers than in Met-carriers, despite statistically equal whole 
brain volumes. We do not know the significance of this effect, but we think it is unlikely that 
the functional MRI results are an artifact of this structural difference, because we calculated 
statistical group comparisons with grey matter density as a control variable, and this did not 
change the result pattern.  
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In the end of the work, methodological issues of genetic research in general and with fMRI of 
memory in particular are discussed, and the field as a whole is evaluated. 
 
 
 
1. Introduction: Individual Differences and Genetics 
 
Performance in higher cognitive functions varies greatly between individuals. One 
person speaks six different languages fluently, while another needs a very big effort 
to learn just one new language. Observers use two kinds of explanation for this 
phenomenon: Maybe the parents and grandparents of the first person were already 
very good or poor in learning languages (‘nature’ or genetic point of view) or he/she 
had excellent opportunities to learn languages since his parents moved every second 
year to another country. Of course most explanations are already a mixture between 
the two points of view: Maybe he/she was very motivated to learn languages, but part 
of this motivation stemmed from the fact that it was easy for him to deal with 
languages. The topic is hotly debated (primarily in the context of intelligence) and has 
political implications: If an ability can be improved by interaction with certain 
environments (training), it would be fair for all citizens to have the same possibilities 
of learning, while if an ability is 100% hereditary, it is probably more economic to give 
persons with higher abilities employments where these abilities are needed and to 
find different jobs for people with different abilities. Personality psychologists started 
to look for more exact operationalizations of the involved concepts and to gather 
objective data. First they postulated that psychological features (and as such, 
abilities) have to fulfill two criteria to be considered as traits: They must be stable (for 
example, joyfulness is no trait because it can be totally different tomorrow than today) 
and consistent over situations (for example, fear is not a trait, because you may fear 
spiders but not crowds). Based on sharpened methodology, personality psychologists 
try to calculate how important genetic influences contrasted to environmental 
influences are for a certain trait. For example, they use monozygotic twins and 
dizygotic twins to estimate heritability (percentage estimate of genetic influence) 
measures. If homozygotic twins correlate significantly more than dizygotic twins in a 
trait, then there is a genetic influence on this trait. If quantifying this with heritability 
measures, one needs assumptions to do so, for example ‘variances caused by 
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genetic and environmental factors are independent’ (which is highly improbable) or 
‘different genes do not interact with each other’ (also highly improbable). The 
calculated heritability values have another immanent problem: They depend on the 
variabilities of genes and environments in a population. In a population where 
everybody went through very good schools, only people with severe disturbances are 
not able to read, and a large percentage of analphabets will have a high load of 
genetic risk factors for dyslexia, so heritability of the trait “dyslectic” is rather high; in a 
different population where some people go to good schools and learn to read with 
adequate methods, while do not have this possibility, heritability of the same trait will 
be much lower. We can also learn from personality psychologists, that there are two 
different kinds of environmental factors during the development of a child (Asendorpf, 
1996): Factors shared by different children of a family (‘shared factors’), and those 
that differ between children of the same family (‘nonshared factors’). An example for 
a nonshared factor would be if a mother speaks more with the oldest child than with 
the following children. This kind of research starts to become interesting if you look 
for nonsummative interaction between persons and environments: For example, 
environments can be ‘hereditary’ in the sense that persons are choosing a similar 
environment than his/her parents would have chosen, without having directly been 
taught to do so. Part of the relative stability of personality during adulthood can be 
explained by the fact that adults are rather able to choose their environment for 
themselves, so they show reactions to more similar situations, which looks like 
personality stability. We should keep this in mind if someone says that heritability of 
memory functions is about 52% (McClearn et al., 1997). For us, this number means 
that it makes sense to search for genes that influence memory functions, because 
even if that heritability value would be somewhat lower or higher, it is substantial 
enough to wonder which genes confer this genetic influence. Trying to do this, it 
starts to be difficult, but also interesting: The interactions of genome and environment 
can be situated in various organizational levels of the organism, and we have to 
understand something of these different levels of explanation before we are able to 
understand what it really means that “a gene is involved in memory”. It is a 
cumbersome, but instructive path for a psychologist to deal with this biological 
concepts: Behaviorism and in a certain sense also cognitive psychology taught us 
that the mind is a “black box”, and in the rest of this work we will try to open it. The 
first step is that we learn some basic things about genetics.  
 - 14 -
 
 
 
 
 
1.1 Genetics: Some Basics 
 
1.1.1 The Genetic Code 
 
Hereditary information is stored in DNA (desoxyribo-nuclein-acid) molecules 
(Knippers, 1997). There are 4 different nucleotid bases (‘letters’), namely adenine 
(A), thymine (T), cytosine (C) and guanine (G). DNA is organized in a double-helix, 
where each strand contains the whole information, and it is mirrored in the other 
strand: A is always facing a T, C is always facing a G. Three letters, a triplet, form a 
word, which can code for an aminoacid in the mature protein. In the cell nucleus, 
DNA has to be transcribed into messenger RNA (mRNA; ribo-nuclein-acid). mRNA 
has to be processed (the ends are often cleaved at the destination) and transported 
to ribosomes, where translation takes place. During translation, the ribosome takes 
the mRNA, reads it triplet for triplet and adds for each triplet a new aminoacid, which 
is provided by a transfer RNA (tRNA). Each aminoacid has its own type of tRNA, 
which binds almost specifically to the mRNA (there are 4x4x4=64 different words, but 
only 23 aminoacids, so some aminoacids have different codes; stopping a sequence 
has its own ‘stop-code’).   
 
 
1.1.2 Genes 
 
The definition of genes is a matter of debate, but for our purposes it is sufficient to 
say that a gene is a chromosome sequence which encodes a certain protein. It 
consists of one or several exons, whose translation can be found directly in a protein 
(are expressed), and introns, the sequences between the exons. Introns are 
important in eucaryotic genes, because they can guide the expression of a gene or 
modify the produced proteins. In complex organisms like humans, every cell type 
needs a different set of proteins, and many cells develop and change their 
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requirements. To accomplish this, the cell needs sophisticated tools adapt the 
transcription to the individual cell. This is done with help of introns: Transcription 
factors, special proteins, can bind the promoter of a gene, an intronic region 
‘upstream’ (which means ‘before’ in the direction of transcription) of the first exon, 
and regulate the transcription. Introns between exons can lead to ‘alternative splicing’ 
which means that certain exons are not translated and therefore are not built into the 
product, a mechanism which can also be regulated by enzymes.  
 
 
1.1.3 Mutations 
 
There are different kinds of mutations (Knippers, 1997): Single nucleotides or longer 
sequences can be deleted (cut out), inserted, translocated to another place or 
inversed. Deletion of just one nucleotide is fatal, because all letters in the whole 
sequence are shifted by one, and may change their meaning. Exchange of one 
nucleotide can have different kinds of effects: Possibly (often if the third letter of a 
triplet is exchanged) the triplet still codes for the same aminoacid. If the new triplet 
codes for an aminoacid with similar features, then the function of the protein may stay 
similar. If the new triplet codes for a very different aminoacid, the function of the 
protein can be changed or impaired (‘missense mutations’). Biochemists often try to 
simulate how a protein is changed by mutations in a certain place. Of course they 
can change the three-dimensional structure or the enzymatic activity of a protein. Or 
a triplet in the sequence is modified into a stop-code, then the production of the 
protein is stopped at that point, and the protein is shortened and may not be able to 
fulfill its function (‘nonsense mutations’).  
 
 
1.1.4 Polymorphisms 
 
If a mutation happens to be stable in a population, which means that its carriers are 
able to confer it to their offspring, then it is called a polymorphism. If a polymorphism 
consists of an exchange of only one letter, it is called a single nucleotide 
polymorphism (SNP).  
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1.1.5 Chromosomes and Meiosis 
 
The human DNA is stored in two times 23 chromosomes: 23 from the mother, and 23 
from the father. A chromosome is an X-shaped DNA molecule consisting of two 
chromatides, which are linked near the middle. The DNA is wrapped on certain 
molecules, the histons, which can be regulated to extend or hide certain parts of the 
chromosomes. The chromosomes are numbered according to their length, so 
number 1 is the longest chromosome (different chromosomes of each type are called 
homologous chromosomes). Since the mother has also two times 23 chromosomes, 
and the father as well, our genome is a selection of 50% of the genome of the father, 
and 50% of the genome of the mother. Mother and father provide one set of 23 
chromosomes each, which is a selection of the genome of their parents. During the 
‘meiosis’ the DNA from the grandparents is mixed (Knippers, 1997, page 210f): First, 
there is homologous recombination, which can exchange pieces of one chromosome 
with the homologous piece of another chromosome. Second, only one homologous 
chromosome (from the grandfather or the grandmother) is assigned to each gamete 
(sperm or ovum). Both mechanisms together act like shuffling cards: They mix and 
select genes. Nearby genes are likely to be inherited together. During fertilization, the 
motherly 23 chromosomes and the fatherly 23 chromosomes are fused in one cell.  
 
 
1.1.6 Regulation 
 
The reader may have noticed that several steps from the DNA to the protein can be 
regulated: Histons can make parts of chromosomes more or less accessible. 
Transcription factors can bind to intronic DNA and promote the transcription or lead 
to alternative splicing. The RNA is processed and has to be tagged to find its right 
place in the cell to be translated by ribosomes. mRNA is short-lived, and its turnover 
(its lifetime) can be regulated by certain mechanisms. Some genes do not code for 
proteins, but for regulatory RNA, which can interfere with transcription or translation. 
In addition, the DNA itself is processed by adding methyl groups. So we have to 
refine the idea of the genome as a book that is read from the beginning to the end.  
We should see the genome rather as a toolbox, where certain mechanics like certain 
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tools and even modify them for their purposes. This is the most basic level where 
environment already starts to work with the genes.  
 
 
 
1.2 Memory 
 
A definition of memory from a psychological point of view can be kept quite simple: 
Memory is each behavioral change that is influenced by experience. This very broad 
definition can be narrowed by two kinds of constraints: For example, psychologists 
have defined memory only as those behavioral changes that depend on the central 
nervous system. The problem with this constraint is that often it is impossible to verify 
if the central nervous system is involved (and probably it is), and no one knows 
where the memories are stored. The second kind of constraints is the level of 
consciousness of the retrieved information. The problem with this kind of constraints 
is that consciousness is difficult to measure, first of all in animals. We will have to 
discuss this second constraint (chapter 1.2.2 about memory systems).   
For the observation of memory, two situations are important: The encoding situation, 
and the retrieval situation. In the encoding situation, information of some form is 
presented, and in the retrieval situation, the observed subject shows some form of 
use of the information encountered in the encoding situation.  
Theorists have introduced a hypothetical process that should happen between 
encoding and retrieval: Consolidation. Consolidation describes a process of 
progressive stabilization of memory after acquisition (see Dudai, 2004 for a good 
review). Consolidation can be seen from two different perspectives: As a ‘hardening’ 
of memory traces (cellular perspective) or as a restructuring into a form that fits better 
into the system and therefore can be stored better (systems perspective).  
There is a term that describes the contrary from a systems perspective: Interference. 
Interference is impaired retrieval by encoding of similar materials. Interference can be 
circumvented by storing additional information that makes the stored items less 
similar (for example, try to recall what you ate for lunch yesterday, the day before 
yesterday and so on; it will be easier to recall if the circumstances were very different 
each time than if you ate at the same place with the same people each time).  
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We will separately discuss the cellular level and the systems level of memory- both 
will be important for understanding the present work. 
 
 
 
 
1.2.1 Cellular Level 
 
1.2.1.1 Hebbian Learning and LTP 
 
Hebb (1949) proposed a very simple mechanism for cellular learning: If a cell A is 
able to activate a cell B, and A activates B several times in a row, then it will become 
easier for cell A to activate cell B. Or to reformulate it in the language of 
neurophysiology, repeated activation of an excitatory presynaptic neuron can 
strengthen the synapse, so activation of the postsynaptic neuron by the presynaptic 
neuron is more probable (the term synapse is very important: a synapse is a small slit 
between two neurons, which enables neurotransmitters to proceed from the 
presynaptic neuron to the postsynaptic neuron, which produces voltage increases or 
decreases in the postsynaptic cell; see Figure 1).  
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Figure 1: a typical synapse 
 
This ‘Hebbian Learning’ rule has been built into numerous learning models in neural 
networks. Such a mechanism was found some years later in the hippocampus of 
rabbits (Bliss and Lømo, 1973): Long term potentiation (LTP). They stimulated the 
perforant path in anaesthetised rabbits with high-frequency stimuli and found that this 
intervention lead to a stronger excitatory post-synaptic potential (EPSP: a positivation 
of the voltage in the postsynaptic neuron) reaction to single pulses for a time span of 
hours to days. The inverted effect does also exist: Lowering the tonic activity of the 
presynaptic neuron can decrease the reaction to single stimuli in the postsynaptic 
neuron (long term depression: LTD).  
Kandel (2001) splits LTP in two phases: Early LTP does not depend on new protein 
synthesis, starts immediately after delivery of the high-frequency stimulus by the 
presynaptic neuron and lasts 1-3 hours at longest. Late LTP does depend on new 
protein synthesis, starts some minutes after the high frequency stimulus and lasts for 
at least one day. Figure 1 shows the involved mechanisms schematically. 
 
presynaptic neuron postsynaptic neuron 
dendrite 
axon 
spine 
bouton 
vesicles 
containing 
transmitter 
synapse 
receptors 
 - 20 -
 
 
Figure 2: Early LTP and late LTP mechanisms (from Kandel, 2001; explanations in 
the text) 
 
Early LTP works as follows: Repeated stimulation of the cell with the neuronal 
transmitter molecule glutamate leads to a strong depolarization of the postsynaptic 
cell (the big cell shown in Figure 2). Depolarization means, that the cell, which has 
normally a negative electric potential compared to the intracellular space, gets more 
positively charged. This process can open NMDA channels, which leads to higher 
calcium (Ca2+) influx. The calcium activates calmodulin-kinases CaMKII and CaMKIV, 
which increase the probability of AMPA channels to open (Miyamoto, 2006). In 
parallel the activated calmodulin activates an enzyme called adenylylcyclase (AC). 
This leads to a reaction which splits ATP (adenosine triphosphate) into cyclic 
adenosine monophosphate (cAMP). cAMP has an influence of potassium (K+)-
channels, which close earlier. This leads to a stronger electric pulse (action potential) 
moving down the axon, so the Ca2+-channels at the synaptic bouton can open longer 
and more transmitter is released into the synapse, which leads to a stronger EPSP in 
the postsynaptic neuron. Monoamines can influence this process: Dopaminergic D1- 
and adrenergic β-receptors activate AC, while the serotonergic 5HT1A-receptor 
inhibits AC (Izquierdo et al., 2006).  
Late LTP works as follows: cAMP activates protein kinases like PKA (protein kinase 
A) and MAPK. Irvine (2006) states that while in neonatal mice, PKA is the most 
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crucial messenger, CaMKII is more important in adult mice. CaMKII activates 
numerous important proteins like PSD-95, tubulin and cAMP phosphodiesterase 
(Izquierdo et al., 2006).  
PKA, CaMKII and ERK (extracellular signal-regulated kinase) activate the CREB-
protein (cyclic adenosine monophosphate responsive element binding 
protein)(Izquierdo et al., 2006). CREB is a transcription factor (see chapter 1.1) which 
binds to a promoter (CRE) and increases transcription of the following genes into 
mRNA, which finally leads to higher concentrations of certain proteins in the cell. 
These proteins can increase the efficiency of synapses in different ways: For 
example, the cell produces more AMPA receptors, which increases the efficiency of 
the transmitter glutamate. The cell also expresses retrograde messengers (like nitric 
oxide, NO, or brain-derived neurotrophic factor, BDNF, see chapter 1.4.4), which are 
brought to the presynaptic cell and trigger changes that ultimately lead to more 
transmitter release per presynaptic pulse, but also to growth of the synaptic 
machinery like axonal boutons. The changes on both sides of the synapse have to be 
coordinated. This works probably over cell adhesion molecules like the cadherins or 
NCAM (Lüscher et al., 2000). Synaptic elements like transmitter receptors are tied to 
the cytoskeleton, which consists of microtubules.  
Izquierdo and colleagues (2006) point out that there are regional differences in the 
brain of which of these messengers are involved. However only the hippocampal 
CA1-structure and the amygdala have been investigated extensively. 
 
 
1.2.1.2 LTP and Spatial Memory 
 
It has been believed for a long time that LTP in the hippocampus is the physiological 
correlate of spatial memory in rodents and episodic memory in humans (see chapter 
1.2.2). A direct proof for this has been presented only some weeks ago by Whitlock 
and colleagues (2006). They used two criteria to show the relation between memory 
and LTP: mimicry and occlusion. First they found that learning in an inhibitory 
avoidance task in rodents has the same effect in the dorsal part of the hippocampal 
subfield CA1 than high-frequency stimulation of the Schaffer’s Collaterals (mimicry). 
Subunits of glutamatergic AMPA receptors were phosphorylated in the same place, a 
mechanism which strengthens signal transmission in the synapse. In addition, there 
 - 22 -
were more AMPA-receptor subunits found in the synaptoneurosome fraction. Third, 
the field excitatory postsynaptic potential (fEPSP;) was increased in CA1. In the 
places where these changes occurred, high-frequency stimulation had less effect on 
these three variables (occlusion) than in places with a smaller learning effect. This 
ingenious study leaves open a small gap in showing that the two processes, memory 
formation and LTP, are perfectly parallel: It does not show an influence of changes in 
LTP on memory formation. This does a second study in the same issue of Science 
(Pastalkova et al., 2006): The authors succeeded in showing that ZIP (ζ pseudo-
substrate inhibitory peptide) an inhibitor of PKM ζ (protein kinase M zeta), a factor 
which is necessary and sufficient for LTP maintenance, practically abolished 
retention in an active avoidance task, where the rat has to avoid a fixed sector in a 
rotating field to avoid an electric shock. There was no effect of ZIP on memory 
acquisition or short term memory. 
 
 
 
 
 
1.2.1.3 Some Basic Forms of Memory 
 
Investigating memory in complex animals like rats is very difficult: There are several 
millions of neurons involved in the simplest processes, and neurons are very small 
and densely packed. Therefore Kandel (2001) and his coworkers followed the 
strategy to use a very simple model organism, the sea snail aplysia, which has only 
about 20000 neurons, the functions of which are relatively easy to find. In the 
beginning no one believed that something complicated like memory would be 
represented in a simple mollusk like aplysia, but Kandel and colleagues found some 
basic mechanisms that are very helpful to understand more complex forms of 
memory. They proceeded in a highly systematical manner and first isolated a reflex 
that can be modified by learning, then looked for the neural circuits involved and then 
for the molecular mechanisms. Kandel and coworkers (reviewed in Kandel, 2001) 
chose a simple defensive reflex of aplysia: Whenever the siphon (a mantle cavity 
around the gill) is touched, aplysia withdraws the gill. Kandel and colleagues 
described three processes which we know from psychophysiology and behaviorist 
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psychology: Habituation, sensitization and classical conditioning. All of these 
processes could be observed in the same synapse. There were two forms of memory 
in all of these processes: A transient form, which lasts minutes (‘short term memory’), 
and an enduring form, which lasts days (‘long term memory’; note that these 
concepts are not the same as the psychological terms, which are systems-based and 
have a different time scale). Long term memory could be induced by stimulating four 
or five times in a timely spaced manner.  
Habituation (weakening of the response by repeated, often regularly spaced inputs) 
led to a homosynaptic (only 1 synapse involved) weakening of the synaptic 
connection. Sensitization, in contrast, led to a heterosynaptic strengthening of the 
synapse: A third, modulatory neuron gave input to the postsynaptic neuron, which 
then showed a stronger reaction to a pulse of the presynaptic neuron. Sensitization 
had also to do with a stronger excitability of the presynaptic neuron (Figure 3).  
 
 
 
Figure 3: Sensitization in aplysia (from Kandel, 2001): SN= sensory neuron, MN= 
motor neuron, black neuron= modulating neuron leading to sensitization 
 
Later they found out that the modulatory neurons work with the monoamine 
transmitters, which are also present in human brains: serotonin (5HT) and dopamine 
(DA). Kandel notes that this mechanism of heterosynaptic sensitization by serotonin 
could be interpreted as an attentional mechanism.  
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1.2.1.4 Synaptic Tagging 
 
Kandel and his coworkers solved another very important problem with aplysia. For a 
long time it was not understood how learning can take place at the level of a single 
synapse: How can one synapse alone change its synaptic strength (weight) without 
changing the weights of all other synapses of the same axon? If rising cAMP levels 
increase the production of plasticity-related protein like AMPA-receptors in the core, 
then those products are transported to all synapses of the same axon.  
Kandel and coworkers found out that synaptic boutons can be tagged with serotonin. 
One puff of serotonin was enough to mark a synapse, so it was the only synapse 
which was able to use the proteins coming from the cell nucleus if the cell was 
sensitizised. The mechanism behind this effect was that serotonin activated protein 
kinase A (PKA), which activated some growth factors, which promote mRNA stability 
and local translation of mRNA into proteins needed for the synaptic strengthening. If 
mRNA is around, this is a relatively fast process, because the synaptic endings 
contain ribosomes, which are the cellular translation machinery.  
 
 
1.2.2 Systems Level 
 
In chapter 1.2.1 we discussed memory of two or three single cells. Kandel (2001) 
showed that even the simplest monosynaptic reflex can be modified by experience in 
several different ways. Memory seems to be a very general feature of virtually every 
cell in the central nervous system; there is even short term memory and long term 
memory, but in another sense than in the psychological literature. There we have to 
deal with different systems. While behavioristic learning psychologists proposed that 
it is not crucial to know the processes that mediate between stimulus and response, 
cognitive psychologists chose an ‘engineer-like’ account figured out how you would 
build a memory if you had to construct one, and worked with computer analogies. 
What I mean with an ‘engineer-like’ account, can be explained with the assumption 
“in a reasonable system, for every function there is a device which fulfills that 
function”. This is the way how an engineer would construct a human being. 
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Experimental psychologists worked with systems for years. This is reasonable if you 
are just interested in functions, but not in how these functions are implemented in the 
organism. Only relatively recently psychologist began to worry about “if you can find a 
memory in the brain” and to learn methods to measure it there. This was the birth of 
neuropsychology. In a way, it is naive to think that we could find something like “a 
memory system” in the brain, since nature does not care about psychologist 
concepts. Keep this in mind when we discuss “physiologically plausible” models of 
memory. The great challenge about neuropsychology is to find ‘bridge’ concepts that 
make sense in both physiology and psychology. But in a way, the human mind is very 
stubborn: If you once integrated a concept, it is very difficult to describe the same 
phenomenon with new concepts. So we should be cautious with parallels between 
physiologic observations and psychological concepts.  
 
 
1.2.2.1 Memory Systems 
 
Squire (1987) differentiated declarative memory from nondeclarative (e.g. procedural 
memory, priming; see Figure 4).  
 
 
 
Figure 4: Memory systems according to Squire (2004) 
 
The graphic assumes that there are two fundamentally different categories of 
memory: The learned things you may be able to declare if you are asked 
(declarative), and the learned things you may not be able to explain if you are asked 
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(nondeclarative). There is a second assumption suggested in the graphic: There are 
different brain areas that can be assigned to declarative versus nondeclarative 
memory. At the first glance, this looks simple and quite intuitive in an ‘engineer-like’ 
manner: Every function has its brain area.  
Tulving (1972) further differentiated declarative memory into episodic and semantic 
memory. While episodic memory involves contextual knowledge (about time and 
space something was learned in; recollection), semantic memory does not involve 
contextual knowledge, but bases on familiarity. Tulving called episodic-like answers 
in a memory-test ‘Rembember’-answers, semantic-like answers ‘Know’ (Tulving, 
1985). This refines the issue about conscious and nonconscious memory content: 
The same item is remembered in a more conscious manner, if you recollect also 
where and when you encountered that item. The same item can be primed and then 
consciously remembered. That declarative and non-declarative memory systems 
cross-talk has been shown by at least two studies: 
An interfering effect of priming on subsequent episodic memory retrieval was shown 
by Wagner and coworkers (Wagner et al, 2000). This held true for both behavioural 
priming and correlated repetition suppression in memory related brain areas as the 
left inferior prefrontal cortex (LIPC: BA 47, 45, 44 and 6) and the posterior fusiform 
gyrus (BA 37): Stronger priming at encoding resulted in reduced episodic memory 
retrieval performance. The authors mention that this is a system-based explanation 
for the spacing-effect already observed by Ebbinghaus (1885). As a mechanism, they 
propose reduced encoding variability: The task-related attention of certain features of 
a stimulus could reduce the number of ways the stimulus can be retrieved (Wiggs 
and Martin, 1998). In a study with subliminal presentation of face-profession pairs, 
Degonda and coworkers (Degonda et al., 2005) showed a negative influence of 
unconscious semantic associative priming on subsequent episodic retrieval. 
Interesting is the pattern of correlations between hippocampal activation at 
unconscious encounter of the stimuli and subsequent retrieval performance: If the 
primed profession associated with a face was incongruent with the profession 
subjects had to associate with the face afterwards, higher hippocampal activation 
went with higher retrieval performance in episodic memory; if the primed profession 
was congruent (same professional category) or identical with the profession learned 
in the subsequent episodic task, hippocampal activation went with lower retrieval 
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performance in episodic retrieval. This pattern speaks for a reversal of the beneficial 
influence of hippocampal activity in episodic memory. 
 
 
1.2.3 Memory Structures 
 
1.2.3.1 The Hippocampus 
 
Some general features: 
 
The hippocampus is the most prominent structure of the medial temporal lobe. It has 
an ideal place to connect lateral temporal areas with parietal and prefrontal areas. It 
is tightly connected to the parahippocampal cortex and receives its principal inputs 
from there. Output structures are also the parahippocampal cortex (over the 
subiculum), but also nuclei in the anterior thalamus (over the fornix fibers) and the 
hypothalamus (corpora mamillaria). Anatomical observations lead to the notion of a 
simple feed-forward structure, which should be organised in lamellae, so that each 
point in the parahippocampal cortex projects within the same y-coordinate (anterior-
posterior) into the dentate gyrus, from there to the CA3 subfield, then to the CA1 
subfield, and over the subiculum back to the parahippocampal cortex (Figure 5).  
 
 
 
Figure 5: Organisation of the hippocampus (from Amaral & Witter, 1989)  
EC: Entorhinal Cortex (a part of the parahippocampal cortex); DG: Dentate Gyrus; 
CA1/3: Cornu Ammonis; S: Subiculum 
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Amaral and Witter (1989) criticized this simplicistic view and stressed the fact that the 
antero-posterior dimension is also important: For example autoassociative fibers from 
the dentate gyrus move over considerable distances along the antero-posterior axis. 
Besides, the simple feedforward structure is too simple and has to be replaced by a 
more complicated model (Figure 6). 
 
 
 
Figure 6: More sophisticated model of hippocampal organisation (left; from Amaral & 
Witter, 1989) EC: Entorhinal Cortex (a part of the parahippocampal cortex); DG: 
Dentate Gyrus; CA1/3: Cornu Ammonis; S: Subiculum; PrS: Presubiculum; PaS: 
Parasubiculum 
 
Physiology:  
It has been shown by several authors that the hippocampus shows a slow, large 
amplitude, almost sinoidal activity, which is probably triggered by pacemaker cells 
located in the medial septal nucleus and the diagonal band of Broca (‘theta’ waves). 
It has been shown that administration of sodium amobarbital raises the threshold of 
hippocampal theta after artificial stimulation in the medial septum, especially at the 
frequency produced spontaneously during exploration (Gray & Ball, 1970), which 
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could explain the behavioral effects of amobarbital on extinction learning. The 
pathway from the medial septum over the ventral or dorsal fornix to the hippocampus 
is more or less paralleled by cholinergic (by acetylcholine; ACh) activity; transsection 
abolishes theta (Rawlins et al., 1979). Theta can be triggered by stimulation in the 
midbrain (see e.g. Pavlides et al, 1988). These authors have shown that induction of 
LTP in the perforant path is modulated by theta: With tetanic stimuli administered 
near the peaks of theta, the threshold is significantly lower than in the troughs. While 
theta waves are observed mainly during exploratory behaviour, in the rest of the time 
(during consummatory behaviour, immobility and slow wave sleep) there can be 
hippocampal sharp waves (‘SPW’) in CA3, often timely adjacent with high-frequent 
(about 200Hz) ‘ripple’ activity in CA1. These ripples are a population pattern of 
several pyramidal neurons, which fire only in a small percentage of the peaks, but in 
a synchronised manner, which is probably imposed by highly synchronised inhibitory 
interneurons, which impose the frequency structure on the firing (Ylinen et al., 1995).  
 
Classical theories of hippocampal function 
O’Keefe and Dostrowski (1971) implanted electrodes in rats and found cells in the 
hippocampus that responded only if the rat was on a certain place on the 
experimental board and faced a certain direction. The reaction was more broadly 
tuned (less selective) if the animal was aroused. The authors suspected that these 
cells act as a spatial map and provide the rat with room-centered information 
(“cognitive map theory”; CM).  
Olton and colleagues (1979) contradicted to the hippocampus processing spatial 
maps and proposed a ‘working memory theory’. They defined working memory as 
dealing with information that changes from trial to trial, in contrast to reference 
memory, which deals with information unchanged over trials, like general rules. They 
showed in an elegant experiment with a 17-arm maze that rats with hippocampal 
lesions are impaired in working memory, but not in reference memory: Arms never 
baited were not searched by the lesioned rats, but they did not know which of the 
baited arms they had searched before. Olton and colleagues pointed out that 
O’Keefe’s results speak also for this theory, since there were “displace” nerve units 
that responded to changes in stimulus arrangements from visit to visit. Note that the 
term ‘working memory’ here has a completely different meaning than in the human 
memory literature. Olton and colleagues pointed out that though a working definition, 
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‘working memory’ and ‘reference memory’ nicely parallel ‘episodic memory’ and 
‘semantic memory’, as used by Tulving (1972). Olton’s theory can be seen as part of 
multiple trace theory (see below). 
Solomon (1979) concluded from experiments with rabbits (like latent inhibition: in this 
paradigm, animals are preexposed to the to-be-conditioned stimulus, which inhibits 
later classical conditioning) that the hippocampus is not only involved in learning 
spatial maps, but also ‘temporal maps’, i.e. temporal sequences of stimuli. Authors 
agree that simple cue learning does not need hippocampal function.  
Rawlins (1985) proposed a ‘discontiguity theory’ of hippocampal function. This theory 
stresses the fact that hippocampal-lesioned animals often do well if they have to 
associate events or objects which overlap in time (e.g. classical conditioning), while 
they fail to associate events or objects that are separated in time more than some 
seconds (e.g. trace conditioning).  
Teyler and DiScenna (1986) proposed a “hippocampal memory indexing theory”. This 
theory asserts that the distributed assemblies of cortical modules activated by a new 
event are stored in the hippocampus.  
Alvarez and Squire (1994) proposed a model to explain system consolidation 
between the medial temporal lobe (MTL) and the neocortex. In their view, the MTL is 
a fast-learning, limited-capacity store. For each learned event, a unique network 
binds widely distributed cortical sites. This network can reinstate the whole 
representation if it is fed with a cue. During consolidation, the cortex grows gradually 
more able to execute this function without help of the MTL, so the MTL can recycle its 
limited capacity for new events (Figure 7). The cortical store, in contrast, is slow-
learning and has a practically unlimited capacity. 
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Figure 7: The Alvarez & Squire (1994) (“SC”) model of declarative memory 
consolidation. From Nadel & Moscovitch, (1998) 
 
 
Nadel and Moscovitch (1998) proposed a different model of declarative memory 
function and consolidation: They noticed that the Alvarez and Squire model has to 
assume a maximum consolidation time window of up to 20 years or more to explain 
memory deficits in amnesics. Nadel and Moscovitch pointed out that it is sparser to 
assume that the hippocampal system is involved not only in episodic encoding, but 
also in episodic retrieval, in line with evidence of imaging studies in human (e.g. 
Rekkas & Constable, 2005).  
Their model is connectionistic and in line with a constructivistic view of thinking and 
memory: An event consists of lots of different aspects, which are probable to be 
stored in different cortical regions. The hippocampal system accomplishes the 
binding of all these aspects into an event in its temporal and spatial context. The 
authors point out that episodic memory in humans matures at an age of 18 months at 
earliest, at the same time as orienting with help of spatial maps. Before that age or in 
amnesics, there is just semantic knowledge (facts without temporal or spatial 
context). The context, which means which aspects belong to an event, is stored in 
the hippocampal system exclusively. This is why there is no episodic retrieval without 
a functional hippocampal system. Retrieval can be initiated from both contextual 
nodes (i.e. from the hippocampus) or from aspect nodes (i.e. neocortex). The theory 
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also states that episodes can be semantisized and become independent of the 
hippocampus, but then they change their form and are less vivid and flexible 
(Moscovitch et al., 2006). Moscovitch and colleagues stress the point that the quality 
of memory traces (vividness, emotionality, personal significance) has to be taken into 
account: Probably retrieval of vivid, episodic representations (recollection instead of 
familiarity; see Tulving, 1972) stay hippocampus-dependent. An interesting side-
issue is that episodic and semantic knowledge have parallels in the theory of 
concepts: Semantic knowledge would be on the level of prototypes, episodic 
knowledge on the level of exemplars (Nadel & Moscovitch, 1998). 
The issue of retrograde amnesia in terms of this model is explained with multiple 
contextual traces in the hippocampal system (this is why this model is called the 
“multiple trace model”, see Figure 8). With each recall, there is a new trace built at a 
random place in the hippocampal system. These traces bind similar but not identical 
nodes of the neocortex. In case of hippocampal damage, elder memories have more 
contextual traces and are therefore less likely to be erased, while new memories with 
less traces are likely to be erased. The model explains why in extensive hippocampal 
damage, the amnesia for semantic knowledge can be graded, while the amnesia for 
episodic knowledge is total. 
 
 
 
Figure 8: The multiple trace model (MTT) for episodic memory (Nadel & Moscovitch, 
1998) 
 
While practically every listed theory explains one aspect of hippocampal function very 
well, they do not explain hippocampal function as a whole. The cognitive map theory 
explains the very interesting findings in animals, while Squire’s system consolidation 
theory is rather based on observations of human amnesics. The most modern and 
plausible theory is the multiple trace theory, though it has also a limited focus. What 
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is the common element between spatial learning (that correlates best with 
hippocampal function in animals) and episodic learning? The simplest explanation 
might be that binding of several objects into an event needs data from different 
modalities, which are stored in the parietal lobe (place) and temporal lobe (objects). 
Also the aspect of time seems to be important. What the hippocampus probably does 
is fast one-trial association of objects belonging to one episode in the temporal order 
of episodes.  
 
 
Subregions:  
Some studies suggest differences along an anterior-posterior axis: In a study 
investigating true and false memories for words, Cabeza and colleagues (2001) 
found that activations in the anterior hippocampus correlated rather with the 
subjective experience of memory (false memories along with true memories), while 
more posterior activations in the parahippocampal cortex separated true memories 
from unstudied items. A similar dissociation was found in a second study (Daselaar et 
al., 2006).  
 
 
Ideas about hippocampal function from newer studies: 
There is an ongoing debate of in which types of memory and which processes the 
hippocampus proper or the hippocampal system is engaged. Lesion studies in 
animals seem to show that lesion of only the hippocampus seems to have small 
effects. In humans, lesion of both hippocampi leads to severe impairment of the 
whole episodic memory. However, it seems to be difficult to find hippocampal 
activation in imaging studies. Possibly the subtraction technique used in fMRI is not 
enough sensitive to hippocampal activation, because the hippocampus is similarly 
active in baseline tasks (Stark & Squire, 2001). Another explanation for the 
discrepancies between human lesion and imaging studies are differences in the 
kinds of representation: For example, dealing with very familiar materials like words 
could diminish hippocampal activation because of the ‘semantic-like’ character of the 
task. Related to this explanation, the hippocampus could serve a kind of association 
device (Ungerleider, 1995) or serving in tasks that require flexible, relational 
representations (Cohen & Eichenbaum, 1993). In a similar vein, Morris (1996) 
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concluded from spatial learning studies with NMDA-receptor-blocked rats in two 
different environments, that spatial learning per se is possible without hippocampal 
LTP, but strategies learned in the first environment can no longer be used in the 
second environment. Morris concludes that the function of the hippocampal system is 
the temporary registration of episodic information in one-trial into an abstract 
representation. 
 
Memory activity of the medial temporal lobe (which can not be measured more 
directly with EEG) and wider parts of the brain are also reflected in electrophysio-
logical measures, in terms of activity in the theta- and gamma- range. In a study with 
electrocorticograms (‘internal EEG’ or ‘iEEG’) in epileptics, Sederberg and colleagues 
(2003) found increased theta activity in the right temporal/frontal cortex in 
successfully learned words than in forgotten words. A second study found similar 
results with MEG in a picture task in healthy subjects: During subsequently 
remembered items relative to forgotten items, there was increased theta activity over 
right parietotemporal areas, while gamma activity was found over BA 18/19. 
Fell and colleagues (2001) could show altered rhinal-hippocampal coupling during 
successful encoding of words compared to unsuccessful encoding: Synchronicity 
was first higher, than lower in the course of successful encoding. The synchronisation 
started 200 ms after stimulus onset, the desynchronisation at 1000-1100 ms after 
stimulus onset. The authors suggest that the synchronisation starts before semantic 
information has reached the medial temporal lobe, while the ‘active desynchroni-
sation’ after 1000ms is a sign of successfully exchanged semantic information.  
 
Electrophysiological studies are beginning to monitor dynamic changes while an 
animal is learning something, like exploring a new radial maze: Frank and colleagues 
(2006) compared the activity of hippocampal CA1 place cells with entorhinal cortical 
cells. They found that the hippocampal cells showed a very rapid plasticity upon 
exposure to a new environment, and instability of the representations formed at the 
beginning of the exploration. There were some CA1 cells that started to be place 
cells only during exploration, while most of the cells were place sensitive already in 
the beginning. In contrast, the cortical cells changed their firing patterns more slowly, 
were not very place sensitive and showed a slow activity decline with training, but not 
as large changes as the hippocampal cells. They interpret their findings in terms of a 
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specialisation of the hippocampus to map rapid changes, whereas the cortex reacts 
much more slowly. This field of research is very interesting but quite at its beginning, 
since we are far from understanding the dynamic interactions of all the involved 
regions and sorts of cells.  
It has been shown that the amplitude of the hippocampal theta during exploration is 
linearly dependent on the running speed of a rat (McNaughton et al., 2006). It has 
been shown that place fields grow larger if the animal is passively moved around, so 
place cells seem to depend on motor input (but possibly also on vestibular activation 
and optic flow).  
 
 
 
 
 
1.2.3.2 Entorhinal/ Rhinal Cortex 
 
Many papers ascribe the entorhinal cortex a prominent role in familiarity-based 
recognition. For example, Brown and Xiang (1998) review evidence that cells in the 
perirhinal system show a reduced reaction to repeated stimuli. In addition, Fernández 
and Tendolkar (2006) propose a second function of the rhinal cortex based on fMRI 
and ERP results: The rhinal cortex could serve as a ‘gatekeeper’ that reacts fast on 
the familiarity of a stimulus and gates encoding of too familiar stimuli. As a basis of 
their proposal, they mention a feature of the rhinal cortex, that can be found in both 
fMRI studies (‘repetition suppression’) and ERP studies (‘anterior medial temporal 
lobe N400’ or ‘AMTL-N400’): This region activates less upon repeated encounter of a 
stimulus, while higher activation at encoding predicts a higher retrieval probability 
(there are also other brain regions showing this feature: The left inferior prefrontal 
cortex (Wagner et al., 2000)). 
In the rat it has been shown that the entorhinal cortex close to the postrhinal-
entorhinal border (near the output into the dentate gyrus) has place representations 
in the form of multicentric place fields (Fyhn et al., 2004) which transform into 
monocentric place fields in the hippocampus. Probably the hippocampal place fields 
depend on collective firing of several entorhinal multicentric ‘grid’ cells. This 
increases the stability of hippocampal place fields relative to entorhinal place fields.  
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In another study, the authors found out which entorhinal cell layers respond to which 
kind of stimuli (Sargolini et al., 2006): Grid cells are found in all principal layers (II 
through V). Some cells in layers III / IV, but not in layer II, respond to head direction 
(sometimes the same cells; “conjunctive” features). The firing of most cells correlated 
also with the speed of the rat. The authors hypothesize that the position vector of the 
rat in allocentric space is updated with this kind of information. The influence of the 
entorhinal cortex for spatial orienting is shown by studies with lesioned rats, which 
are not able to return directly to their home cage (reviewed in McNaughton et al., 
2006). Possible grid cells are not formed by experience, but by neonatal cortical 
waves (McNaughton et al., 2006).  
 
 
 
 
1.2.3.3 Extended Hippocampal System 
 
In a review paper, Aggleton and Brown (2006) try to elucidate the importance of two 
diencephalic systems for episodic memory, the medial and the lateral system. The 
medial system comprises the subiculum, the medial mamillary nucleus, the anterior 
medial and anterior ventral thalamus and the ventral tegmental area. In this system 
there are neurons firing in the theta rhythm. The medial system could optimise 
encoding over feedbacks to the hippocampus and strengthen LTP. Via links to the 
frontal cortex it could serve strategic aspects of memory and reduce interference by 
separating between encoding and retrieval. 
The lateral system comprises the presubiculum, the postsubiculum, the lateral 
mamillary nucleus, the anterior dorsal thalamus and the dorsal tegmental nucleus. In 
this system, there are head-direction cells (cells that fire only if the head looks in a 
certain direction), so it is implicated in navigation.  
There are interesting ideas of information processing in the hippocampal system: 
Spatial and nonspatial information from the medial and lateral entorhinal cortex could 
converge on the hippocampus. An important role of the hippocampus in episodic 
memory could be the minimizing of similarities between representations (which is 
reflected in remapping of place cells on changing inputs, first of all in CA3, but also in 
CA1: Small changes lead to rate remapping, large changes of stimulus configurations 
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or context to global remapping, which is a complete reorganization of the 
hippocampal place code; McNaughton et al., 2006).  
 
 
1.2.3.4 Amygdala 
 
Gewirtz and Davis (1997) found a dependence of second order operant conditioning 
of NMDA receptors in the basolateral amygdala: Perfusion of an NMDA antagonist 
prevented efficient association of a second unconditioned stimulus (US) with a 
conditioned response. The intervention did not influence the already established first 
order conditioning. Similarly, Wallace and Rosen (2001) found that lesion of cells of 
the basolateral amygdala prevented contextual fear conditioning, but not 
unconditioned fear.  
Henson and colleagues (1999) found that the (bilateral) amygdala activates more 
during ‘New’-answers than during old (‘Remember-’ or ‘Know-’) answers in word 
recognition. They supposed that this structure does a kind of novelty detection for 
memory encoding, leading to a more effective encoding by other mediotemporal 
structures through arousal.  
 
 
1.2.3.5 The Basal Ganglia 
 
Packard and colleagues (1989) cite studies which say that the basal ganglia support 
simpler forms of memory (like habits or reference memory) whereas the 
hippocampus supports more sophisticated forms of memory (declarative memory, 
working memory in the “animal-researcher’s” sense of the word; see Olton et al., 
1979). In an own study, they found that hippocampal-lesioned rats were impaired in 
win-shift tasks (that require to know which arms of a maze have already been visited) 
but not in win-stay tasks (where cues show which arms are baited), whereas 
caudate-lesioned rats were impaired in win-stay tasks, but not in win-shift tasks. They 
observed that healthy rats have a tendency to win-shift if they have the choice 
between win-shift and win-stay. They conclude that the “hippocampal-memory 
system” and the “caudate-memory system” in this case compete in unlesioned rats. 
However, they note also that the importance of reinforcers is higher in the win-stay 
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task: They reinforce the reaction in a more direct manner. This led to the idea that the 
basal ganglia accomplish “cued learning” (e.g. Graybiel, 1995). This was elaborated 
with another study by Packard and McGaugh (1992), who were able to establish a 
double dissociation between caudate lesioned and fornix lesioned animals: Caudate 
lesioned animals failed in a version of the water maze task that depended on cues 
(one coloured ball was an escape platform, the other was not) and did well in a 
spatial version (the escape platform was always in the same quadrant of the maze), 
in fornix lesioned rats it was the other way round.  
In a similar double-dissociation lesion study with rats, Kesner and colleagues (1993) 
found that while hippocampal-lesioned rats showed mainly impairment in a memory-
task that required room-centered spatial navigation, caudate-lesioned rats were 
impaired in a memory-task requiring memory for responses in body-centered 
coordinates. They propose an ‘attribute memory model’ which states that which 
brain-regions are used for a memory task depends on the attributes of the stimuli that 
have to be learned. 
A nice study in human patients (Knowlton et al., 1996) showed a double dissociation 
in a task where subjects had to predict good or bad weather with cards that mapped 
good weather probabilities: While amnesics solved the task, but did not remember 
the task episode, Parkinson’s patients remembered the episode, but were not able to 
solve the task.  
In a study dealing with theoretical models, Atallah and colleagues (2004) propose a 
more sophisticated model which says that the role of the caudate is to support one 
reaction and to inhibit competing reactions (which are stored in the premotor cortex). 
The basal ganglia learn slower and therefore better fit the slow cortical learning. The 
model proposes that the ventral striatum receives more inputs from the hippocampus 
and the amygdala, so that lesions to the ventral striatum also impair spatial learning, 
while the dorsal striatum rather receives inputs directly from the posterior cortex, 
which impairs response-based strategies (Figure 9).  
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Figure 9: “Classical” and new model of hippocampal/striatal system interaction (from 
Atallah et al., 2004) 
 
Atallah and colleagues propose another dichotomy important for basal ganglia 
function: The main effect of dopamine in the basal ganglia is to enhance “Go” firing or 
to inhibit “Nogo” firing. The authors say that “Go” cells express dopamine D1 
receptors, while “Nogo” cells express D2 receptors, so dopamine in the caudate 
excitate “Go” cells and at the same time inhibit “Nogo” cells, which would explain the 
changes in “win-shift” or “win-stay” tasks. DA cells are known to activate upon 
unexpected reward and to dip if expected reward does not occur. A later paper 
(Frank, 2005) further elaborates these thoughts: The direct pathway from the striatum 
to the internal part of the globus pallidus (Figure 10) which promotes thalamocortical 
activation, could facilitate the execution of responses (“Go”), while the indirect 
pathway from the striatum over the external part of the globus pallidus to the internal 
part of the globus pallidus could inhibit the execution of responses (“Nogo”). Both 
kinds of inputs then could compete in the internal globus pallidus, where the most 
appropriate reaction (or stimulus provoking a reaction) could be selected and 
promoted.  
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Figure 10: The direct and indirect striato-thalamic pathways (from Frank, 2005). VTA: 
ventral tegmental area; SNc: substantia nigra, pars compacta; SNr: substantia nigra, 
pars reticulata; GPe: globus pallidus, pars externa; GPi: globus pallidus, pars interna 
 
The author cites literature stating that dopamine D1 receptor activation leads to 
sharpening of excitatory currents by enhancing signal-to-noise ratio (enhancing both 
excitatory and inhibitory effects of dopamine), while D2 activation inhibits excitatory 
currents. This should influence learning, since dopamine has been shown to support 
LTP. For example, Parkinson patients show impairment in ‘probability reversal’ task, 
where subjects have to learn with feedback that one event is more probable than the 
other, but in the middle of the experiment the probabilities switch, and the subject has 
to reverse his expectations without knowing the underlying rule. Medication 
enhancing dopamine transmission (L-Dopa or dopamine agonists) improve task-
switching but impede this probability reversal task, probably by inhibiting unlearning 
of the probabilities of the first half in the second half of the experiment. fMRI studies 
show ventral striatum activation during error in the second half of this task. A more 
recent fMRI study showed caudate activation in trials with feedback as opposed to 
trials without feedback, and even a differential response in right caudate upon 
negative feedback compared to positive feedback (Tricomi et al., 2006). Frank 
concludes that the basal ganglia are critically involved in cognitive reinforcement 
learning. In addition, he proposes that dopaminergic activity in the basal ganglia 
could be related to the speed/ threshold of updating working memory content in the 
frontal lobe, which could explain the frontal deficit in Parkinson disease.  
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1.2.3.6 The Frontal Lobe 
 
In an early PET study, Shallice and colleagues (1994) noted a hemisphere shift from 
encoding to retrieval: During encoding, the left prefrontal cortex was activated 
significantly in their study, during retrieval the right (they worked with different 
subjects during encoding and retrieval). Cabeza and Nyberg (2000) differentiated 
between brain regions involved in retrieval success (BA 10, 9 and 46 bilaterally), 
retrieval effort (BA 47 and 10, more left than right) and retrieval mode (BA 10 right). 
They mention a dissociation between free recall and cued recall: There are more 
activations in right BA 9 and 46 in free recall, but more activations of the frontal insula 
and BA 47 in cued recall.  
Based on earlier studies and a study on true and false memories (see above), 
Cabeza and colleagues (2001) tried to classify frontal lobe contributions to memory 
into 3 subregions: 
The ventrolateral prefrontal cortex (Brodmann area 45 in their study) is important for 
semantic processing and responds more to new and learned (old) items than to foils. 
The dorsolateral prefrontal cortex (BA 46, 9 and 8) seems to be associated with 
monitoring and responds more to learned items than to new and falsely remembered 
items. The ventromedial prefrontal cortex (BA 11) responds more during falsely 
remembered than old items and could reflect verification processes. Lesion of this 
region should lead to confabulations.  
Rajah and McIntosh (2006) contrasted frontal brain regions activated in episodic 
memory retrieval (learning word pairs and their temporal order) with frontal regions 
used in a strategic control task (reversed alphabetizing of words). They found more 
activity in the left inferior frontal gyrus (BA 47) during episodic memory retrieval, but 
more activity in the right dorsolateral PFC during the strategic task (for example, right 
BA 9 and 44/ 45). The latter activation could be due to manipulation or monitoring.  
Dove and colleagues (2006) contrasted intentional and incidental encoding and 
found bilateral mid-ventrolateral prefrontal (BA 45-47) activation in intentional 
encoding only. Intentionality correlated with retrieval success. They conclude that this 
region can reflect also intentionality in retrieval. They support a theoretical model 
which assumes that the ventrolateral prefrontal cortex biases modal representations 
in the more posterior brain over attentional processes. 
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Source Memory: ‘Source memory’ designates the ability to retrieve the sources of 
facts or events, i.e. when and where facts were encountered. Therefore, source 
memory can be seen as a special case of context memory. Studies with patients with 
frontal brain lesions often show impaired source memory despite normal memory for 
the events or facts (Janowsky et al., 1989). A side result of this paper is that source 
memory can diminish also in normal aging.  
In an ERP study, remembering of the items could be seen in a P350 potential, while 
a later positivity 700-800ms after the stimulus could be seen over frontal areas, if 
subjects were asked for the source of the word (Senkfor and Van Petten, 1998). This 
potential was not sensitive to correct or false remembering of the source, so the 
authors conclude that it reflects the search for the source and not the successful 
finding of the source. They mention the possibility that search for an item or search 
for the source of an item could be similar processes, but source retrieval could often 
be more difficult, because it needs serial finding of two pieces of information. In a 
fMRI study, the authors tried to dissociate frontal areas involved in item recognition, 
source recognition and semantic encoding in a word task (Dobbins et al., 2002). The 
left posterior IPFC (Inferior PreFrontal Cortex; BA 44/ 46/ 9) was active in all of these 
operations; the left anterior IPFC (BA 45/47) was active during source recognition 
and semantic encoding; the left frontopolar (BA 10) and posterior dorsolateral PFC 
(BA 8) was exclusively engaged during source recognition. Activity in all these 
regions was not correlated with retrieval success, but probably more with retrieval 
attempt. In an ERP study, Kuo and Van Petten (2006) found an early (200-400ms) 
and a late (700-800ms; frontal) potential differentiating old from new items. Both 
potentials did not differentiate between correctly and incorrectly identified sources, 
but later (>800ms) posterior potentials did. Similarly to Dobbins and colleagues 
(2002) they conclude that prefrontal engagement has only to do with strategies to 
overcome weak memory traces, but not with source memory in itself. 
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1.2.3.7 The Anterior Cingulate 
 
Anterior Cingulate activations (BA 24, 32) have been involved in response selection 
and initiation of action, but also in episodic memory retrieval, maybe more in verbal 
memory tests than with pictorial materials (Cabeza & Nyberg, 2000).  
 
 
1.2.3.8 The Parietal Lobe 
 
Cabeza and Nyberg (2000) summarize data stating that medial parieto-occipital 
regions are involved in episodic retrieval (mainly retrieval success), namely the 
retrosplenial cortex (BA 29 and 30), the precuneus (BA 7 and 31) and the cuneus 
(BA 19, 18, 17). Also lateral parietal regions seem to be involved in spatial memory 
and in the perceptual component of memory.  
In the study of Cabeza and colleagues (2001), lateral (BA 39/40) and medial (BA 7) 
areae are implicated in recognition and respond to correctly remembered items more 
than to falsely remembered items (retrieval success). 
Activation of these areas seems to be specific for episodic memory and not to be 
observed in semantic memory (reviewed in Ungerleider, 1995). 
 
 
 
 
 
1.2.3.9 Occipito-Temporal Junction 
 
Meltzer and Constable (2005) found a region at TT -51, -51, -17 (which corresponds 
to inferior temporal gyrus, BA37) which was active during both encoding and retrieval 
in a word pair association task. 
 
 
1.2.3.10 Precuneus and Posterior Cingulate 
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There are numerous reports of precuneus activation during retrieval: for example, 
Shallice and colleagues (1994; word retrieval; TT -6 -68 36 and 12 -72 28); Fletcher 
and colleagues (1995; word retrieval; TT coordinates 6 -46 36, together with other 
activations in the bilateral precuneus, the left anterior cingulate and the right fusiform 
and superior temporal gyri). The authors conclude that the precuneus is involved in 
imagery during retrieval, and more speculatively, in conscious processes in memory 
retrieval (‘visual imagery buffer’ or ‘mind’s eye’). Henson and colleagues (1999) found 
that the left precuneus in a word recognition task shows a dependence on memory 
quality, in that ‘Remember’-answers activate most, ‘Know’-answers less, and ‘New’-
answers least.  
A large review paper about the precuneus confirms this kind of view (Cavanna & 
Trimble, 2006): It ascribes functions with first-person perspective like self-
consciousness and the general state of goal-directed behaviour (as opposed to sleep 
or anaesthesia) to the precuneus. It also seems to be involved in covert attention 
shifts (similar to the simultanagnosia observed in Balint’s syndrome, where often only 
isolated parts of the field of view are perceived). The authors stress its high metabolic 
rate (‘hot spot’). Besides, it has connections to practically everywhere (frontal BA 46, 
8, 9, anterior cingulate, thalamus, basal ganglia, the ‘temporoparietooccipital cortex’) 
but NOT with primary sensory areas. They postulate that it can be separated in two 
functionally different areas, an anterior ‘mental imagery strategy’ area (about MNI +/- 
10, -70, 50) and a posterior ‘successful episodic memory retrieval’ area (about MNI 
+/- 6, -67, 35; perhaps it would be more accurate to say ‘dorsal’ instead of ‘anterior’ 
and ‘ventral’ instead of ‘posterior’). 
 
 
1.2.3.11 Summary 
 
Looking at the broad range of brain areas that have been involved in memory, it 
becomes clear that memory is a matter of the whole brain. Roughly, we can separate 
the areas into two different parts: Areae that store information (like the lateral 
temporal lobe, wide parietal and occipital areas) and areae that integrate and select 
information (like the medial temporal lobe, basal ganglia, and frontal cortex). While 
activation of the first kind of areae often correlates with retrieval success, activation of 
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the second kind of areae can also have to do with difficulty in memory search 
(especially in the frontal lobe; retrieval attempt).  
 
 
 
1.2.4 Memory and Sleep 
 
Pavlides and Winson (1989) have shown a higher activity of CA1 place cells in both 
REM sleep and slow wave sleep (SWS) if exposed to their place during the day 
before sleeping relative to place cells not exposed to their place. 
Wilson and McNaughton (1994) have shown that during slow wave sleep (SWS), 
hippocampal place cells in rat CA1 encoding the same area in space coactivate if 
they have been coactivated during the day (Figure 11). These correlations seem to 
be stronger during hippocampal sharp waves. Sharp waves and ripples (a special 
form of bursts occurring during slow wave sleep; see above) are initiated in CA3. The 
coactivation during sleep is interpreted as ‘playback’ of learned episodes. 
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Figure 11: Cross correlations between CA1 cells coding for the same place (left) or 
different places (right). (From Wilson and McNaughton, 1994). 
 
In a PET study with humans, Peigneux and colleagues (2004) have shown higher 
activity in the hippocampus and parahippocampal gyrus during slow wave sleep 
(SWS) in subjects who had done a spatial learning task relative to subjects who had 
done a simple reaction time task. Besides, retrieval performance increase from day 1 
to day 2 correlated with the activation in spots in the bilateral parahippocampal gyrus 
during SWS, but not during REMS.  
 
Plihal and Born (1999) have shown that low cortisol levels observed in SWS are 
important for memory retention during sleep: Additional cortisol administered in the 
first half of the night lead to diminished performance in pair associate learning, but 
not in a procedural task (mirror tracing). 
Gais and Born (2004) have shown a profound influence of low acetylcholine (ACh) 
levels on declarative memory consolidation during sleep: The whole beneficial effect 
of sleep on a word pair associate task could be abolished by administration of 
physostigmine, an acetylcholineesterase inhibitor. The agent was without effect on a 
procedural learning task (mirror tracing). In waking subjects, no effect was observed. 
The authors conclude that probably a low ACh level during slow wave sleep in 
change with high ACh levels during REM sleep promote memory consolidation. 
 
Several studies tried to correlate sleep spindles with consolidation. Sleep spindles 
are very regular characteristic sinusoid waveforms occurring at preferentially in sleep 
stage 2, which are astonishingly synchronous over the whole cortex. They are 
triggered by an intermediate hyperpolarisation in thalamocortical neurons. Spindles 
over medial prefrontal areas have been shown to be tightly correlated with the 
occurring of hippocampal sharp waves (Siapas and Wilson, 1998). Hippocampal 
spikes precede prefrontal spindles. It is not clear if both are synchronised by 
ascending brainstem-thalamic pathways, or if hippocampal outputs directly trigger the 
spindles in PFC. Spindles could eventually lead to improved conditions for LTP. 
Taken together with the results of Wilson and McNaughton (1994), this points on a 
correlation of spindles with memory-related activity during slow wave sleep. 
Sejnowski (2000) hypothesized that spindle activity opens ‘the gates for molecular 
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synaptic plasticity’, probably over Ca2+ entrance and CaMKII, while brief periods of 
fast oscillations could tag synapses carrying new associations by short-term 
potentiation. An interplay between spindle activity and bursts could explain the 
selective strengthening of synapses overnight.  
 
Direct evidence for involvement of spindles in consolidation has been found in a 
study by Gais and colleagues (2002). They compared spindle activity in subjects who 
had fulfilled an associative word learning task, compared with subjects who had done 
a letter comparing task in the same word stimuli. Spindle activity was increased in the 
learning group in sleep stage 2. Spindle power correlated with retrieval success in the 
learning group. Another study found a significant correlation between spindle density 
and performance improvement over the sleep period, but no generally increased 
spindle density in the night after a word pair learning task compared to the baseline 
task (a odd letter finding task) (Schabus et al., 2004). A third study found correlations 
of the all-night numbers of sleep spindles with verbal memory performance 
(predominantly over left central to frontal electrodes) but no correlation with face 
recognition (Clemens et al., 2005). Interestingly, decrease of spindle density is a 
feature of Alzheimer’s disease (even at a quite early stage) and other dementias 
(Montplaisir et al., 1995).  
Several studies have shown an influence of REM sleep on learning (Smith, 1995): 
The animal literature is quite consistent and shows similar effects with different types 
of task, with a greater effect in simple tasks (‘reference memory’) than in more 
complex tasks (‘working memory’). The results of human studies are less consistent, 
with big differences across tasks: Declarative memory tasks show practically no 
effects; procedural tasks show quite consistent effects (but they are difficult to 
interpret, because under ‘procedural’ there are tasks as diverse as the tower of Hanoi 
task or word stem completion or Corsi block tapping), while simple motor task could 
rather be influenced by stage 2 sleep deprivation (motor pursuit; but it seems 
methodologically difficult since this was concluded from differences in selective REM 
deprivation and 2nd half of the night sleep deprivation; stage 2 sleep can not be 
disrupted without disrupting SWS and REM sleep). It seems to be difficult to conduct 
well-controlled studies with matched S (sleep drive) and C (circadian) processes 
(Borbély, 1982). Stickgold (2005) stresses an important difference in the result 
pattern of different motor tasks: In the serial reaction time task, a more explicit 
 - 48 -
instruction leads to improvement during sleep only, while an implicit instruction leads 
to improvements also during waking periods. Imaging studies point also on strategy 
changes during sleep in motor tasks. For declarative memory, a difficult issue is to 
show that improvements after a sleep period compared to a waking period is not due 
to less interference from perceptions made while awake (Stickgold, 2005). 
 
It is also not clear which kinds of consolidation are strengthened by sleep: Systems 
consolidation or cellular consolidation. The ‘replay’ studies (Wilson & McNaugthon, 
1994), speak for systems consolidation. But also cellular consolidation seems to play 
a role: Several genes important for memory are upregulated during sleeping, like the 
calmodulin-dependent kinase IV (CaMKIV) and calcineurin, and zif-268, an 
immediate early gene which participates in activity-dependent synaptic plasticity 
(reviewed in Stickgold, 2005). Experimental induction of LTP in the hippocampus 
leads to zif-268 activation in the amygdala, entorhinal cortex and auditory cortices, 
later also in somatosensory and motor cortices.  
The influence of sleep on system consolidation is extremely interesting and difficult to 
measure, because newly learned materials interact with the structure of the 
knowledge a subject already has, which is difficult to measure. One study sheds light 
on these issues: Ellenbogen and colleagues (2006) succeeded in showing that sleep 
after learning a first list of word pairs protects from associative interference (A-B-> A-
C) by learning of a second list with different associates. This shows an effect of sleep 
on systems consolidation. 
 
 
1.3 Memory Genes 
 
Genetics has been a booming field since practically the whole human genome has 
been deciphered. Unfortunately, this was the smaller part of the work. Now we know 
the sequence of half a dozen persons and the genetic variants that happened to be 
found between them. Many more variants will be found in the future. The definition of 
a gene from the sequence is already not straightforward in all cases. But the difficulty 
starts if we search for the functions of each individual gene. The advantage of the 
deciphered genome is that it is possible to find a gene if you have the sequence of a 
candidate protein which is identified to do something (like being involved in an 
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illness). Genetic research is shifting from diseases to normal variants, which 
influence cognitive functions. Of course the action of genes on cognitive functions 
like memory is always indirect: Most of the genes code for transcription factors 
(chapter 1.1.2) or signal molecules, which regulate the concentration and distribution 
of other proteins. The influence of genes on memory is likely to be mediated by brain 
structure and single cell function. In most of the genes expressed in the brain, we do 
not even know what they are doing exactly on the level of neurophysiology. Until 
now, this field of research often works unsystematically and just tries to involve 
always the same genes in different disorders and functions (BDNF is such an 
example). Until now, candidate genes often are known from one of two fields: Either 
they have been involved in diseases (like APOE, Cyp46) or they are likely to be 
involved in neurophysiology, like receptor proteins (e.g. the serotonin 2A receptor 
gene). Often they are likely to influence not a single psychological function, but 
several (‘generalist genes’, see Butcher et al., 2006; Kovas and Plomin, 2006). In the 
following I will briefly review some genes that have been investigated by our group.  
 
 
1.3.1 The Presenilin 1 (PS1) Gene 
 
The presenilin 1 gene is known from Alzheimer’s disease (as the name says; in 
biochemistry, proteins are often named after the first context they have been found to 
be involved in). From the (fortunately rare) familial cases, most carry mutations in the 
PS 1 gene, which have full penetrance, which means that every carrier of the 
mutation will get the disease, if he reaches the age of onset (which is about 45- 50). 
Presenilin 1 is a molecule of the γ-secretase complex at the inner side of lipid rafts in 
the cell membrane, which helps to split APP (amyloid-precursor protein) into amyloid 
β (Aβ). It does not only split APP, but also other molecules like notch, which is 
important for development. Some mutation in the PS1 gene lead to increased 
production of Aβ42, which is a form of Aβ that aggregates very fast, which may finally 
lead to Alzheimer pathology. In a study with a young (20 years) carrier of the C410Y 
variant of this gene, we found fMRI overactivation in memory tasks relative to age- 
and education matched controls. Besides, we found first signs of an impaired 
episodic memory performance at that age, 25 years before he will get Alzheimer’s 
(Mondadori et al., 2006b). Probably this is no normal variant of memory, but a sign of 
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brain pathology (like neurofibrillary tangles in the medial temporal lobe), but for us it 
was a good proof of principle to see that memory problems can be seen in terms of 
compensatory overactivation in the fMRI signal.  
 
 
1.3.2 The Apolipoprotein E (APOE) Gene 
 
APOE is the most important lipid transporter in the brain. There are two frequent 
polymorphisms, which form three allelic types. The most common form is ε3 (which 
has arginine at residue 112 and cysteine at residue 158). ε4 is similar to APOE found 
in monkeys, so its probably the ancestral allele (arginine at residue 112 is switched 
into cysteine), while ε2 is the rarest form (cysteine at residue 158 is switched into 
arginine). ε2 and ε4 are both risk factors for certain diseases: ε2 carriers have a 
higher risk for hyperlipoproteinemia, while ε4 carriers have a higher risk for 
Alzheimer’s disease and cardiovascular disease, especially homozygous ε4/ ε4 
carriers. ε2 even seems to have a protective effect (reviewed in Mahley and Rall, 
2000). Carrying ε4 could have also some advantages, since intelligence was 
modestly higher in a sample of young women (Yu et al., 2000), and young knock-in 
mice carrying the human APOE ε4 instead of mouse APOE showed a stronger LTP 
than knock-in mice carrying the human APOE ε3 instead of mouse APOE (Kitamura 
et al., 2004). Interestingly, ε3 and ε2 could have evolved in parallel with the longer life 
expectancy in human beings, to support healthy aging. There should be an 
evolutionary pressure on humans to grow older to help to grow up grandchildren 
(grandmother genes; Finch and Sapolsky, 1999).  
Our study indeed showed better memory in ε4 carriers: In a large sample of students 
and trainees, ε4 carriers showed a slightly better memory performance, and in a 
subsample of 34 ε2, ε3 and ε4 carriers, ε4 carriers showed less retrieval-related fMRI 
activation to reach the same memory performance and decreased their activation if 
they had to learn the same face-word associations three times, while the other 
genotypic groups increased activation up to run 3. We interpreted in terms of better 
memory abilities in ε4-carriers (Mondadori et al., 2006).  
 
 
1.3.3 The Cytochrome P450 46A1 (Cyp46) Gene 
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The cytochrome pigment 450 proteins are a family of liver enzymes (“hydroxylating 
monooxygensases”). The cyp 46 A1 enzyme is expressed in the brain and can 
hydroxylize cholesterol to 24S-hydroxycholesterol (24-OHC). This is important for the 
cholesterol turnover (degradation; cholesterol stays in the brain for several years until 
it is replaced) in the brain, because cholesterol is not soluble in blood, while 24-OHC 
is soluble, so it can be transported to the liver and further catabolized (deconstructed) 
there. Possibly too high cholesterol in the brain is a risk to get Alzheimer’s, so it could 
be that Cyp46 has an influence on getting Alzheimer’s. The catabolite 24-OHC has 
also various functions: It helps to regulate cholesterol anabolism (construction) over 
‘liver X-receptors’. It was reported that in Alzheimer’s patients, the concentration of 
24-OHC correlated positively with a good mental status (Lütjohann et al., 2000).  
There is also another way how Cyp46 could influence memory: Cyp 46 degrades 
also sterols like estrogen, testosterone or cholesterol, which influence memory 
performance.  
Cyp46 is a complicated gene with 15 exons. An intronic polymorphism, rs754203, 
has been implicated to be associated with Alzheimer’s disease (Papassotiropoulos et 
al., 2003): Homozygous TT carriers should have a higher risk than CC or CT carriers. 
We wondered if this polymorphism has an influence in young, healthy persons, 
matched our sample from the APOE studies in two groups (TT versus CC/CT) and 
found a similar pattern as in the APOE study: non-risk-allele carriers overactivated in 
fMRI in memory tasks. Finally we resigned from publishing these results, for two 
reasons: There were no convincing data that TT carriers have a better memory, and 
there were no data indicating that this polymorphism really changes anything in the 
expression or distribution of the gene. Papassotiropoulos (personal communication) 
finally supposed that this polymorphism is not causing anything, but was in our 
population in a linkage disequilibrium (correlated) with another polymorphism in the 
promoter of the gene, which has an effect on the risk of getting Alzheimer’s. 
However, this polymorphism was never found. 
 
 
1.3.4 The Serotonin 2A Receptor Gene 
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The serotonin 2A receptor gene is highly interesting for learning (see chapter 2.1.3/ 
2.1.4). Serotonin is an indoleamine implicated not only in pain, but also in mood and 
depression. It is well-known that memory is impaired during depressive episodes. 
One study directly showed effects of tryptophan depletion on subjects undergoing a 
memory task in fMRI (van der Veen et al., 2006). Tryptophan is the precursor for 
serotonin, so tryptophan depletion leads to decreased serotonin in the brain. During 
encoding, dietary tryptophan depletion reduced right hippocampal activation, and 
retrieval performance was impaired as compared to the same subjects on another 
day (crossover design). In wide parts of the brain, tryptophan depletion led to 
compensatory overactivation.  
There is a His452Tyr polymorphism in the serotonin 2A receptor gene. The serotonin 
2A receptor is expressed strongly in the cortex, especially the frontal cortex (Buhot, 
1997). Platelet cells of His/Tyr carriers show a blunted receptor response upon 
pharmacologic stimulation with serotonin (Ozaki et al., 1997; Göthert et al., 1998). 
Our group has shown strongly (21%) reduced word learning in 452 His/Tyr carriers 
after delays of 5 minutes and 24 hours (the pattern does not look like a consolidation 
effect, but like an effect of early episodic memory, because the difference does not 
get larger between 5 minutes and 24 hours after learning (Figure 12).  
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Figure 12: Effect of the His452Tyr polymorphism (de Quervain et al., 2003) 
 
In a later study, Reynolds et al., (2006) showed an effect of a nearby polymorphism 
(1438 G/A) on deterioration at the age of 65 years in figural memory in a recognition 
task, but not in two other episodic memory tasks (recall of faces / names).  
A volumetric study using voxel-based morphometry and mask-based volume-of-
interest (VOI) meaurements found reduced white matter volumes in the temporal lobe 
and reduced grey matters volumes in the left hippocampus, the left inferior temporal 
gyrus, and bilaterally in the middle and superior temporal gyrus (Filippini et al., 2006).  
 
 
1.3.5 The Brain Derived Neurotrophic Factor (BDNF) Gene 
 
BDNF was the second neurotrophin which was discovered, and its amino acid 
sequence is quite similar to nerve growth factor (NGF), the first discovered 
neurotrophin. Neurotrophins are molecules that can be taken up by neurons and give 
a “survival signal” to the neuron. This process is important for neuronal plasticity, 
because during development, too many neurons are grown, and the brain has to 
choose which ones have to die (apoptosis). BDNF is expressed strongly in the brain, 
first of all in hippocampus, amygdalae and cortex (see Murer et al., 2001 for a 
review). BDNF acts on all sorts of neurons and was implicated as a therapy against 
Alzheimer’s and Parkinson’s disease, because BDNF expression is downregulated in 
these diseases. The importance of this protein can also be seen in its fine-tuned 
genetic regulation: There are 8 different versions of mRNA, with 4 different promoters 
and 2 different kinds of untranslated region at the end (Timmusk et al., 1993), though 
the protein stays always the same.  
BDNF is probably involved in memory function: Knockout mice have impaired long 
term potentiation (LTP), and LTP can be rescued by reexpression of BDNF in 
neuronal cultures (Korte et al., 1996).  
There is a common polymorphism (Val66Met) in the pro-region of the protein. The 
pro-region is a part of the protein that is always translated from the mRNA, but 
cleaved off at the destination of the protein. The pro-region is used by the protein to 
find its right place, like an address on a postcard. So the polymorphism does not 
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change the protein itself, but its distribution (Egan et al., 2003): valBDNF is 
expressed in the soma and dentrites of neurons, whereas metBDNF stays mainly in 
the soma. This has probably consequences for the survival of presynaptic cell, since 
BDNF works as a retrograde messenger that is taken up by the axon and transported 
back to the nucleus, where it acts as a transcription factor. Consistent with the above 
findings, humans with a Met-allele had showed a lower metabolism in the left 
hippocampus (as measured by NAA= N-acetyl-aspartate; a marker for neuronal 
function which can be used in MR-spectroscopy) and a lesser memory performance 
in a dose-dependent manner (which means, Met/Met<Val/Met<Val/Val; Egan et al., 
2003). The same group found a lower activation of Val/Met carriers than Val/Val 
carriers in fMRI during a visual episodic memory task (Hariri et al., 2003).  
We investigated the same polymorphism in the sample from the APOE study 
(Mondadori et al., 2006), with inconsistent results. However we compared grey 
matter with a manual volume-of-interest account and with voxel-based morphometry 
and found a tendency of reduced grey matter volumes in the medial temporal lobe 
and significantly reduced grey matter volumes in wide parts of the brain in Val/Met 
carriers relative to Val/Val carriers (Figure 13).  
 
 
 
Figure 13: Glass brains showing voxels (volume elements) in the brain where Val/Val 
carriers have more grey matter than Val/Met carriers (left) and vice versa (right) 
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Two weeks after doing these calculations, a study was published (Pezawas et al., 
2004) with approximately the same results (also smaller volumes in Met-carriers, but 
the areae of the significant spots only partly overlapped: we did not find occipital 
spots, but more temporal spots).  
 
 
 
1.3.6 The KIBRA Gene 
 
A genome-wide search among 502627 single nucleotide polymorphisms with pooled 
blood of subjects of 4 performance classes yielded two polymorphisms that were 
significant even if corrected for multiple comparisons. As the two polymorphisms 
were tested with a second population, only the polymorphism rs17070145 in the ninth 
intron of the KIBRA gene was still significant (Papassotiropoulos et al., 2006): T allele 
carriers had significantly better memories for words than homozygous CC cariers, 
despite of statistically equal working memory (mean CC carriers: 7.6 (SEM 0.2); 
mean CT/TT carriers: 9.4 (0.2)). The KIBRA protein has been found to be a binding 
partner of dendrin, a putative modulator of synaptic plasticity (Kremerskothen et al., 
2003). A truncated form expressed in the hippocampus contains a domain interacting 
with protein kinase C zeta (PKCζ; Buther et al., 2004) which has been implicated in 
LTP maintenance (Sacktor et al., 1993, Drier et al., 2002).  
In our face-profession association fMRI task (Mondadori et al., 2006) with 
performance-matched KIBRA genotypic groups, CC carriers showed more activation 
than CT/TT carriers in wide parts of the brain, in the hippocampus (Figure 14), frontal 
cortex (Brodmann’s areae 6, 8 and 9) and in the parietal cortex (BA 40). This higher 
activation to reach the same behavioral level (in our interpretation) is consistent with 
the worse memory of the CC carriers.  
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Figure 14: Overactivation of CT/TT carriers over CC carriers in the medial temporal 
lobe (Papassotiropoulos et al., 2006) 
 
 
 
 
 
 
 
 
 
 
 
 
1.3.7 The Prion Protein Gene (PRNP) 
 
This gene will be introduced a second time in the introduction of the paper in chapter 
2. Here we will summarize some aspects that were not touched or only very short in 
the paper. The term prion (derived from “protein” and “infective”; Prusiner, 1982) first 
circumscribed with “proteinaceous infectious particles that resist inactivation by 
procedures that modify nucleic acids” (Prusiner, 1998) or “a proteinaceous infectious 
particle that lacks nucleic acid” (Prusiner & Scott, 1997). From a broader perspective, 
a definition could also be “elements that impart and propagate conformational 
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variability” (Prusiner, 1998). There are three hypotheses about how the infectious 
agent could look like (Oesch et al., 1985): The most important one is the “protein only 
hypothesis”. It states that a prion is a special form of a normal protein, which is able 
to impose its conformational state to the normal form of the protein. The infectious 
form is called PrPSC, (SC for “scrapie”), the normal cellular form PrPC. There are also 
two other hypotheses, the “virino hypothesis”, which assumes that the infectious 
agent consists of a scrapie-specific genome coated with host-derived PrPSC, and the 
“conventional virus” hypothesis, which assumes that the infectious agent is a virus 
with unusual properties (Weissmann, 1996; 2004). The virus hypotheses are 
constrained by the fact that there is an upper bound in molecular weight for the 
agent.   
In a seminal paper, it was shown that the sequence of the infectious protein agent is 
coded by a cellular gene (Oesch et al., 1985). Then it was found that this amino acid 
sequence corresponds with the mRNA of a mouse or hamster protein found in 
uninfected animals, (“PrPC”) (Chesebro et al., 1985). Later it was confirmed that they 
are encoded by the same gene, and concluded that their different properties must be 
due to posttranslational events (Basler et al., 1986). Weissmann (2004) points out 
that although the resistance of PrPC knockout mice (see below) confirms the ‘protein 
only hypothesis’, it has never been proved directly (i.e., by showing that pure prions 
can infect an animal).   
 
 
 
 
 
1.3.7.1 Prions in Fungi 
 
At least 5 molecules have been found to have prion-like properties (namely 
conformational switch into a more protease-resistant form): The prion protein PrP and 
three fungal ‘prions’, namely the Sup35 protein (leading to the psi- - PSI+-switch, see 
below) and the Ure2p protein (leading to the URE3-phenotype, causing to a 
deregulation of nitrogen catabolite repression) in yeast, and the Het-s protein in 
Podospora, the switch of which seems to be functional to limit virus spread (reviewed 
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in Brockes, 1999). Another functional prion in yeast seems to be the β-protein (see 
below). 
 
There are 4 principially different ways in which prions act (Figure 15): Some trigger a 
toxic cascade (PrPSC), some are connected with loss of function (URE3, PSI), some 
with a gain of function (Het-s), and some have a self-activating action (β-enzyme). 
 
 
 
Figure 15: Ways of action of different prions (from Wickner et al., 2004) 
 
The PSI+ phenomenon in yeast switches cells into an altered state by a prion-like 
mechanism: Sup35 is a protein that suppresses transcription together with Sup45. In 
a psi- cell, Sup35 is soluble and able to suppress translation of nonsense mutations. 
In PSI+ cells, most of the Sup35 is insoluble, and its insolubility is inherited from 
generation to generation. The lack of soluble Sup35 leads to occasional translation of 
nonsense mutations.  
A similar cytoplasmatically inherited genetic element (which means, the information is 
not in the DNA, but in the cell), [URE3], exists in yeast (Wickner, 1994). Yeast 
(saccharomyces cerevisiae) cells use the Ure2/URE3-protein to regulate nitrogen 
metabolism: Under nitrogen-rich conditions, Ure2 binds to a transcription factor and 
prevents its entry into the nucleus. Under nitrogen-poor conditions, Ure2 is switched 
into URE3-amyloid aggregates, so there is not enough Ure2, and the transcription 
factor comes to action and triggers changes in nitrogen metabolism.  
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HET-s is a prion of the fungus podospora. The HET-s protein regulates compatibility 
between genetically identical or different cell colonies. There are two alleles in the 
het-s locus, het-s and het-S. The het-s allele exists in two forms: The prion protein 
HET-s, which is incompatible with HET-S, and the non-prion protein HET-s*, which is 
compatible with HET-S. Hence, the prion form is responsible for the lethal 
incompatibility reaction. HET-s is self-propagating and digested less by proteinase K 
than HET-s* (Coustou et al., 1997). HET-s and HET-S differ in 13 amino acids, 2 of 
which are most critical. Proline at codon 33 instead of histidine and asparagin acid 
instead of alanin at codon 23 enables prion switching. In contrast to the other 
mentioned prions, the prion-domain of HET-s is C-terminal and not Q/N-rich 
(reviewed in Wickner et al., 2004).  
β is another prion in yeast. It is a self-activating form of the vacuolar protease B 
(coded by the PRB1-gene) and can be transmitted from one cell of a syncytium to the 
other. The β-stage is crucially dependent on the concentration of the protein. Cells 
without β are not able to undergo meiosis and to produce spores and are more prone 
to starving, so β has definitely an advantageous effect (Wickner et al., 2004). 
In their review-paper, Wickner and colleagues (2004) point out that fungi and plants 
are likely to have many different prions, because they would enable rapid switches 
upon environmental changes over their syncitial/interconnecting structures. 
 
 
CPEB and long term memory: 
CPEB (cytoplasmic polyadenylation element binding protein) regulates mRNA 
translation. It acts by elongating the poly-A-tails of dormant mRNA. Most of the time, 
CPEB activates mRNA, but sometimes it represses mRNA. The activation of CPEB is 
normally controlled by phosphorylation, but the neuronal isoform of Aplysia CPEB 
lacks the normal phosphorylation sites. Si and colleagues (2003a) have found that a 
neuronal isoform of the Aplysia CPEB has prion-like properties: It has a region very 
rich in glutamine (Q) and asparagine (N), shows high conformational flexibility (not 
one stable secondary structure) and can be found as soluble species or self-
perpetuating aggregates. In vitro, only the aggregates were able to bind CPE, the 
soluble proteins were not.  
These issues were taken up by another study by Si and colleagues (2003b): It was 
shown that pulses of serotonin (5HT) in aplysia induce long term facilitation (LTF) 
 - 60 -
and CPEB-expression in parallel. Interestingly, injection of CPEB-antisense 
oligomers abolished the long term (72h) effect, but not the short term effect (24h) of 
5HT. So probably the protein is not necessary for marking a synapse (PKA-
dependent process), but for maintenance of the marking (rapamycin-dependent 
process). The same phosphorylation-independent “neuronal” form of CPEB has been 
found in mice, men and flies. 
Shorter and Lindquist (2005) point out that such a mechanism could explain how 
molecular memory traces persist on much longer time-scales than the molecules 
involved. This mechanism probably works better than other mechanisms proposed 
for the molecular correlate of memory traces: autophosphorylation loops, self-
sustaining activity loops in complex signalling networks or transcription factors that 
stimulate their own synthesis. 
 
 
1.3.7.2 Biological Chemistry of the Prion Protein 
 
The prion protein (PrP) is a sialoglycoprotein found predominantly on the surface of 
neurons, attached by a glycosylphosphatidylinositol (GPI) anchor. 
The primary structure (Figure 16; the sequence of aminoacids) of the prion protein is 
quite similar in humans, rats, mice and hamsters; sheep and bovine protein is 
somewhat more different; most different is the chicken protein (Prusiner & Scott, 
1997). The protein consists of an N-terminal region with 5 octarepeats, a long 
hydrophobic and very homologous region in the middle and the GPI-anchor at the C-
terminal side (Stahl et al., 1987), which can be released by PIPLC 
(phosphatidylinositol-specific phospholipase C) in PrPC, but not in PrPSC (Stahl et al., 
1990; Whittington et al., 1995). The N-terminal side contains a signal sequence which 
targets the protein to the endoplasmatic reticulum (ER), where the peptide is 
removed (Stahl & Prusiner, 1991). 
Biosynthesis of PrP is completed in several steps: The 22 N-terminal and the 23 C-
terminal aminoacids are cleaved, two Asn residues are glycosylated, and a glycosyl 
phosphatidyl-inositol (GPI) anchor is attached to Ser231 (Weissmann, 1996).  
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Figure 16: PrP primary structure (from Brown, 2001) 
 
Although PrPC and PrPSC probably have identical primary structures, their secondary 
structures are markedly different (reviewed in Prusiner, 1998): PrPC contains about 
40% α-helix and little β-sheet, while PrPSC contains about 30% α-helix and 45% β-
sheet. Figure 17 shows plausible secondary structures of PrPC and PrPSC. 
Copper binding imposes a more regular (α-helical) strucure to the octapeptide repeat 
part in the N-terminal tail of the protein (Miura et al., 1996). High copper-
concentrations support endocytosis of PrP from the cell surface (reviewed in 
Unterberger et al., 2005).  
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Figure 17: Plausible secondary structures of PrPC (left) and PrPSC (right) (from 
Prusiner, 1998). Corkscrew signatures are α-helices, arrows are β-sheets. 
 
 
There are at least 5 variants of the protein (Brockes, 1999; Ermonval et al., 2003; 
Harris, 2003): The normal form is GPI anchored (normal and N-terminally truncated 
form). The secretory form (Hay et al., 1987), SECPrP is the precursor of the GPI-
anchored molecule, but can sometimes be encountered in the cell lumen. The 
transmembrane form has two conformations, one with the C-terminal end towards the 
cell lumen (‘ctmPrP’), and one with the N-terminal end towards the cell lumen 
(‘ntmPrP’). Both forms span the cell membrane with the same stretch of amino acids, 
TM1 (‘TM’ for transmembrane; AA111-134). ctmPrP is enriched in certain familial prion 
diseases (in certain mutations in the transmembrane region) and has been claimed to 
be toxic (see below or Hegde et al., 1998, 1999).  
 
 
Expression of the cellular form (PrPC) has been shown in wide parts of the brain, 
predominantly in neurons, following a size effect: Large neurons have more PrPC 
than small ones (with the exception of some Purkinje cells in the cerebellum). The 
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distribution over brain structures seems to be rather uniform and does not 
significantly change following scrapie infection (Kretzschmar et al., 1986). Expression 
in the brain is strongest in the hippocampus (about 10x more than in spinal cord or 
cerebral cortex), somewhat weaker in the septal nuclei and in the nucleus caudatus, 
and even less in thalamus and in subthalamic nuclei and in the spinal cord. Olfactory 
bulb and cerebellum showed very little staining (Bendheim et al., 1992). Staining is 
localised in some cells and especially in the neuropil (compared to the diffuse 
staining of PrPSC in the extracellular space; Bendheim et al., 1992). Another group 
found PrPC immunoreactivity in the hippocampus, the entorhinal cortex, the ventral 
striatum and the substantia nigra (Moya et al., 2000; see also Figure 18). The authors 
conclude that PrPC is found in synapse-rich areas of highly plastic structures. The 
staining was found pre- and postsynaptically (Moya et al., 2000), while immuno-
electron microscopy studies showed it to be predominantly in presynaptic 
membranes (reviewed in Fournier et al., 2000). Another group observed more PrPC 
in the deep layers of the cortex compared to the superficial layers; is also expressed 
in white matter and glia, with a rostrocaudal decrease (Moleres et al., 2005). 
 
There are two different ideas about subcellular PrPC-distribution (Schmitt-Ulms et al., 
2001): One assumes concentration in calveolae-like domains in lipid rafts (see e.g. 
Vey et al., 1996), the other a more wide and homogeneous distribution in the 
membrane. PrPC seems to be taken to the synapse over anterograde transport in a 
special glycosylated form (Rodolfo et al., 1999). At least sometimes PrPC can also be 
found in the nucleus (reviewed in Ermonval et al., 2003). Mironov and colleagues 
(2003) found most PrP is in the (presynaptic and postsynaptic) plasma membrane 
and on the way there (ER, endosomes), but none in synaptic vesicles, the 
mitochondria or in clathrin-coated pits. They were enriched in synapses, but seemed 
to move over the whole membrane and not to be bound to certain compartments. 
Interestingly, some 1-2% of the neurons showed PrP in the cytosol. These cells 
looked normal (not necrotic or apoptotic) and were found in the hippocampus, 
thalamus and somatosensory cortex. The authors conclude that they probably are a 
second isoform than the one found in plasma membranes.  
 
In the peripheral organs, PrPC is expressed primarily in lungs, heart, spleen and 
skeletal muscles, but hardly in the liver (Bendheim et al., 1992). 
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Figure 18: Expression of PrP in the hamster brain (A adult, B&C postnatal day1) 
(from Moya et al., 2000); F: frontal cortex; ER: endoplasmatic reticulum; Hi: 
hippocamus; Th: thalamus; Mes: mesencephalon, Cb: cerebellum; Str: striatum; SN: 
substantia nigra; BS: brain stem; subP: subplate; CP: cortical plate; sc: corticospinal 
tract; lot: lateral olfactory tract; Olf B: olfactory bulb 
 
In a developmental study, Salès and colleagues (2002) systematically looked at PrPC 
expression (stained with the antibody mab3F4) in the maturing hamster brain. In 
most regions, expression peaked around postnatal day P21 (Figure 19). In general, 
only neurons were stained. Staining started shortly after neuronal differentiation (e.g. 
embryonic day 14.5 for retina, olfactory bulb and cortical plate). First, there was a 
staining of axons (during their elongation), then maximal staining shifted to synapses 
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and neuropil (in adults). Regions developing early, e.g. the olfactory bulb and the 
striatum, showed the adult staining pattern at birth already.  
Mobley and colleagues (1988) showed that injection of NGF (nerve growth factor) in 
neonatal hamster medial septum raised PrPC-levels in cholinergic neurons 
dramatically (x10) and ChAT (choline acetyl transferase; an enzyme connected with 
action of the neurotransmitter acetyl choline) in parallel (x2).  
PrPC staining seems to be strongest in plastic regions, which can also be seen in 
Figure 19, since the olfactory bulb and hippocampus, regions where cell proliferation 
still takes place in the adult, remain highly stained, while all the other regions already 
diminish their PrPC activity. 
 
 
 
Figure 19: Time course of PrPC expression in the hamster brain (from Salès et al., 
2002) 
 
 
 
 
1.3.7.3 Features of the Prion Protein Gene (PRNP):  
 
The human prion protein gene (PRNP) can be found in a single exon on the short 
arm of chromosome 20 (Stahl & Prusiner, 1991). There are one or two additional, 
noncoding exons upstream of this big ‘exon 3’; most mammals have 3 exons, while in 
humans, the second exon is hardly ever expressed, so the mRNA consists only of 
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the sequences encoded by exons 1 and 3. Figure 20 shows the intronic and exonic 
polymorphisms around the prion gene (PRNP), including the doppel gene (PRND). 
 
 
 
Figure 20: Location of SNP’s in the vicinity of the prion gene (from Mead et al., 2001) 
 
The doppel protein is similar to the prion protein, but has no octarepeat region (which 
is important for copper binding). Doppel is expressed very weakly in the adult mouse 
brain, but strongly in the testis (male mice lacking doppel are infertile; Behrens et al., 
2002). During development, there are higher levels in the CNS (Moore et al., 1999; 
Silverman et al., 2000).  
 
 
Prion protein knockout (PRNP0/0) mice:  
(A ‘knockout mouse’ is a mouse lacking a certain gene that has been destroyed 
before development). PRNP0/0 mice have been shown by different groups to be 
highly resistant against scrapie-infection (Büeler et al., 1993, Prusiner et al., 1993). 
The susceptibility can be reintroduced with transgenes: Syrian hamster transgenes in 
PRNP0/0 mice made them susceptible to hamster prions.  
These PRNP0/0 mice look quite healthy, despite no measurable protein or mRNA 
concentration (Büeler et al., 1992; Manson et al., 1994).  
 
 
1.3.7.4 Prion Diseases  
 
They are biologically unique in that they can be simultaneously infectious and 
inherited. These diseases include Creutzfeldt-Jakob Disease (CJD), Gerstmann-
Sträussler-Scheinker Syndrome (GSS) and Kuru in humans, Scrapie, BSE (Bovine 
Spongiform Encephalopathy) and Chronic Wasting Disease (CWD) in animals. After 
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a long latent period, “transmissible spongiform encephalopathies” (TSE) are rapidly 
processing, fatal neurodegenerative diseases (Glover et al., 1997). 
TSEs are spread by prions, which appear to consist only of a plasma-membrane 
protein (“protein only hypothesis”) with a normal conformation, PrPc, and a 
pathological conformation, PrPsc. The pathological conformation seems to be 
dominant and induces a conformational switch in PrPc->PrPsc. Cardinal difference of 
PrPsc from PrPc is its resistance to proteinase digestion and its insolubility. Upon 
treatment with proteinase K, PrPc is degraded completely, whereas PrPsc loses an N-
terminal domain with the octarepeats and yields PrP 27-30, which forms rod-like 
structures which behave as amyloid (unbranched fibrils, stained with Congo red, 
cross β-pleated sheats). Otherwise, no chemical difference between the two proteins 
has been reported (Stahl & Prusiner, 1991).  
The mechanism of prion replication is not fully understood. There are two models, the 
“refolding” model, in which cellular PrP is folded upon the template of a infectious 
prion (‘heterodimer’ model: Prusiner, 1991) or an aggregate of two or several prions 
(Griffith, 1967), while in the “seeding” model, the infectious prion can be stabilised 
only in a crystal-like structure, the ‘seed’ (Come et al., 1993).  
Neuropathology is regionally highly correlated with the premorbid amount of PrPC. 
Plaques appear relatively late in the course of the disease (DeArmond et al., 1987). 
Although infectious agents of different prion diseases can affect different species, 
prion diseases show a relative ‘species barrier’ in terms of prolonged incubation 
times if moving from one species to another (Stahl & Prusiner, 1991).  
The mechanism of neurodegeneration is not understood yet (Aguzzi & Miele, 2004). 
The debate if PrPSC is toxic at all lead to the idea that there is another toxic form 
called PrP*. Besides, it could be that the toxicity depends on the aggregation state 
(Gavin et al., 2005). Brown and colleagues (1996) found out that presence of 
microglia is needed for neurotoxicity of PrP(106-126), an artificial peptide widely used 
as a model for TSE pathology. TSE’s lead to more oxidative stress and a weaker 
response to oxidative stress (reviewed in Unterberger et al., 2005): Accumulation of 
PrPSC promotes generation of ROS (reactive oxygen species), which upregulates 
PrPC, which in turn leads to more conversion into PrPSC (vicious circle). Besides, 
ROS prevent copper binding to PrPC and lead to higher Cu toxicity. In another paper, 
Brown (2000) found a second pathologic mechanism in prion protein mutated at 
codon 117 (A117V), a mutation found in GSS (Gerstmann-Sträussler-Scheinker 
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Syndrome): This mutation destabilises microtubuli, which leads to toxic Ca-influx into 
the cell over L-type calcium channels. The deposition of neurofibrillary tangles in 
some case of this and other mutations are interpreted as accumulated tau-protein, 
which was not able to bind the microtubuli because of the PrP mutation.  
According to an alternative view, cell death is more related to PrPC isoforms than to 
PrPSC: Hegde and colleagues (1998) found in mice with different PRNP mutations, 
that one of two transmembrane isoforms (see above), ctmPrP (the form in which the 
C-terminal end is in the ER lumen) can confer severe neurodegeneration. In a patient 
died of GSS, they found raised ctmPrP levels but practically no PrPSC. Vincent and 
colleagues (2001) point out the similarities between the metabolic mechanisms in 
APP (amyloid precursor protein) and PrP: Both molecules have two kinds of 
cleavage, an “α”-cleavage leading to neurotrophic products, and a “β”-cleavage 
leading to potentially neurotoxic products [and amyloids]. In both molecules, the α-
cleavage exactly splits up the amyloidogenic part and is done by the same enzymes 
(ADAM10 for constitutional and TACE for PKC-regulated α-cleavage). 
 
 
Human Prion Diseases:  
Incidence is less than 2 per million and year (Unterberger et al., 2005). Approximately 
15% of the cases of human prion diseases are inherited autosomal dominantly, 
whereas most of the cases (about 80%) are sporadic. A small number of cases come 
from accidental inoculation (e.g., iatrogenic: for example through corneal transplants 
or bovine growth hormones; Whittington et al., 1995). A new variant of CJD, “vCJD”, 
is probably caused by infection with bovine prions. 
In sporadic CJD, homozygous 129Met/Met and 129Val/Val (see below) genotypes 
are heavily overrepresented (Palmer et al., 1991); practically all victims of vCJD were 
found to be 129Met/Met homozygotes (Andrews et al., 2003). 
The “diagnostic triad” for CJD consists of (1) dementia, (2) myoclonus and (3) 
abnorm periodic EEG (repeated phases of 1s bi- or triphasic complexes: PSWC = 
periodic sharp wave complexes). Cases with absence of EEG abnormalities AND 
involuntary movements are practically never CJD. Brown and colleagues (Brown et 
al., 1986) evaluated clinical courses and symptoms in a large sample of 230 
pathologically verified patients in France. 4-8% of the cases were familial. Age of 
onset varied between 19 and 83 years, with mean 61.5 years. The mean duration of 
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the illness was 7.6 months, median duration of the illness 4 months. In about one 
third of the patients, there was a prodromal phase with aesthenia and disturbances of 
sleeping and eating patterns. Disease onset was fast or even sudden in 20% of the 
patients. Disease started with dementia in 2/3 of the patients. In 1/3, there were 
motor complaints before onset of dementia. Further symptoms were mainly 
cerebellar: gait disturbance, clumsiness, diplopia, bizarre color perception, 
generalized or hemianoptic loss of vision. In this French population, only 10% of the 
patients survived more than 1 year. However, there were also long-term cases of up 
to 10 years. This was very different in a Japanese population, where the disease 
lasts about twice as long. Rapid onsets correlated with predominantly neurological 
symptoms, and early onset correlated with long disease courses.  
Two independent polymorhisms have been shown to be associated with sporadic 
CJD: The well-known M129V polymorphism in exon 2, and SNP1368 upstream of 
exon 1 (Mead et al., 2001; see Fig. 4). 
 
 
1.3.7.5 Suggested Functions of the Prion Protein in Healthy 
 
We review only functions within the central nervous system. Possibly there are also 
functions in hematopoietic stem cells (Zhang et al., 2006), and in the peripheral 
immune system (Cashman et al., 1990; Diomede et al., 1996).  
 
 
1.3.7.5.1 Astrocytic Glutamate Uptake 
 
Brown and Mohn (1999) have shown that astrocytes lacking PrPC are slower in 
glutamate uptake than wild type cells grown under the same conditions. This is 
important, since glutamate is toxic for neurons. PrPC-lacking cells were also more 
sensitive to H2O2-induced oxidative stress and additionally reduced glutamate 
uptake. Cu2+-ions also reduced glutamate-uptake in PrP-lacking, but not in wild-type 
cells at the chosen concentration. This effect probably acts over oxidative stress by 
enzymatic products of Cu2+. The authors suppose that low Cu2+-levels in PrP-
deficient cells could lead to an ‘internal’ oxidative stress, because protecting enzymes 
like superoxide-dismutase (SOD) need PrPC to work properly. Many conditions like 
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ROS, mercuric chloride, simulated ischemia or hypoxia reduce glutamate uptake by 
astrocytes, which has the potential to lead to neuronal death. Other authors state that 
glia do not express PrPC at all (e.g., Steele et al., 2006). 
 
 
1.3.7.5.2 Neuroprotection 
 
Kuwahara and colleagues (1999) have shown that expression of cellular prion protein 
can rescue mouse hippocampal cells from apoptosis in vitro cells, from which serum 
was removed (compared to comparable cells not expressing PrPC). Besides, 
PRNP0/0 cells extended shorter neurites than PRNP+/+ cells.  
Bounhar and colleagues (2001) replicated and extended this finding. They showed 
that PrPC could prevent Bax-induced apoptosis in human primary neurons in vitro, 
while a PrP with excised four octapeptid repeats, or mutated PrP from families with 
fCJD (T183A, D178N) failed to stop apoptosis. However, cellular PrPC without the 
GPI-anchor signal peptide succeeded in preventing apoptosis. Frigg and colleagues 
(2006) have demonstrated a protective effect against bright light in mouse retinal 
cells. They compared apoptosis through bright light in PrP knockout, wild type, and 
two sorts of PrP overexpressing mice. Whereas the overexpressing mice showed 
practically no retinal apoptosis in a certain luminance condition, wild type mice 
showed little effect, while in knockout mice there was a high amount of apoptotically 
died retinal cells. The authors found out that PrP ultimately influences caspase-1, a 
pro-apoptotic signal molecule. 
 
 
1.3.7.5.3 Metal and Reactive Oxygen Species (ROS) Metabolism 
 
PrPC can bind copper or zinc by virtue of its octapeptide repeat region. Normally the 
Cu concentration is about 16-20μM in the blood, 0.5-2.5 μM in the cerebrospinal fluid 
and about 15 μM in the synaptic cleft. PRNP0/0 mice have been shown to have 
normal Cu-content in the serum, but dramatically reduced Cu-concentrations in the 
brain and synaptosome (16.2μg/g instead of 193μg/g in the brain). Zn-concentrations 
did not differ. That Cu is really bound to PrPC in vivo, has been shown by PrPC 
depletion: It greatly reduced Cu content in wild type, but not in PRNP0/0 mice (Brown 
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et al., 1997a). The function of this is not fully clear, but there are two kinds of models 
(Harris, 2003): An uptake model proposes that PrPC binds extracellular copper to 
deliver it to an acidic endosomal compartment. An efflux model proposes that PrPC 
binds copper in the ER or golgi apparatus and takes it out of the cell. The PrPC 
molecule has been shown to have a very high affinity to bind copper, in a similar 
range as CuZnSOD (superoxide dismutase) (Thompsett et al., 2005). The four most 
affine binding sites are in the octarepeat region at the N-terminal. Copper and zinc 
stimulate PrPC endocytosis in cultured neuroblastoma cells (Pauly & Harris, 1998). 
Brown and colleagues (1999) have shown that cellular PrP shows an encymatic 
activity similar to superoxide dismutase (SOD). Interestingly, they show that PC12 
cells are killed by PrP106-126, a toxic artificial peptide consisting of a stretch of PrP, 
only in the presence of microglia. The authors also review literature showing that 
PRNP0/0-mice are more sensitive to both oxidative stress and copper toxicity. Copper 
promotes enzymatic reactions leading to more ROS (Fenton- and Haber-Weiss-
reaction). Therefore Brown and colleagues (1997b) hypothesize that binding of 
copper to PrPC may increase its activity as an anti-oxidant. Brown and colleagues 
(Brown et al., 1999) hypothesize that a loss of extracellular balance of ROS and their 
products by PrPSC accumulation could be sufficient to cause pathology of prion 
diseases. It has been shown that in neurodegenerative disorders (like AD, TSEs, PD 
or LBD) with increased oxidative stress, PrPC is upregulated (reviewed in 
Unterberger et al., 2005). PrPSC is not able to bind Cu with a reasonable affinity, 
probably because of the altered conformation (Thompsett et al., 2005).  
 
 
1.3.7.5.4 NO-Metabolism 
 
Keshet and colleagues (1999) have shown that scrapie infected mice as well as 
PRNP0/0 mice show abnormal distribution of NOS (Nitric Oxide Synthase), an 
enzyme crucial for NO production. NO, a gaseous free radical, is involved in 
processes such as development, synaptic plasticity, regeneration, and regulation of 
transmitter release. Neuronal Nitric Oxide Synthase (nNOS) was not concentrated in 
the rafts in scrapie infected mice as in PRNP0/0 mice, which lead to reduced NO 
generation in these mice, since rafts are probably used to bring together different 
signal molecules. The authors state that this is the first reported biochemical similarity 
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of scrapie-infected and PRNP0/0 mice. Thus this finding gives a rare hint on loss of 
function. 
NO-metabolism could be important in our context, because NO as a retrograde 
messenger has a role in long term potentiation and therefore probably in memory 
function.  
 
 
1.3.7.5.5 Sleep 
 
Tobler and colleagues (1996) have shown a longer activity-sleep cycle in PRNP0/0 
mice in total darkness than in any other mouse strain. In transgenic mice expressing 
PrP, the length of the activity-sleep cycle was between PRNP0/0 and wild type mice. 
In contrast to the wild type animals, PRNP0/0 mice showed practically no shortening 
of the cycle in total darkness. In light-dark cycling environments, PRNP0/0 mice 
showed more activity in the second half of the night, while wild type animals showed 
more activity in the first half of the night; total activity per day did not differ. Sleep 
architecture and reaction to sleep deprivation was also different: PRNP0/0 mice 
showed a much stronger increase of slow wave activity after sleep deprivation. The 
authors mention a possible analogy to familial fatal insomnia, FFI.  
Later, the same group found that sleep deprivation in PRNP0/0 mice leads to a larger 
increase of slow wave sleep time and that slow wave sleep is more fragmented 
(Tobler et al., 1997). The authors interpret this as a lower habitual sleep pressure, but 
also a less stable sleep control (fragmented sleep is known to lead to attentional 
problems during the day in humans). A further finding was a lower peak frequency of 
theta waves in PRNP0/0 mice on a129Ola background, compared to their wild type 
counterparts (Huber et al., 1999). This finding was paralleled by less exploratory 
behavior (which is accompanied by hippocampal theta) and more quiet waking 
phases in the knockout mice. Besides, the knockout mice showed a higher latency in 
the passive avoidance test despite comparable learning performance.  
In a later paper, both effects (theta peak at lower frequency and more slow waves in 
sleep after sleep deprivation) were shown to occur over the posterior part, but not the 
anterior part of the brain (Huber et al., 2002). The authors state that these effects 
could be due to either changed (inhibitory or serotonergic) neurotransmission or 
changed influence of oxidative stress in these posterior brain areas. 
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Related to the function in sleep is the idea that PrPC has a function in cholinergic 
neurons in general (maybe even in the neuromuscular junction). This idea is based 
on two observations: Most, but not all, cholinergic neurons contain PrPC, and the 
PrPC aminoacid sequence shows similarities to the sequence of chicken 
acetylcholine receptor-inducing activity protein (ARIA) (reviewed in Bendheim et al., 
1992). 
 
 
1.3.7.5.6 Neuronal development and plasticity 
 
Possibly, PrPC could act as a ligand for laminin/the laminin receptor. Rieger and 
colleagues (1997) have shown that PrPC binds the 37-kDa laminin receptor precursor 
(LRP), which is located at the cell surface, at the same binding domain as laminin 
binds the LRP. Additionally, they have shown that scrapie-infection (probably the 
PrPSC accumulation) upregulates the LRP. They conclude that the LRP could act as 
a receptor or coreceptor for PrPC on mammalian cells (see also Gauczynski et al., 
2001). Graner and colleagues (2000) demonstrated that PrP binds laminin and that 
this interaction is important for neuritogenesis of cultured hippocampal neurons. PrPC 
antibodies inhibited cell adhesion. Laser-inactivation of cell surface PrP perturbed 
laminin-induced differentiation and promoted neurite retraction. These findings are 
important for learning, since long term potentiation (LTP) has been shown to depend 
on laminin (Nakagami et al., 2000). 
From the observation that in hamster development (P2) but not in adult hamsters, 
PrPC is found along fiber bundles, there was the idea that PrPC could be involved in 
axonal growth, perhaps as an adhesion protein (Moya et al., 2000). The authors point 
out that this could also explain the (Colling et al., 1997) finding of abnormous mossy 
fiber organisation in PRNP0/0 mice. 
Satoh and colleagues (2000) looked for differential gene expression in prion protein 
deficient as compared to wild type mouse fibroblasts. They found expression of 15 
genes reduced, among these genes important for cell proliferation and adhesion 
(Cyclins, Eps8 receptor tyrosine kinase substrate; Eps8 is an adapter molecule 
linking receptor tyrosine kinases to intracellular factors). In contrast, the expression of 
27 genes, mainly belonging to the insulin-like growth factor-I (IGF-I) pathway, was 
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increased. The authors conclude from these data that PrP is involved in the 
organisation of signalling complexes (like PDGF, EGF, Ras, PI3K and NO). 
Mouillet-Richard and colleagues (1999) found clues that PrP could be involved in 
neuronal differentiation: PrP is not expressed in progenitor cells, but in differentiated 
cells. In their study, they found a differential decrease of 5HT-expressing murine 
1C11 cells shortly after starting to express the main enzyme for 5HT-production, 
while there was no similar decrease in cells committed to be NA-producing cells. 
Later (Mouillet-Richard et al., 2000) they looked for downstream pathways triggered 
by PrPC. They used murine 1C11 undifferentiated and differentiated cells and found 
decreased fyn phosphorylation upon PrPC antibodies in differentiated cells, but not in 
undifferentiated cells. Since the laminin-receptor is found on the surface only, and 
fyn-signalling within the cell, they looked for mediators and found caveolin1α and 1β. 
Caveolin was found in differentiated cells only. Further experiments showed that 
caveolin antibodies really stopped fyn activation. Investigation of subcellular 
localisation of the fyn-activation showed that neurites give virtually the whole signal.  
Alternatively, fyn phosphorylation could have been triggered by NCAM, an abundant 
neuronal adhesion molecule from the immunoglobulin superfamily (Cunningham et 
al., 1987). PrPC binds NCAM in mouse neuronal cells (Schmitt-Ulms et al., 2001). It 
has been shown that NCAM antibodies weaken LTP amplitude (Lüthi et al., 1994).  
Influences of the tyrosin kinase fyn on memory functions were found by Grant and 
colleagues (1992). Ca2+ influx in the postsynaptic cell after LTP activates a cascade 
of different protein kinases, including tyrosine kinases. This cascade leads to a 
release of retrograde messengers, which are thought to enhance transmitter release 
from the presynaptic cell. Inhibitors of tyrosine kinases block LTP, but they are not 
specific enough to show which tyrosine kinases are most important for LTP. Grant 
and colleagues constructed knockout mice lacking one of four nonreceptor tyrosine 
kinases, which all are expressed in the adult mouse hippocampus, but found effects 
on memory just in FYN- mice. These mice showed a higher threshold for LTP 
induction despite normal synaptic transmission (EPSP amplitudes, paired pulse 
facilitation). There was no effect in NMDA-receptor function as tested with voltage 
clamp. The authors suppose that the higher LTP threshold could go with lower Ca2+-
levels, since lower Ca2+-levels have been observed in T-cells of FYN- mice. Possibly, 
NMDA- Ca2+ is not enough to properly trigger LTP, but also Ca2+ from internal stores. 
They also showed more cells and an abnormal morphology in CA3. On the 
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behavioral level, they showed practically abolished spatial learning in the Morris 
water maze (see Figure 21) despite normal single cue learning. In test trials, FYN- 
mice spent not more than ¼ of the time in the target quadrant (chance level). 
 
  
 
Figure 21: escape latencies over learning runs on consecutive days in the Morris 
water maze (from Grant et al., 1992) and abnormal cross-sections in fyn-- compared 
to wild type mice 
 
Schneider and colleagues (2003) showed an influence of PrPC over PKC on NADPH 
oxidase, MEK (Mitogen-activated protein kinase kinase) and ERK 1/2 (Extracellular 
Regulated Kinases 1/2), which are important for reactive oxygen species (ROS) 
production and cell-redox homeostasis in general. In differentiated neurons, this 
pathway was triggered by caveolin and fyn, but there was also another pathway 
acting on ERK 1/2, possibly over Grb2->ras-> raf on MEK and ERK 1/2 (Figure 22). 
The ERK’s have been shown to be involved in important functions as cell survival 
and proliferation.  
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Figure 22: Pathways triggered by PrPC in nonneuronal and neuronal undifferentiated 
(left) and neuronal (right) cells; (from Schneider et al., 2003) 
 
Kanaani and colleagues (2005) have shown an effect of recombinant prion protein 
recPrP on embryonic rat hippocampal neurons in vitro. There was a five-fold increase 
in axonal length and a 4.6-fold increase in synaptic-like contacts after 7 days of 
exposure to recPrP, an artificially refolded PrP similar to PrPC (high α-helix-content). 
Inhibitors of protein kinase C (PKC) and of Src kinases (e.g. p59Fyn) blocked the 
effect of recPrP on axon elongation, while inhibitors of PI3-kinase showed a partial 
inhibition. This could mean that these pathways are responsible for the action of PrP 
on axonal growth. The effect was specific in that N- or C-terminal parts or the Dpl-
protein did not have an effect.  
Steele and colleagues (Steele et al., 2006) looked for neuronal development in 
proliferating zones (dentate gyrus in hippocampus and subventricular zone) in cells 
differing in PrPC expression (PRNP0/0, wild type and overexpressing cells) and found 
rising concentrations in adult cells compared to progenitor cells. Cells overexpressing 
PrPC showed earlier differentiation and proliferation, but in the end cell numbers were 
comparable between PRNP0/0, wt and overexpressing cells. The authors conclude 
that PrPC is a sort of ‘commitment switch’ for neurons. 
 
A new paper could possibly link several functions reviewed here: Nieznanski and 
colleagues (2006) found that cellular PrP is able to inhibit tubulin oligomerization, 
probably by direct binding (Nieznanski et al., 2005). Tubulin is main component of 
microtubules. Build-up and destruction of microtubules by polymerisation and 
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oligomerisation is a sensitive process (Nogales & Wang, 2006), which is very 
important for synaptic plasticity, and possibly late LTP. 
 
 
1.3.7.5.7 Neurophysiology and Learning  
 
Collinge and colleagues (1994) recorded electrical activity of hippocampal cells from 
normal and PRNP0/0  mice and found weakened GABAA-receptor mediated IPSP and 
impaired long-term potentiation. The EPSP amplitude in null mice decreased very 
fast. The authors propose that abnormal clustering of GABAA-receptors (farther from 
the synapse) lead to abnormal IPSP, which lead to NMDA-receptor overactivation, 
which impairs normal LTP. 
Manson and colleagues (1995) have confirmed impaired or abolished LTP in 
PRNP0/0  mice and even shown a gene dose effect, in that heterozyguous PRNP+/- 
mice, which have reduced PrPC in the brain, show also an LTP impairment with weak 
LTP or even only “short time potentiation” (STP, Figure 23). 
 
 
 
Figure 23: Impaired LTP in PRNP0/0 mice; the table shows impairment even in 
heterozygous mice (from Manson et al., 1995) 
 
Whittington and colleagues (1995) have shown that this deficit can be rescued with 
an appropriate concentration of a human PrP transgene. 
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Other groups did not find any electrophysiological differences between wild type and 
homozygous PRNP0/0 mice (Herms et al., 1995 [Purkinje cells]; Lledo et al., 1996 
[CA1]). 
Another study showed different granulation and mossy fiber sprouting in gyrus 
dentatus and CA3 in PRNP0/0 mice, combined with smaller electrophysiological 
excitability in terms of lacking superimposed population spikes (Colling et al., 1997). 
The authors explain the smaller excitability with a downregulation to prevent epileptic 
activity, which could arise of the unfavorable cellular architecture similar to the 
architecture seen in human epileptics or in kainic acid lesion models of epilepsy in 
animals. 
Mallucci and colleagues (2002) constructed conditional PRNP0/0 mice to test effects 
of post-birth knockout on neurophysiological measures. The mice stopped to produce 
PrP 10 weeks after birth and were greatly normal. Like PRNP0/0 mice, they showed 
reduced slow and medium after-hyperpolarisation (AHP) in CA3. A PrP transgene 
rescued this phenotype. In both types of mice, there were no signs of 
neurodegeneration. As a mechanism, they propose a PrP influence on fyn-signalling 
(see below or Mouillet-Richard, 2000), which could influence Ca2+-dependent K-
channels to reduce after-hyperpolarisation. The authors state that these 
neurophysiological differences are similar to those observed in scrapie. However, 
loss of normal function of PrPC does not seem to be the reason for the disease. 
Maglio and colleagues (2004) found a lower threshold for LTP in dentate gyrus 
preparations of 3-4 months old mice. By in situ localisation, they found a higher 
expression of NMDA NR2A and NR2B receptor subunits, which could possibly 
account for the higher excitability of the dentate gyrus neurons. In a recent paper 
(Maglio et al., 2006), they confirmed a lower threshold for LTP generation in aged (9 
month old) mice. In addition, LTP persisted longer in aged knockout mice than in 
aged control mice. The authors state that this gives a hint that prion protein could 
serve the regulation of synaptic transmission, and that a normal downregulation 
during aging does not take place in knockout mice. They say that a higher plasticity in 
aged mice not necessarily parallels better learning, since higher excitability could 
lead to a saturation effect. Besides, the higher excitability could result from an 
impaired GABA-ergic inhibition (see Collinge et al., 1994).  
In a study with mice of two different genetic backgrounds, a selective spatial learning 
deficit could be rescued by introduction of hamster PrP (Criado et al., 2005). On a 
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neurophysiological level, they found a weaker paired-pulse facilitation and LTP. Both 
effects could be at least partly restored with hamster PrP. 
 
 
1.3.7.6 The Met129Val Allelic Variant 
 
There are two variants per allele: Methionine (Met, coded by ATG) and Valine (Val, 
coded by GTG). 129Met is the ancestral allele, 129Val is found in humans exclusively 
(Schaetzl et al., 1995). The polymorphism is found in a short β-sheet (Schätzl, 2001). 
The normal population has a frequency of 37% Met/Met, 51% Val/Met and 12% 
Val/Val (Palmer et al., 1991).  
Studies have shown that the Met-allele has a higher propensity to form β-sheet 
structures in artificial peptides (Petchanikow et al., 2001) and in the native human 
protein (Tahiri-Alaoui et al., 2004).  
In a large sample, Val/Val carriers had lower MMSE scores at the age of 65 years, 
compared to age- and gender-matched Val/Met or Met/Met-groups (Berr et al., 1998). 
Val/Met versus Met/Met-carriers did not differ. The effect was similar like the effect of 
APOE ε4 and was independent from the APOE-effect. The authors do not list 
differences in subtests. A similar effect was found in another large-sample study 
(Croes et al., 2003): Homozygous Val/Val carriers showed earlier cognitive decline in 
MMSE scores, namely at an age around 60. At later age (after 65), cognitive declines 
were comparable among genotypes. 
Rujescu and colleagues (2002) report reduced whole brain white matter volumes and 
larger volumes in schizophrenic or healthy Met/Met carriers relative to Val/Met or 
Val/Val carriers. However, they do not list data on the healthy subjects alone. 
Besides, Met/Met carriers were significantly older than the Val/Met-Val/Val group. 
In a large randomly selected German sample (n=335), Rujescu and colleagues 
(2003) found higher scores of Val/Val carriers than Val/Met or Met/Met carriers in 
HAWIE intelligence scores (Val/Val: 117.4(SD14.4); Val/Met: 112.2(14.1); Met/Met: 
110.9(15.2)). These came from broad advantages in verbal and performance 
subtests, most prominently in the digit symbol test, which relies on working memory 
and executive function. 
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Differential expression: 
Garmy and colleagues (2006) have observed differential expression of human 
valPrPC or metPrPC in intestinal epithelial cell lines. For example, in HT-29 cells, only 
metPrPC RNA was found (the authors do not mention how this would be possible in 
Val/Val homozygous individuals). The authors stress the importance of their findings 
for disease, since cells containing the Met allele seem to be required for the 
generation of infectious prions (Wadsworth et al., 2004), and intestinal epithelial cells 
could be a first target for infection with PrPSC (Morel et al., 2005), so these cells could 
promote prion spreading. 
 
Influence on memory: 
Papassotiropoulos and colleagues (Papassotiropoulos et al., 2005) found better 
memory for words in a 24h-recall in young, healthy carriers of at least one 129Met 
allele (129MM: n=159 and 129MV: n=151) compared to 129VV carriers (n=44), but 
not in immediate or 5min recall. This result was observed in two independent 
(academic vs non-academic) groups. The paper in the center of this dissertation tried 
to replicate this finding in an indirect way with fMRI, to constrain more precisely when 
it starts, and to find hints where it comes from. 
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Abstract 
There are large inter-individual differences in memory abilities. A considerable part of 
these differences could be explained by genetic variability. An earlier behavioral 
study (Papassotiropoulos et al., 2005) has shown that the prion protein Met129Val 
polymorphism interferes with word retrieval after a 24 hours time lag. We tried to 
replicate this finding in an event related fMRI study with three genotypic groups 
(Met/Met, Val/Met, Val/Val), which were carefully matched for sex, age, education, 
other memory-related genes and performance in episodic memory. We found greater 
fMRI activation during word recognition in Val-carriers compared to Met-carriers both 
30 minutes and 24 hours after learning of a word list, despite matched performance. 
In addition, correlations between fMRI activations and recognition performance were 
rather positive in Met-carriers and rather negative in Val-carriers. We interpret our 
results as a lesser memory performance in Val-carriers than in Met-carriers. 
Independently from the fMRI results, we found higher grey matter densities in wide 
parts of the brain in Val-carriers. These differences point to a role not only of the 
prion protein, but also of the Met129Val polymorphism in neuronal plasticity at a time-
scale of minutes to hours.  
 
Introduction 
While estimations from twin studies indicate that about 50% of individual differences 
in memory performance can be explained by genetic factors (McClearn et al., 1997), 
little is known about which genes influence memory in healthy individuals. Probably 
effects of single genes are very small, and virtually any genetic variant involved in 
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CNS function could lead to differences in memory performance. From about 3-6 
million single base pairs differing within the human genome (‘Single Nucleotide 
Polymorphisms’ or SNP’s), some 100000 are estimated to influence CNS functions 
(Goldberg and Weinberger, 2004). Another problem is that found associations can 
not directly be proven to be causal in humans, since polymorphisms can be linked to 
other polymorphisms (‘linkage disequilibrium’), so it can hardly be decided which 
variant confers the measured difference. Goldberg and Weinberger (2004) propose 
strategies to circumvent these problems: (1) Knowledge-based selection of few 
candidate genes instead of testing every gene; (2) replicating results with different 
methods or accounts and (3) confirming results with independent populations. 
Studies using this research strategy isolated important genes in two different 
domains: Genes directly involved in neurophysiology (for example the gene encoding 
the serotonin 2A receptor; de Quervain et al., 2003) or genes involved in diseases 
affecting the CNS (for example the apolipoprotein E gene, which is a risk gene for 
Alzheimer’s Disease; Bookheimer et al., 2000).  
The actual study investigated the Prion Protein Gene (PRNP) involved in all mammal 
prion diseases like Bovine Spongiform Encephalopathy (BSE) in cows or Creutzfeldt-
Jakob Disease (CJD) in humans. The infective agent, the ‘prion’ (Prusiner, 1982) has 
practically the same aminoacid sequence as a cellular gene (the PRNP gene) (Oesch 
et al., 1985). Its product, the prion protein (PrP) is found predominantly in synaptic 
membranes (Moya et al., 2000) throughout the brain, at the highest concentrations in 
the hippocampus, septal nuclei and in the nucleus caudatus (Bendheim et al., 1992). 
In some cells prion protein is also found in the cytosol, but it is unclear in what kinds 
of cells and why (Mironov et al., 2003). However the normal protein, termed PrPC (C 
for ‘cellular’) and the infective protein, PrPSC (SC for ‘scrapie’) differ in their 
secondary structure: PrPC consists of about 40% α-helix and little β-sheet, PrPSC of 
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about 30 % α-helix and 45% β-sheet (Prusiner, 1998). PrPSC seems to be the 
dominant form and to replicate by refolding PrPC into PrPSC. As a consequence, 
PrPSC is much more prone to aggregate to amyloid structures. The influence of this 
differential folding on the pathologic process is not understood yet. 
Studies in Aplysia have shown that a similarly switching protein, the ‘cytoplasmic 
polyadenylation element binding protein (CPEB)’ helps to stabilize long term 
memories (‘long term facilitation’ (LTF); Si et al., 2003a, b). In vitro, only CPEB 
aggregates were able to bind CPE, while the soluble form was not. CPEB has also 
been found in humans. Shorter and Lindquist (2005) point out that this mechanism 
could nicely explain how molecular memory traces can persist longer than the 
molecules involved. However to our knowledge there are no data about this 
mechanism in other species than Aplysia. 
Studies with PRNP knockout mice also point on an influence of PrP on memory 
functions: Lacking PrP strongly shortens long term potentiation (LTP; Collinge et al., 
1994; Manson et al., 1995; Whittington et al., 1995; Criado et al., 2005; but see 
Herms et al., 1995; Lledo et al., 1995), the cellular basis of long term memory 
(Whitlock et al., 2006; Pastalkova et al., 2006). Maglio and colleagues (2004; 2006) 
found a lower threshold for LTP induction in PRNP knockout mice, which was 
probably due to differential NMDA receptor subunits composition. One study found a 
spatial learning deficit in PRNP knockout mice, which could be rescued with hamster 
PrP (Criado et al., 2005). 
In young, healthy humans a common ATG (Met) to GTG (Val) substitution at codon 
129 has been shown to influence long term memory: In two large independent 
samples (academics and non-academics), Papassotiropoulos and coworkers (2005) 
showed a lower performance of Val/Val carriers in free recall of words 24 hours after 
learning, with comparable performance at immediate recall and recall after 5 minutes. 
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We planned the present study to replicate and refine this finding with fMRI and to 
learn whether different brain networks are involved during recognition of single words 
learned 30 minutes or 24 hours ago. We introduced a new interval of 30 minutes to 
determine if the genetic differences have rather to do with overnight consolidation 
effects or with classical late LTP. Since studies showed that LTP faded in this time-
scale in knockout mice (see e.g. Collinge et al., 1994), we expected to see 
differences in recognition-related fMRI activation already in the 30 minutes condition.  
We followed the logic of earlier studies (Bookheimer et al., 2000; Bondi et al., 2005; 
Mondadori et al., 2006) to match memory performance between groups and to 
interpret differences in recognition-related fMRI activation in terms of cognitive effort 
to reach the same memory performance (memory performance was not treated as a 
dependent variable). This led us to the following hypotheses about carriers of the 
different Met/Met Val/Met and Val/Val combinations: 
(1) the more Val alleles, the more activation during word recognition 
(2) the more Val alleles, the more negative correlations and less positive correlations 
between fMRI activation and performance level within group.  
(3) because the prion protein is expressed strongest in hippocampus, striatum, 
septum and olfactory bulb, but less in frontal/ parietal areas (Bendheim et al., 1992), 
we do not expect significant activation differences in a working memory task 
(4) standardized neuropsychological tests of memory (which has been matched in 
our groups), verbal abilities, intelligence and executive functions do not differ 
between groups of young prion 129 Met/Met Val/Met and Val/Val genotype carriers  
(5) local differences in grey matter concentration or whole brain volume differences 
could be found, since differences in the structure of single brain areas have been 
observed in knockout mice (in the dentate gyrus and CA3 of the hippocampus: 
Colling et al., 1997) and prion protein has been found to be expressed widely during 
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axonal growth (Salès et al., 2002), which could influence the global brain structure; 
however, we are not able to predict the direction of possible differences, because we 
do not know if or how the Val or Met alleles differentially influence neuronal growth.  
 
Methods 
Subjects 
From 46 subjects who passed the fMRI experiment, 5 had to be excluded (2 because 
of too much motion in the scanner, 3 because of excessive repetition of the words 
learned on day 1). From the 41 remaining subjects, 36 were chosen for the study, 
yielding equal groups of 12 subject of each genotype (Met/Met, Val/Met, Val/Val; 
mean age 23.2 (SD 2.0) years; 7 female in each group). The subjects reported no 
psychiatric or neurological problems and denied taking illegal drugs or prescription 
medication. All subjects gave written informed consent to participate in the study. The 
experiments were approved by the ethics committee of the Kanton Zurich. 
 
Matching 
Groups were matched for age, years of education, apolipoprotein E (APOE) 
genotype and serotonin-2a receptor genotype (de Quervain et al., 2003), Kibra 
genotype (Papassotiropoulos et al., submitted) and behavioral performance in the 
episodic memory experiment in terms of number of correct ‘Remember’ answers in 
the 24h condition (Table 1). Behavioral performance in the fMRI task is not treated as 
a dependent variable of the study, and imaging data were evaluated only after having 
completed the matching procedure. Performance matching is important since 
activation depends on performance (McDermott et al., 2000; Meltzer and Constable, 
2005), and we did not want results to be confounded with performance effects. 
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Experimental Procedure  
Subjects underwent a neuropsychological examination in advance of the main 
experiments. The experimental session was conducted on two consecutive days at 
the same time of day (Figure 1). On day 1, subjects had to learn a first list of words, 
followed by a free recall; the rest of the experiment was conducted on day 2. On day 
2, subjects first learned a second word list. Then they practiced the working memory 
task. Then they moved into the scanner. After the survey images, they were 
instructed about the recognition task. Then they underwent the recognition task, in 
five big time-series of 7 min 15 s. Then they underwent the working memory task. In 
the end of the session, the anatomical images were obtained. Total scanning time 
was 59 minutes plus brakes. After moving out of the scanner, subjects had to answer 
a structured interview.  
 
fMRI Experiment on Word – Recognition 
Subjects had to learn two lists of 50 verbs with the instruction to form a sentence with 
autobiographical content for each verb. The two lists were learned 24h 30min (day 1) 
and 30min (day 2) before the recognition test. To match the percentages of correctly 
recognized words between time lags, an additional instruction was administered on 
day 1: The experimenter read the sentences to the subjects, giving only the first two 
phonemes of the verb, and the subjects had to retrieve the verb. If they did not 
respond within 3 seconds, the experimenter said the verb. After the learning phase, 
subjects had to recall as many verbs as possible within 5 minutes. Subjects were not 
told that they had to remember the learned verbs after the free recall to avoid 
rehearsal between study-phase and test-phase (this was checked in the structured 
interview). 
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The total of 300 items (50 old words learned 24 hours ago, 50 words learned 30 
minutes ago, 100 foils, 50 letter strings, 50 null trials) were presented in 6 time-series 
of 50 items in pseudorandom sequence (same sequence for all subjects) in a fast 
event related design. Mean inter stimulus interval was 8.82s, with a pseudo-random 
jittering of up to 2.5s to safely sample the whole length of the hemodynamic response 
function. Stimuli were presented with Presentation (http://nbs.neuro-bs.com).  
Each trial started with the word or letter string, presented for 2000ms, followed by a 
fixation cross for 6820ms plus or minus the pseudorandom jittering of up to 2.5s 
(range: 4320 to 9320ms). Each time series took about 7 min 15 s. To control for the 
liveliness of the recollection of the verbs, we used Tulving’s Remember / Know 
operationalisation (Tulving, 1978): Subjects were instructed to indicate recognition in 
terms of ‘Remember’ (full, lively recollection including context knowledge), ‘Know’ 
(mere familiarity) or ‘New’ (Tulving, 1985). For the nonwords, subjects had to 
compare the first and the last letter and to indicate ‘Identical’ for same letter in same 
case (e.g. bxxxb or BxxxB), ‘Same’ for same letter with different cases (Bxxxb) or 
‘Different’ for different letters (Bxxxc or bxxxc). Responses were collected with a 
response box that subjects held in their dominant hand. 
 
fMRI Experiment on Working Memory 
The experiment included one fMRI time-series with a 2-back task for the assessment 
of working memory and a baseline task (‘x-target’). Stimuli were presented block-
wise, in 5 alternating blocks of 13 stimuli per condition. Blocks were announced by an 
instruction slide.  Instruction slides were shown for 3s, stimuli for 1.845s, adding to 
27s per block. The 2-back task required subjects to respond to a letter repeat with 
one intervening letter (e.g. S – f – s – g). The ‘x-target’ task required subjects to 
respond to each letter ‘x’ (Mondadori et al., submitted).  
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Materials 
Stimuli were concrete, frequent, easily imaginable verbs. Most of them were drawn 
from a German handbook of word norms (Hager and Hasselhorn, 1994). From these 
verbs we built 4 lists of 50 verbs carefully matched for word length, semantic content, 
and normative ratings of imaginability, concreteness and valence. These 4 lists were 
used for all subjects. The lists learned on day1 / day2 were counterbalanced to avoid 
list effects on the delay conditions. Nonwords were 100 consonant strings matched to 
the verbs in length. Stimuli were written white on black in Arial bold 72pt letters (the 
letters covered an angle of 0.87x0.65°). For the working memory experiment, stimuli 
were 50 upper- or lowercase letters typed in black on a white background (viewing 
angle 4.4x3.3°). 
 
MRI Data acquisition 
MR measurements were performed on a 3T Philips Intera whole body MR scanner 
equipped with an eight-channel Philips SENSE head coil. Functional data were 
obtained from 32 transverse slices (without interslice gaps) parallel to the AC-PC 
plane covering the whole brain with a measured spatial resolution of 2.8 x 2.8 x 4 
mm3 (acquisition matrix 80 x 80) and a reconstructed resolution of 1.7 x 1.7 x 4 mm3. 
Data were acquired using a SENSE-sshEPI (Schmidt et al., 2005) sequence with an 
acceleration factor of R = 2.0. Other scan parameters were TE = 35 ms, TR = 3000 
ms, θ = 82°. A standard 3D T1-weighted scan was obtained for anatomical reference 
with a measured spatial resolution of 1 x 1 x 1.5 mm3 (acquisition matrix 224 x 224) 
and a reconstructed resolution of 0.9 x 0.9 x 0.8 mm3, TE = 2.3 ms, TR = 20 ms, θ = 
20°.  
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fMRI Data Analysis 
Image pre- and postprocessing and the statistical analyses were performed with 
SPM2 (http://www.fil.ion.ucl.ac.uk/spm). Standard preprocessing procedures were 
applied, realignment, normalization and spatial smoothing (7 mm Gaussian kernel) 
(Friston et al., 1995a). On the single subject level, data were analyzed according to 
the fixed effects model (SPM2). The six head movement parameters were included in 
the model as confounding factors. Data were high-pass filtered with a standard filter-
value of 128s, which corresponded nicely to the rule of thumb ‘2 times maximal 
stimulus onset asynchrony times TR’. On the second level, within-subject contrasts 
were entered into random effects analyses (ANOVAs and T-tests, SPM2) which 
account for variance between subjects (Friston et al., 1995b). We also computed 
correlations between the within-subject recognition contrasts and behavioral 
measures (simple regression, SPM2). Thresholds were set at a p < 0.001 level, 
uncorrected for multiple comparisons. We chose an extend threshold of 12 voxels, 
with the exception of the hippocampus, where we report also smaller activations of at 
least 5 voxels (because of the high a priori probability to be involved in episodic 
memory, and the small volume of this structure).  
 
Anatomical MRI Data Analysis 
Based on the 3D-T1-weighted structural MRI images, group differences were 
computed with optimized voxel based morphometry (VBM) (Ashburner and Friston, 
2000; Good et al., 2001) with a Matlab-Script in SPM2 (http://dbm.neuro.uni-
jena.de/vbm.html), which compares voxel-wise comparisons of grey-, white-matter or 
liquor probabilities between groups. The procedure yields whole-brain grey-, white-
matter and liquor volumes as a by-product. 
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ANOVAs with PRNP genotype as independent variable and head size as covariate 
were computed to determine group differences in brain volumes. Thresholds were set 
at p<.05 for whole brain data and at p < 0.001 for probability maps (considered were 
only spots of 100 voxels or more to reduce false positives; analogous to the minimal 
volume of 12 voxels in functional data; for the hippocampus, 40 voxels or more), not 
corrected for multiple comparisons. Head size was considered as a covariate of no 
interest (ANCOVAs) to avoid possible bias for head sizes in the normalization 
process used in the VBM procedure. 
 
Neuropsychology 
Memory functions were assessed with the “Verbaler Lern- und Merkfähigkeitstest” 
(VLMT, German version of Rey Auditory Verbal Learning Test; Helmstädter et al., 
2001), and the subtests “visuelle Paarerkennung” (visual pair associate) and “verbale 
Paarerkennung” (verbal pair associate) of the Wechsler Memory Scale Revised 
(Härting et al., 2000), German version. Intelligence was measured with the subtests 
“Zahlennachsprechen” (digit span), mosaic test and “Gemeinsamkeiten finden” 
(abstract thinking) of the Hamburg Wechsler Intelligence Test (Tewes, 1991), and the 
vocabulary test MWT-B (Mehrfachwahl-Wortschatz-Intelligenztest; Lehrl, 1999). 
Executive functions were assessed with the Stroop Test (Stroop, 1935), which 
measures the suppression of interference. Data were evaluated with ANOVAs and T-
Tests. Thresholds were set at p<.05, not corrected for multiple comparisons.  
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Results  
Neuropsychology 
The performance-matched groups did not differ significantly in all standardized 
neuropsychological tests of memory, verbal and figural intelligence, vocabulary and 
executive function (Table 2).  
 
Performance in fMRI Tasks 
The genotype groups did not differ significantly in performance, neither in number of 
correct answers, nor in reaction times (Table 3). This held true not only for number of 
correct ‘Remember’-answers in the 24h recognition task (matching), but also for free 
recall and 30min recognition task. Numbers of ‘know’ answers misses and false 
alarms were relatively low, but also comparable between groups. Performance 
between time intervals (30min/ 24h) was comparable (e.g. Correct Remember 
answers p=.528 in the sample pooled for genotypes; n=36). 
The baseline task showed a roof effect (most of the subject reached the maximum); 
reaction times did not differ significantly as well. The same held true for the baseline 
of the working memory task (‘x-target’). Performance in the working memory (‘2-
back’) task did not differ significantly between genotype groups.  
 
fMRI Results: Pooled Sample 
In the recognition task, the event-related design allowed us to differentiate between 
activations in correctly recognized items from activations in falsely recognized items 
(false alarms). The study was designed to obtain a high number of ‘remember’ 
answers. This allowed us to have a purer measure of episodic memory. On the other 
hand, there were not enough ‘know’ answers to be analyzed separately, so we 
included only ‘remember’ answers in the evaluated contrasts. One-sample t-tests 
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with the whole sample (n=36) yielded reasonable activation patterns of the 
recognition conditions over the low-level letter baseline task: Activation in recognition 
(both ‘Remember 30 min ’ and ‘Remember 24 h’) trials significantly exceeded the 
letter string baseline task in frontal areas (Brodmann’s Areas BA 47, 10, 9, 8 and 6), 
caudate, middle temporal gyrus, angular/supramarginal gyrus and posterior 
cingulate, predominantly on the left side (due to the verbal nature of the task). In the 
inverted contrast, activation spots were located in frontal areas (BA 44, 45, 46 and 6), 
the thalamus, in all temporal gyri, insula, parietal areas (BA 1 and 7) and in the 
inferior occipital gyrus (BA19). Frontal activations were often right-lateralized, the rest 
spread on both hemispheres.  
With false alarms as a higher-level baseline, activations were much more 
symmetrical to the midline (Tab. 4). Frontal activations were confined to the 
dorsolateral prefrontal cortex (BA 8, 46), because the contrast reflects retrieval 
success. There was a more wide-spread activity in the temporal lobes bilaterally, 
including the parahippocampal gyrus (BA 28 right, 36 left). There were activations in 
the angular/ supramarginal gyri on both sides (BA 39, 40). Inverted contrasts showed 
practically no activations, except the inferior frontal gyrus (BA 11 right) if compared to 
the 24h-recognition condition, probably showing a higher retrieval effort in items 
misclassified as old.  
The working memory task (2-back task) compared to a simple ‘x-target’ baseline 
showed activation pattern in a fronto-parietal network (BA 47 and 7 bilaterally, BA 10 
and 19 left; see Table 3, Figure 1), the inverted contrast showed activations in BA 11 
left, insulae bilaterally, the parahippocampal gyrus bilaterally and precentral and 
postcentral gyrus. The parahippocampal activations in the very easy baseline task 
relative to the more demanding working memory task could be seen as a ‘wandering 
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mind’ phenomenon of the subject freely remembering things that are not demanded 
by the task (Stark and Squire, 2001).  
 
fMRI Results: Genotype Effects 
We calculated ANOVAs between genotype groups (Table 5, Figure 2). ANCOVAs 
with performance (in terms of hits minus false alarms) as a covariate yielded 
qualitatively similar results (not shown). Areas activating in relation to recognition 
success can be seen in the correlations (supplementary Table S2, Figure 3). 
Carriers of one respectively two Val alleles consistently showed more activation in a 
dose-dependent manner (Val/Val > Val/Met > Met/Met; Table 5, Figure 2). This effect 
can be seen in both the 30min and 24h conditions (slightly more consistent in the 
30min condition) and with both false alarms and the letter task as baseline. There 
was no evident localisation of these differences; they were situated in all areas 
involved in retrieval effort or retrieval success. During False Alarms, Met carriers 
activated more than Val carriers, also in a dose-dependent manner. Most of these 
activations were situated in the right hemisphere. Comparisons between 
homozygous (Met/Met and Val/Val) versus heterozygous (Val/Met) carriers showed 
few significant differences, so the effects have to be seen as the additive influences 
of the Val-allele rather than effects of homozygosity versus heterozygosity. 
Correlations of retrieval success activation (Remember-answers over False Alarms) 
with recognition performance showed an impressive dissociation: While Met/Met and 
Val/Met carriers showed either no or positive correlating spots (more prominently 
30min after learning), Val/Val carriers showed far more negative correlations, which 
means the higher the activation of a subject in such a region, the worse the 
performance compared to other persons of the same genotype group (supplementary 
Table S2, Figure 3).  
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In the working memory task, Val/Met carriers showed slightly more activations in the 
right frontal / temporal lobe than the two extreme groups (Table 5). This group 
showed also more positive correlations of activation with retrieval success 
(supplementary Table S2).  
 
sMRI Results: Genotype Effects 
In our sample, whole brain volumes for grey matter, white matter and cerebrospinal 
fluid were comparable between prion protein subgroups, with a small tendency for 
smaller brains in Val/Val carriers (Table 6).  
We also compared local maps of grey matter probabilities (Voxel Based 
Morphometry (VBM); Ashburner and Friston, 2000) between genotype groups. We 
chose parameters as closely analogous as possible to the functional ones. 
ANCOVAs with head size as covariate (ANOVAs yielded very similar results, data not 
shown) showed higher grey matter probabilities in Val carriers in wide parts of the 
brain, in a dose-dependent manner. This seems to go parallel with the functional MRI 
results. However, the most significant spots are situated in very different areas 
(Figure 4). To control for the influence of such partial volume effects, we conducted 
voxel-wise ANCOVAs with grey matter densities as covariate (BPM: Casanova, 
2006). Some activation spots changed, but the overall pattern of Val overactivation 
relative to Met carriers persisted (data not shown).  
 
 
Discussion 
Exploration of the influences of single genes or genetic polymorphisms on a cognitive 
function goes in two steps (Ramus, 2006): (1) Candidate genes have to be found and 
replicated by showing that carriers (humans or animals) of different genetic variants 
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differ systematically in the function of interest. This is called the ‘top-down’ step, 
because it leads from the level of a whole brain or organism to the genetic level. (2) It 
has to be shown how the genetic variant influences the function, which is much more 
difficult, because it leads us ‘bottom-up’ through several levels from the gene over 
protein expression levels and cellular functions and functions of whole organs to the 
level of the whole brain or organism. 
In our example, the study of Papassotiropoulos and colleagues (2005) was dedicated 
to the first step: It found a lesser performance in PRNP M129V carriers in word 
retrieval 24 hours after learning, but not five minutes after learning. This result pattern 
was found in two independent samples (students and trainees) containing 240 and 
114 individuals. The actual study had two aims: First, we wanted to replicate the 
behavioral results by different means, and second, we looked out for potential 
mechanisms using functional MRI and structural MRI and broader 
neuropsychological measures than in the Papassotiropoulos’ (2005) study. In 
addition, introducing a new 30 minutes retrieval condition should help to narrow the 
time window of the effect. The replication belongs to step (1) cited above, but the 
study can possibly also say something about the mechanisms (2), since brain 
imaging may be nearer to genetics than behavior. 
Hypotheses (1) and (2) cited in the introduction are a translation of the behavioral 
findings of the Papassotiropoulos’ et al study into an fMRI setting. We followed the 
logic of earlier studies (Bookheimer et al., 2000; Bondi et al., 2005; Mondadori et al., 
2006) and compared fMRI activations during memory tasks (in our case, word 
recognition) in genetic groups with matched performance in the task. Consequently, 
we matched not only for performance and other genes implicated in memory 
processes (Table 1), but tried also to control for the phenomenological quality of the 
recognition by using Tulving’s Remember-Know differentiation (Tulving, 1972), which 
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introduces a criterion for the liveliness of a memory representation, namely if 
contextual features of the situation can be retrieved, which is a feature of episodic as 
compared to semantic memory. Under this condition, we interpret (1) stronger and 
more wide-spread fMRI activation during recognition of words and (2) more areas 
with negative instead than positive correlations between fMRI activation and 
recognition performance in terms of more difficulty of a person to reach the same 
memory performance level, and therefore less capacities of his/her memory system. 
Using this strategy, we found a clear cut result pattern: During recognition of words 
learned both 30 minutes or 24 hours 30 minutes earlier, (1) individuals with more Val 
alleles of the PRNP Met129Val polymorphism showed more activity than individuals 
with less Val alleles (i.e. more Met alleles; Figure 2; Table 5) and (2) individuals with 
more Val alleles showed more negative correlations and less positive correlations 
between fMRI activation and recognition performance (hits minus false alarms; 
Figure 3; supplementary Table S2) than individuals with less Val alleles. We interpret 
these additional increases in blood oxygenation in Val carriers, which are not 
associated with increased, but with reduced recognition performance, in terms of an 
unsuccessful effort to overcome weaker memory skills (Figure 5). In this light, our 
study replicates the cited behavioral findings in two large samples with different 
methodology. However, our effect gets continuously stronger with rising number of 
Val alleles and is not only found in homozygous Val/Val carriers. 
 
 
Given this finding of reduced memory performance of PRNP 129 Val carriers as 
compared to Met carriers, we now try to speculate about the mechanisms in the light 
of the actual study and the fast-growing literature on the prion protein. We will do this 
in four steps: First we will review some findings about the prion protein Met129Val 
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polymorphism. Second, we will try to choose which biological memory mechanisms 
are likely to occur in the same time window as our observed results. Third, we will 
speculate about the functional specificity of the observed genotypic differences. And 
fourth, we review some additional findings in the light of the actual study. 
The Met129Val substitution is the most-studied single nucleotid polymorphism (SNP) 
of the prion protein gene. 37% of caucasian populations carry the Met/Met-
combination, 51% Val/Met and 12% Val/Val (Palmer et al., 1991). Met seems to be 
the ancestral allele, while Val was found in humans exclusively (Schaetzl et al., 
1995). It has been shown that metPrP has a higher propensity to form β-sheets than 
valPrP (Tahiri-Alaoui et al., 2004), which promotes the formation of amyloid 
structures. This polymorphism has a profound influence on the risk to develop CJD-
symptoms: Heterozygous Val/Met carriers are strongly underrepresented in affected 
cases (Mead et al., 2001). Studies about differences in healthy carriers of the 
different alleles are rare: It would be very useful to have experiments with knock-in 
mice, but to our knowledge such studies do not exist. 
We now try to speculate about the mechanisms that could have lead to our results: In 
our young, healthy sample, pathological mechanisms can probably be ruled out, so 
we have to look for physiological mechanisms that could influence memory 
performance. We do not see any evident pattern of the memory-related activations 
between genotype groups suggesting that carriers of one allele use rather one 
memory system and carriers of the other allele another. The locations of the 
activation spots look rather random, while the consistent overactivation of the Val-
allele carriers relative to the Met-allele carriers is striking. We have to assume that 
Val-carriers need more activation in broad parts of the brain to reach the same 
memory performance as the Met-carriers. Our study and the study of 
Papassotiropoulos and colleagues (2005) allow to pinpoint the time course of the 
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differential processes between the genotypic groups: We do not see any hints for 
differences in learning and recall after five minutes (though, we do not have any 
imaging data for these time points). So we can assume that the observed differences 
are not due to different abilities in learning or in language functioning. At the 30 
minutes time lag, we see already large differences in activations and in correlations 
between activation and recognition success within groups, so the difference probably 
develops in the course of minutes (but is too weak to be seen with behavioral 
methods after five minutes). After 24 hours, there was a behavioral effect in the large 
sample study and an at least equal effect as at the 30 minutes condition in the 
imaging study: Although differences in activation were rather smaller in the 24 hours 
condition than in the 30 minutes condition (Table 5), the negative correlations 
between activation in Val/Val carriers and recognition success became stronger over 
time lags, while Met/Met carriers did not show significantly less positive correlations 
(Supplementary Table S2). In sum, the prion group differences seem to develop in 
the time frame of minutes and stay until one day after learning. This nicely fits the 
electrophysiological data cited in the introduction, which say that measures like LTP 
are changing after some minutes in PRNP knockout mice. Of course our effects are 
much smaller, but we do not compare humans with or without expressed prion 
protein, but humans with slightly modified types of prion protein, which could possibly 
influence enzymatic activity of the protein. The relation between LTP and 
hippocampal learning has been assumed for a long time and shown quite 
convincingly recently (Whitlock et al., 2006; Pastalkova et al., 2006). Although there 
are not yet any cell-level data comparing cells expressing metPrP with valPrP (which 
is not found in mice), data involving prion protein in cellular plasticity are 
accumulating: PrP binds laminin (Rieger et al., 1997) and NCAM (Schmitt-Ulms et al., 
2001), molecules important for LTP (Nakagami et al., 2000, Luethi et al., 1994); it is 
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involved in NO-metabolism (Keshet et al., 1999), which is also important for LTP (see 
e.g. Miyamoto, 2006); and it has even been shown to influence tubulin 
oligomerization in vitro, a process important for microtubule formation and neuronal 
plasticity (Nieznanski et al., 2006).  
Given our prion protein gene group difference in single word learning, we should ask 
ourselves how specific these effects are. For comparison, we conducted a working-
memory task (2-back task) and compared results between the same genotype 
groups. There were only few differences in brain activations (Table 5), but more 
positive correlations between task activation and working memory success in Val/Met 
carriers than in the other groups (supplementary Table S2). This means that 
hypothesis 3 is incorrect. At any rate, the pattern is fundamentally different from the 
pattern in the episodic memory task (no gene dose effect, no negative correlation in 
the group with most activation spots). Are there other hints on different working 
memory performance in Val/Met carriers? In the neuropsychological paper-and-pencil 
tests, we assessed verbal memory, visual memory, different intelligence measures 
and one executive function. There were no significant differences in ANOVA’s 
between genotypic groups in all of these tests (Table 2). This means that hypothesis 
4 turns out to be true. However, in other populations, which were older and not 
matched for memory performance (which is often positively correlated with 
intelligence), there were genotypic differences: In a normal elderly population, Val/Val 
carriers performed worse than the two other genotypic groups in the mini-mental 
status score, which consists of orientation, visuoconstruction, working memory and 
memory (Berr et al., 1998). Unfortunately the authors do not say which subtests 
differ. One study (Rujescu et al., 2003) reports higher intelligence scores in healthy 
middle-aged (mean age 44.6 years) Val-carriers than in Met-carriers in the HAWIE-R 
battery (Härting et al., 2000). The subtest with the strongest difference was the Digit 
 - 101 -
Symbol test, which assesses the speed of translating numbers into symbols, but the 
difference was also found in the Block Design task and the Similarities task (which 
assesses abstract thinking). All of these three significant differences showed the 
same gene dose effect (the more Val-alleles, the higher performance). The sample 
was torn randomly from the German population of Munich. However, these studies 
yield no explanation for the difference of the Val/Met group in our experiment. 
Because of the protein expression not only in the hippocampus, but also in wide 
parts of the brain, more pronouncedly in subcortical and very plastic structures 
(Bendheim et al., 1992), we do not suppose that episodic memory is the only function 
where differences could be observed. For example, there could also be differences in 
emotional functions or operant conditioning.  
The second important finding of our study were anatomical differences between 
genotype groups, which we had proposed in hypothesis 5. Whole brain grey matter 
or white matter volumes did not differ significantly (Table 6), in contrast to a study 
which showed smaller white matter volumes in Met/Met carriers in a mixture of 
healthy and schizophrenic subjects (Rujescu et al., 2002). There was a non-
significant tendency of smaller brains in carriers of the Val-allele compared to Met-
carriers. However in voxel-based morphometry, Val-carriers showed regions with 
higher grey matter density compared to Met-carriers, while Met-carriers showed 
practically no regions with higher grey matter densities than Val-carriers. The 
reported results are corrected for brain size, but ANOVAs without correcting brain 
size yield qualitatively similar results (data not shown). These differences seem to be 
independent of the functional MRI results, since voxel-wise ANCOVAs of the 
functional contrasts which controlled for grey matter density in the same voxel did not 
change the pattern of overactivation of Val-carriers relative to Met-carriers. The 
anatomical finding in itself is interesting, because it gives us a second, independent 
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hint that the Met129Val polymorphism really influences enzymatic activity of the 
protein. It is not clear from our findings when this influence exerts. Prion protein is 
widely expressed during brain maturation and shows a shift from axons to synapses 
(Rieger et al., 1997). This points to a shift in function, from cellular plasticity to 
synaptic plasticity. Since voxel-based morphometry measures probably not only cell 
density, but also synaptic density, our grey matter concentration difference could map 
both kinds of plasticity, leading to a developmental difference in cell density or a post-
birth difference in synaptic density due to activation-dependent synapse growth. It 
has also been shown that neurite outgrowth or retraction can be triggered over prion 
protein concentration (Rieger et al., 1997; Graner et al., 2000). Lack of prion protein 
does not abolish brain development, but can lead to anatomical abnormalities as in 
the hippocampal gyrus dentatus or CA3 (Colling et al., 1997). 
The prion protein seems also to be involved in the regulation of the sleep cycles 
(Tobler et al., 1996). For our study, we asked subjects also for habitual sleep length 
and sleep length in the ‘consolidation night’ between learning of the first word list and 
recognition and did not find any significant differences or correlations with memory 
performance (however there was a tendency for longer sleep in the consolidation 
night in Met-carriers).  
  
In summary, we find that Val-carriers have more difficulty to reach the same episodic 
memory performance than Met-carriers. This effect sums up with each Val-allele. 
This effect seems to be specific for episodic memory, because we do not see it in a 
working memory task. The difficulty of Val-carriers as compared to Met-carriers 
seems to start at a time point between 5 minutes and 30 minutes after learning and 
stays at least until 24 hours after learning. Additionally, we find higher grey matter 
concentrations in Val-carriers than in Met-carriers dispersed over wide parts of the 
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brain. These two effects, the difference in brain activation and the difference in grey 
matter density seem to be independent of each other. There are several candidate 
mechanisms that could explain the observed differences: Early LTP, late LTP, and 
possibly developmental differences in brain structure.  
Since the Val-allele is the novel allele, it seems counterintuitive that it has just 
developed to confer difficulty in episodic memory. It seems also unlikely that the rare 
cases of Creutzfeldt-Jakob disease, against which Val/Met heterozygosity is a 
relative protection, have exerted enough evolutionary pressure to promote the Val-
allele. More likely explanations are that the Val-allele has developed because it better 
fits into the changed genetic environment created by other genetic changes, or it 
confers advantages in trade-off of the memory-disadvantage. A hint for this is the 
higher intelligence in Val-carriers in the study of Rujescu et al. (2003). In our sample, 
this difference could not be found (although we partly administered the same 
neuropsychological tests), possibly because our sample was variance-constrained 
(2/3 students, and newspaper-recruited volunteers, who are often more intelligent 
than the mean population), an effect that probably acted stronger on intelligence than 
on memory. Although intelligence and memory often positively correlate, one can 
speculate that up to a certain degree one ability could also be compensated by the 
other, which could explain a possible memory-intelligence trade-off. In that sense, it 
could be a good choice to be a Val/Met heterozygous.  
Extensive work has to be done on several levels to proceed in the question of how 
the prion protein and its Met129Val polymorphism influence cognitive function: From 
the systems side, we should try to replicate the memory and intelligence findings and 
find the processes where Val-carriers and Met-carriers differ most. From the cellular 
and molecular side, we should find out if and which enzymatic activities differ 
between metPrP and valPrP and if there are different patterns or levels of expression 
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in the cells. Also developmental studies comparing knock-out-knock-in mice and cell 
cultures with human metPrP versus valPrP would be of great help. There are already 
many studies with PRNP knockout mice or cells which found many functions of the 
protein (in this paper we reviewed only functions important for memory), but it is 
unclear what properties of the molecule are crucial to exert these functions. The 
Met129Val polymorphism could be of help to further investigate the mechanisms 
behind these functions, because it seems also to influence higher cognitive functions 
in humans, so it is likely that it influences also the cellular processes observed in 
knockout mice or cells. If the prion protein has a signal function which works over 
conformational switching, which one could suspect if comparing it to aplysia CPEB 
(see introduction or Si et al., 2003a, b), then it seems likely that this mechanism is 
altered by the Met129Val polymorphism, which influences the 3-dimensional 
structure of the protein. But even without a role of the switching mechanism in normal 
cells, there could be differences in enzymatic activities, which could influence the 
protein’s likely functions in neuronal plasticity.  
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Table 1. Prion Protein Genotype Groups 
          
PRNP M129V Met/Met 
(n=12)
Val/Met 
(n=12)
Val/Val 
(n=12) 
χ2 or ANOVA p
  
Sex (female) 7 7 7 1
  
Handedness (right) 10 10 11 0.55
  
Age (M (SEM)) 22.8 (0.3) 23.8 (0.6) 23.4 (0.8) 0.46
  
Years of education (M (SEM)) 15.5 (0.3) 16.3 (0.4) 15.6 (0.5) 0.32
  
Genotypes APOE (3/3, 3/4, 2/3, 2/4) 9, 2, 0, 1 8, 1, 1, 2 10, 1, 0, 1 0.78
  
Genotypes 5HT2A (CC, CT) 8,4 11,1 8,4 0.26
  
Genotypes Kibra (CC) 3 5 5 0.62
  
correct answers “remember” 24h (M (SEM)) 40.3 (1.6) 40.6 (1.7) 41.1 (1.5) 0.65
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Table 2. Neuropsychological Data of the three Prion Genotype Groups (M, SEM) 
     
PRNP Genotype Met/Met 
(n=12)
Val/Met 
(n=12)
Val/Val 
(n=12) 
ANOVA p 
   
Memory   
   
Verbal Learning VLMT, Run 1 8.8 (0.7) 8.8 (0.8) 9.3 (0.8) 0.87 
   
Verbal Learning VLMT, Run 5 14.5 (0.2) 14.4 (0.3) 14.5 (0.2) 0.96 
   
Verbal Learning VLMT, Interference List 8.0 (0.6) 8.9 (0.7) 8.3 (0.6) 0.59 
   
Verbal Learning VLMT, Recall after Interference 14.5 (0.3) 14.1 (0.4) 14.3 (0.3) 0.65 
   
Verbal Learning VLMT, Late Recall 14.8 (0.1) 13.7 (0.6) 14.3 (0.4) 0.22 
   
Verbal Learning VLMT, Recognition 15.0 (0.0)§ 14.7 (0.2) 14.9 (0.1) 0.13 
   
Verbal Association Learning WMS-R, Runs 1-3 21.9 (0.6) 21.3 (0.9) 21.8 (0.5) 0.76 
   
Verbal Association Learning WMS-R, Late Recall 7.8 (0.1) 7.7 (0.2) 7.8 (0.1) 0.73 
   
Visual Association Learning WMS-R, Runs 1-3 17.0 (0.4) 16.8 (0.5) 16.8 (0.4) 0.90 
   
Visual Association Learning WMS-R, Late Recall 6.0 (0.0)§ 6.0 (0.0)§ 5.8 (.17) 0.38 
   
   
Intelligence   
   
Digit Span (HAWIE-R) 15.6 (1.3) 16.0 (1.0) 14.8 (0.8) 0.69 
   
Mosaic Test (HAWIE-R) 43.2 (1.5) 40.1 (2.0) 44.8 (1.9) 0.33 
   
Abstract Thinking (HAWIE-R) 27.8 (0.6) 27.3 (0.8) 26.4 (1.2) 0.56 
   
Vocabulary (MWT-B) 30.7 (0.8) 31.4 (0.8) 30.3 (0.9) 0.64 
   
   
Executive Functions   
   
Interference (Stroop: Time Run 3) 20.7 (1.6) 20.9 (1.8) 18.9 (1.3) 0.63 
        
§ all subjects in these groups reached the maximum 
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Table 3. Performance in fMRI tasks (M (SEM)) 
     
PRNP Genotype Met/Met 
(n=12)
Val/Met 
(n=12)
Val/Val 
(n=12) 
ANOVA p 
   
Free Recall   
   
Day 1, Correct 30.5 (1.7) 32.4 (1.7) 27.8 (1.0) 0.11 
   
Day 2, Correct 20.3 (1.9) 23.6 (1.6) 21.5 (1.6) 0.39 
   
30min Recognition   
   
Hits 'Remember' 40.9 (2.2) 39.6 (1.7) 39.8 (2.0) 0.88 
   
Hits 'Know' 5.8 (1.4) 7.0 (1.1) 5.4 (0.9) 0.6 
   
Miss 3.3 (1.1) 3.4 (0.9) 4.7 (1.3) 0.65 
   
Mean Reaction Times Hits 'Remember' (ms) 2087 (131) 2187 (157) 2307 (137) 0.55 
   
24h Recognition   
   
Hits 'Remember' 40.3 (1.6) 40.6 (1.7) 41.1 (1.5) 0.93 
   
Hits 'Know' 7.3 (1.2) 6.5 (1.2) 6.0 (1.0) 0.71 
   
Miss 2.4 (0.6) 2.9 (1.1) 2.9 (0.8) 0.89 
   
Mean Reaction Times Hits 'Remember' (ms) 1982 (131) 2218 (174) 2400 (194) 0.22 
   
Distracters   
   
False Alarms 'Remember' 4.2 (1.0) 4.5 (1.8) 3.6 (0.9) 0.58 
   
False Alarms 'Know' 18.6 (3.4) 15.5 (3.9) 14.1 (2.3) 0.61 
   
Correct Rejections 77.0 (4.0) 78.8 (4.5) 82.2 (2.3) 0.62 
   
Mean Reaction Times Correct Rejections (ms) 2918 (206) 3320 (265) 3069 (122) 0.39 
   
Baseline Task   
   
Identical', Correct 12.0 (0.0) # 12.0 (0.0) # 12.0 (0.0) #  
   
Identical', Mean Reaction Times (ms) 1584 (112) 1568 (98) 1686 (137) 0.74 
   
Same', Correct 12.0 (0.0) # 12.0 (0.0) # 11.9 (0.3)  
   
Same', Mean Reaction Times (ms) 1647 (118) 1796 (139) 1913 (147) 0.39 
   
Different', Correct 26.0 (0.0) # 25.8 (0.5) 25.9 (0.3)  
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Different', Mean Reaction Times (ms) 1700 (134) 1796 (153) 1828 (138) 0.8 
   
Working Memory Task   
   
X-Target', Hits - False Alarms 12.8 (0.1) 12.9 (0.1) 12.9 (0.1) 0.77 
   
X-Target', Mean Reaction Times Hits (ms) 505 (22) 536 (27) 537 (20) 0.55 
   
2-Back', Hits - False Alarms 9.1 (0.9) 8.7 (1.2) 9.8 (0.9) 0.74 
   
2-Back', Mean Reaction Times Hits (ms) 673 (35) 706 (35) 732 (38) 0.52 
   
# All Subjects Reached the Maximum   
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Table 4. Brain Activations (Whole Sample, n=36) in Different Contrasts (1-
sample t-test; p<.05, Family Wise Error Corrected, extent threshold 12 voxels, 
for hippocampus 5 voxels) 
        
   MNI Coordinates 
      
Brain Area Side BA x y z Z # vox
   
Rem 30min > False Alarms 
        
Middle Frontal Gyrus R 8 30 24 46 5.45 26
   
 R 8 28 34 52 5.35 26
   
Middle Temporal Gyrus L 21 -60 -10 -20 5.40 27
   
 R 37 62 -56 -6 5.97 70
   
Superior Temporal Gyrus L 22 -62 -48 16 5.28 12
   
Parahippocampal Gyrus R 28 24 -18 -22 5.74 88
   
Angular Gyrus L 39 -48 -72 38 6.04 344
   
Inferior Parietal Lobule R 39 48 -70 24 6.54 598
   
  L 40 -56 -46 50 5.61 17
   
Posterior Cingulate L 31 -10 -54 36 6.67 1354
   
False Alarms > Rem 30min 
        
no significant activations   
   
Rem 24h > False Alarms 
        
Middle Frontal Gyrus R 46 50 40 0 5.22 21
   
  R 8 22 40 50 5.26 21
   
 R 8 28 22 44 5.25 28
   
Claustrum R  34 -10 -2 5.92 144
   
Inferior Temporal Gyrus L 20 -58 -6 -24 5.82 42
   
 R 20 54 -8 -30 5.57 30
   
Middle Temporal Gyrus R 21 58 -30 2 5.41 23
   
Superior Temporal Gyrus L 22 -60 -50 16 5.47 90
   
  R 42 58 -26 14 5.35 40
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Parahippocampal Gyrus L 36 -22 -6 -32 5.67 59
   
  L 36 -28 -18 -30 5.48 33
   
  R 28 24 -20 -24 5.85 119
   
Inferior Parietal Lobule L 40 -62 -42 30 5.25 29
   
 R 39 48 -70 24 6.69 1245
   
  R 40 60 -42 48 5.41 15
   
Middle Occipital Gyrus L 19 -44 -80 32 6.69 546
   
False Alarms > Rem 24h 
        
Inferior Frontal Gyrus R 11 32 26 -4 5.76 42
   
2-Back > X-Target 
        
Inferior Frontal Gyrus L 47 -34 24 -6 7.69 623
   
  R 47 38 24 -8 >7.7 7502
   
Middle Frontal Gyrus L 10 -32 56 6 5.77 213
   
Fusiform Gyrus L 19 -48 -66 -14 5.25 32
   
Superior Parietal Lobule Both 7 14 -70 56 7.66 6145
   
X-Target > 2-Back 
        
Inferior Frontal Gyrus L 11 -34 36 -16 5.88 34
   
Insula L  -40 -14 16 6.88 1241
   
  R  44 -22 18 7.28 1189
   
Parahippocampal Gyrus L 36 -26 -16 -24 6.25 262
   
  R 34 30 2 -24 6.25 101
   
  R 35 28 -36 -16 5.67 35
   
  R 28 26 -18 -24 5.59 21
   
Postcentral Gyrus L 3 -42 -28 60 5.45 33
   
  R 1 24 -30 66 5.18 21
   
Precentral Gyrus L 4 -48 -12 32 5.54 12
   
 R 4 40 -26 68 5.65 24
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Table 5. Activation Differences between Prion Gene Groups: (Met/Met vs 
Val/Met vs Val/Val, 12:12:12) in Different Contrasts (ANOVAs and 
consecutive 2-sample T-Tests; p<.001 uncorrected, extent threshold 12 
voxels, in hippocampus 5 voxels)  
                
   MNI coordinates 
      
Brain Area Side BA x y z Z # vox
   
Rem 30min > False Alarms 
        
Met/Met > Val/Val   
   
no significant differences   
   
Val/Val > Met/Met   
        
Inferior Frontal Gyrus L 45 -40 36 6 3.83 69
   
  R 44 40 6 24 3.84 56
   
 R 47 44 26 -8 3.73 55
   
Middle Frontal Gyrus L 9 -38 24 26 3.79 23
        
 L 9 -28 42 32 3.50 13
   
Thalamus R  10 -12 6 3.65 31
   
Caudate L  -10 10 -4 4.11 45
   
Fusiform Gyrus L 19 -26 -92 -16 3.88 34
   
 R 20 30 -34 -28 4.02 62
   
Middle Temporal Gyrus L 21 -64 -46 4 4.14 64
   
 L 21 -52 -2 -24 3.64 28
   
 L 21 -50 -50 0 3.41 29
   
  R 21 66 -34 4 4.46 28
        
  R 21 60 -10 -10 3.83 29
   
Insula L  -28 10 12 4.28 21
   
Parahippocampal Gyrus L 28 -22 -14 -30 4.04 58
   
Superior Parietal Lobule L 7 -26 -72 32 4.32 115
        
 L 5 -10 -44 58 3.55 13
   
  R 7 18 -68 34 3.47 12
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Angular Gyrus L 39 -48 -76 24 4.21 35
   
Inferior Parietal Lobule R 40 36 -24 24 3.69 18
   
Posterior Cingulate R 23 10 -58 14 3.48 26
   
Met/Met > Val/Met   
   
no significant differences   
   
Val/Met > Met/Met   
   
Inferior Frontal Gyrus R 44 50 16 16 3.59 12
   
Middle Frontal Gyrus L 46 -34 42 14 3.47 14
   
Claustrum R  28 6 -10 3.56 15
   
Superior Temporal Gyrus L 22 -62 -44 6 3.43 49
   
Parahippocampal Gyrus L 27 -22 -22 -16 3.80 23
   
Val/Met > Val/Val   
   
no significant differences   
   
Val/Val > Val/Met   
   
Precuneus R 7 20 -68 32 4.55 23
   
Inferior Parietal Lobule R 39 36 -72 26 3.86 24
   
Superior Occipital Gyrus L 19 -28 -84 28 3.62 12
 
 
   
Rem 24h > False Alarms 
        
Met/Met > Val/Val   
   
no significant differences   
   
Val/Val > Met/Met   
   
Inferior Frontal Gyrus L 44 -58 14 22 3.76 51
   
Middle Temporal Gyrus L 21 -52 2 -24 3.82 30
   
Insula R  32 10 -8 3.71 26
   
Superior Parietal Lobule L 7 -28 -74 32 3.46 24
   
Posterior Cingulate L 23 -6 -22 32 3.53 19
   
Met/Met > Val/Met   
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no significant differences   
   
Val/Met > Met/Met   
Inferior Frontal Gyrus R 45 48 20 14 3.45 18
   
  L 44 -58 14 20 3.55 21
   
Middle Frontal Gyrus L 46 -36 44 12 3.53 19
   
Putamen R  28 8 -8 4.01 48
   
Middle Temporal Gyrus L 21 -56 -54 -4 3.71 14
   
Parahippocampal Gyrus L 28 -20 -14 -30 3.51 15
   
Hippocampus (Body) L  -34 -26 -14 3.37 8
   
Val/Met > Val/Val   
   
no significant differences   
   
Val/Val > Val/Met   
   
Middle Temporal Gyrus R 21 46 -50 0 3.69 17
 
 
 
 
  
2-Back > X-Target 
        
Met/Met > Val/Val   
   
no significant differences   
   
Val/Val > Met/Met   
   
no significant differences   
   
Met/Met > Val/Met   
   
no significant differences   
   
Val/Met > Met/Met   
   
Inferior Temporal Gyrus R 20 40 0 -28 3.53 13
   
Superior Temporal Gyrus L 41 -56 -18 6 3.37 17
   
Val/Met > Val/Val   
   
Inferior Frontal Gyrus R 11 24 28 0 3.65 15
   
Val/Val > Val/Met   
   
Inferior Frontal Gyrus R 44 54 14 4 3.32 7
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Table 6. Whole Brain Volumes of the Prion Genotype Groups (M (SEM); ccm3) 
          
PRNP Genotype Met/Met 
(n=12)
Val/Met 
(n=12)
Val/Val 
(n=12) 
ANOVA p 
   
Grey Matter 697 (21) 690 (18) 663 (16) 0.39 
   
White Matter 431 (17) 417 (12) 398 (10) 0.22 
   
Cerebrospinal Fluid 462 (18) 449 (11) 432 (13) 0.34 
   
Total (Grey, White and CSF) 1589 (54) 1558 (38) 1492 (38) 0.30 
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Figure 1. 
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Figure 2. 
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Figure 3. 
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Figure 4. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 - 126 -
 
 
 
 
Figure 5. 
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Figure legends 
 
Figure 1. Experimental procedure 
 
Figure 2. Comparison of activations in the contrast ‘30min Recognition minus False 
Alarms’ between prion genotype groups (Anovas with subsequent paired 
comparisons; only ‘Remember’-answers; n=12 per group). The same ‘transitive’ 
pattern (Val/Val > Val/Met > Met/Met) can also be seen in the 24h condition. Clusters 
were plotted for p>.001 (uncorrected) and an extent threshold of 12 voxels or more 
(exception hippocampus: 5 voxels or more). 
 
Figure 3. Comparison of correlations of the activations in the contrast ‘30min 
Recognition minus False Alarms’ with recognition performance (hits minus false 
alarms; only ‘Remember’-answers; n=12 per group). The same pattern (Met/Met and 
Val/Met only positive correlations, Val/Val only negative correlations) can also be 
seen in the 24h condition. Clusters were plotted for p>.001 (uncorrected) and an 
extent threshold of 12 voxels or more (exception hippocampus: 5 voxels or more). 
 
Figure 4. Voxel-wise comparison of local grey matter concentrations between prion 
genotype groups (Ancovas with whole brain volume as a covariate and subsequent 
pair-wise comparisons; n=12 per group). Clusters were plotted for p>.001 
(uncorrected) and an extent threshold of 100 voxels or more (exception 
hippocampus: 40 voxels or more).The settings were chosen to match the functional 
activity maps as closely as possible (voxels in the anatomical images were 1x1x1 
mm, in the functional data 2x2x2 mm; therefore the 8-times larger number of voxels 
for the extent threshold). 
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Figure 5. Model to explain the fMRI results: The model assumes that activation up to 
a certain degree (the group-specific threshold) is functional and increases 
performance, while it decreases performance if lying above the group-specific 
threshold. Since carriers of more Val-alleles seem to have more difficulty with 
memory, their threshold lies lower than the threshold of carriers of less Val-alleles. 
Therefore most Val-carriers at the same performance level (which was matched) tend 
to enter the dark grey activation level, where their performance does not profit from 
additional activation (negative correlations within genotype group), whereas Met-
carriers would still profit from additional activation (positive correlations within group). 
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Supplementary Tables: 
Table S1. fMRI Activations in the Word Recognition Task, Compared to Low-
Level Baseline (Compare the First and Last Letter of a Letter String; Whole 
Sample, n=36) in Different Contrasts (1-Sample T-Test; p<.05, Family Wise 
Error Corrected, Extent Threshold 12 Voxels, in Hippocampus 5 Voxels) 
               
   MNI Coordinates 
      
Brain Area Side BA x y z Z # vox
   
Rem 30min > Compare Letters 
       
Inferior Frontal Gyrus L 47 -48 22 -12 7.52 1321
   
  L 8 -42 12 42 5.58 87
   
  R 47 36 22 -14 5.75 135
   
Middle Frontal Gyrus L 10 -32 48 4 6.20 157
   
  L 6 -42 8 56 5.72 65
   
Superior Frontal Gyrus L 9 -12 56 34 5.54 52
       
 L 10 -18 60 24 5.26 13
   
Caudate L  -12 6 12 5.98 108
   
  R  10 10 6 7.68 92
   
Middle Temporal Gyrus L 21 -62 -40 -6 6.53 331
   
  L 21 -56 -10 -18 6.08 58
   
Supramarginal Gyrus L 40 -40 -64 42 6.73 621
   
Posterior Cingulate L 23 -6 -26 26 5.59 26
 
   
Compare Letters > Rem 30min 
       
Inferior Frontal Gyrus R 44 52 8 30 5.49 96
   
Middle Frontal Gyrus R 46 50 42 0 6.39 91
   
Medial Frontal Gyrus L 6 -22 -14 54 6.30 92
   
  R 6 28 6 68 5.02 178
   
Thalamus L  -14 -24 4 7.09 52
   
 L  -20 -32 10 5.51 16
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  R  14 -24 -4 5.65 52
   
Inferior Temporal Gyrus L 20 -40 -4 -22 5.77 19
   
  R 20 40 2 -28 5.92 53
   
Insula L  -42 2 4 6.06 283
   
  R  36 8 6 6.01 65
   
Postcentral Gyrus L 1 -50 -28 46 6.80 1566
 
   
Rem 24h > Compare Letters 
       
Inferior Frontal Gyrus L 47 -48 22 -12 >7.5 1745
   
  R 47 36 22 -14 7.24 265
   
Middle Frontal Gyrus L 8 -40 10 42 5.89 263
   
  L 6 -40 2 56 5.53 42
   
Superior Frontal Gyrus L 9 -14 54 30 5.82 291
   
Caudate L  -12 8 10 6.68 201
   
  R  10 14 6 5.77 154
   
Middle Temporal Gyrus L 21 -60 -40 -6 6.55 392
   
  L 21 -56 -10 -18 5.70 70
   
Angular Gyrus L 39 -48 -72 40 6.24 434
 
   
Compare Letters > Rem 24h 
       
Inferior Frontal Gyrus R 45 48 38 4 5.72 33
   
  R 44 52 8 32 5.67 117
   
Middle Frontal Gyrus R 6 30 -4 56 5.75 113
   
Thalamus L  -20 -30 2 2.68 39
   
  R  18 -30 4 5.21 16
   
Inferior Temporal Gyrus R 20 40 2 -26 6.12 36
   
Middle Temporal Gyrus L 21 -40 -4 -22 5.29 13
   
Superior Temporal Gyrus L 22 -56 -2 0 6.01 26
   
Insula L  -42 2 6 6.27 95
   
 - 131 -
 L  -40 -16 -8 5.38 27
   
  R  34 8 4 5.71 32
   
Superior Parietal Lobule R 7 30 -62 42 7.51 5961
   
Postcentral Gyrus L 2 -48 -36 60 6.72 1222
   
Posterior Cingulate L 31 -14 -30 42 6.12 60
   
Inferior Occipital Gyrus L 19 -42 -74 -14 7.41 1813
 
   
False Alarms > Compare Letters 
       
Inferior Frontal Gyrus L 47 -28 22 -10 7.23 943
   
 L 47 -42 42 -8 5.65 60
   
  R 47 38 22 -12 7.12 358
 
   
Compare Letters > False Alarms 
       
Inferior Frontal Gyrus R 44 52 6 30 5.90 58
   
Middle Frontal Gyrus R 46 50 40 0 6.27 107
   
  R 6 28 14 52 5.66 106
   
Thalamus L  -16 -30 0 5.81 144
   
  R  18 -28 4 5.83 147
   
Middle Temporal Gyrus R 21 58 -2 -18 5.56 26
   
  L 37 -60 -62 -8 >7.5 15625
   
Superior Temporal Gyrus R 22 60 2 -4 5.53 82
   
Fusiform Gyrus L 37 -40 -56 -4 5.30 16
   
 R 20 26 -16 -26 5.24 16
   
Claustrum R  36 -10 -4 7.49 1055
   
Parahippocampal Gyrus L 36 -22 -4 -30 5.44 27
   
Postcentral Gyrus L 7 -24 -38 58 5.42 15
   
Inferior Parietal Lobule L 40 -64 -30 24 7.00 1612
   
Inferior Occipital Gyrus R 18 36 -86 -10 5.52 35
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Table S2. Significant Correlations of Activation Contrasts with Behavioral 
Measures (in parentheses) in Prion Gene Groups: (Met/Met, Val/Met, 
Val/Val, 12:12:12) for Different Contrasts (p<.001 Uncorrected, Extent 
Threshold 12 Voxels)  
               
   MNI Coordinates 
      
Brain Area Side BA x y z Z # vox
   
Rem 30min > False Alarms with (Hits 30min - False Alarms) 
   
Met/Met, r>0   
   
Superior Temporal Gyrus R 22 58 -24 10 3.69 12
   
Met/Met, r<0   
   
no significant correlations        
   
Val/Met r>0   
   
Medial Frontal Gyrus L 8 -18 36 28 4.10 27
   
Val/Met r<0   
   
no significant correlations   
   
Val/Val, r>0   
   
no significant correlations   
   
Val/Val r<0   
   
Middle Frontal Gyrus R 46 34 34 22 3.95 26
   
Superior Temporal Gyrus L 22 -50 -44 16 3.88 32
   
Posterior Cingulate L 30 -12 -46 4 3.82 23
   
Middle Occipital Gyrus L 18 -26 -98 6 3.65 18
   
 L 18 -28 -88 2 3.63 18
   
Cuneus R 17 18 -90 0 4.13 18
 
   
Rem 24h > False Alarms with D_24 Rem 
   
Met/Met, r>0   
   
no significant correlations   
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Met/Met, r<0   
   
no significant correlations        
   
Val/Met r>0   
   
Anterior Cingulate R 24 10 -16 46 3.81 22
   
Inferior Temporal Gyrus R 37 50 -54 -22 4.04 14
   
Superior Temporal Gyrus R 22 52 -48 14 4.07 102
   
Fusiform Gyrus R 19 44 -68 -8 3.89 26
   
Val/Met r<0   
   
no significant correlations        
   
Val/Val, r>0   
   
Caudate L  -12 24 12 3.77 12
   
Val/Val r<0   
   
Inferior Frontal Gyrus L 44 -42 10 22 4.57 42
   
  L 47 -40 40 -6 3.96 34
   
 L 47 -34 24 0 3.71 31
   
  L 47 -22 34 -4 3.71 38
   
  L 45 -56 20 28 3.51 53
   
  R 47 38 40 -8 4.26 24
   
 R 9 48 12 34 3.42 15
   
Middle Frontal Gyrus L 46 -38 42 22 4.72 80
   
  L 6 -26 -2 32 3.98 26
   
  R 9 36 52 22 3.86 102
   
Putamen R  18 16 -2 3.50 18
   
Superior Temporal Gyrus R 38 54 16 -14 3.82 33
   
Insula L  -34 10 -10 3.70 22
   
Superior Parietal Lobule R 7 10 -74 54 3.91 25
   
Postcentral Gyrus L 1 -60 -22 38 4.11 43
   
  L  -38 -28 52 4.10 87
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Inferior Occipital Gyrus R 18 34 -88 -10 3.97 44
   
Cuneus L 19 -8 88 42 4.50 83
 
   
2-Back > X-Target with (Hits - False Alarms) 2-Back 
   
Met/Met, r>0   
   
Insula R  44 -8 0 3.90 33
   
Met/Met, r<0   
   
Inferior Parietal Lobule L 7 -38 -62 48 3.70 41
   
 R 40 42 -58 52 4.05 30
   
Val/Met r>0   
   
Middle Frontal Gyrus L 10 -28 48 2 3.57 18
   
  R 6 24 12 66 3.53 15
   
Medial Frontal Gyrus R 6 16 -26 60 4.75 137
   
Inferior Temporal Gyrus L 37 -48 -62 -18 3.33 13
   
  R 37 52 -58 -16 4.77 185
   
Middle Temporal Gyrus R 21 62 -6 -4 3.48 16
   
Superior Temporal Gyrus R 22 46 -44 14 3.59 13
   
Fusiform Gyrus R 37 32 -50 -14 3.92 16
   
Paracentral Lobule R 5 6 -44 64 3.77 26
   
Postcentral Gyrus L 1 -28 -42 44 4.07 51
   
  L 1 -18 -42 74 4.03 37
   
Inferior Parietal Lobule L 40 -52 -50 20 3.87 36
   
Superior Parietal Lobule L 5 -28 -50 64 3.44 21
   
 R 7 18 -80 34 4.41 151
   
Inferior Occipital Gyrus R 19 40 -78 -10 3.56 16
   
Middle Occipital Gyrus L 19 -46 -70 -12 3.46 18
   
 R 19 40 -76 10 3.96 76
   
Superior Occipital Gyrus L 19 -26 -86 38 4.08 19
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 L 19 -18 -86 18 3.94 19
   
Lingual Gyrus R 19 22 -52 -6 3.89 26
   
Val/Met r<0   
   
no significant differences        
   
Val/Val, r>0   
   
Superior Frontal Gyrus L 8 -16 26 38 3.66 16
   
  L 8 -6 26 46 3.57 33
   
Caudate R  8 16 0 4.23 18
   
Inferior Parietal Lobule R 40 58 -56 40 3.85 14
   
Superior Parietal Lobule R 7 14 -52 36 3.78 13
   
Middle Occipital Gyrus R 19 48 -80 12 3.80 14
   
Val/Val r<0   
   
Amygdala R  20 -8 -12 3.98 13
   
Inferior Parietal Lobule R 40 50 -30 58 3.78 33
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Table S3. Grey Matter Concentration Differences between Prion Gene 
Groups: (Met/Met vs Val/Met vs Val/Val, 12:12:12 ANCOVAs with Whole 
Brain Volume as a Covariate and consecutive 2-sample Comparisons; 
p<.001 uncorrected; Extent Threshold 100 Voxels, in Hippocampus 40 
Voxels; Corresponding to Extent Threshold for fMRI Data)  
       
   MNI Coordinates 
      
Brain Area Side BA x y z Z # vox
           
Met/Met > Val/Val   
   
Lingual Gyrus R 18 6 -93 -20 3.68 998
   
Cerebellum L  -16 -91 -41 3.59 818
   
Cerebellum R  45 -80 -44 3.66 465
   
Val/Val > Met/Met   
   
Orbital Gyrus L 11 -7 65 -14 3.45 115
   
 R 10 16 68 -13 3.36 122
   
Middle Frontal Gyrus L 9 -23 56 21 3.78 190
   
 L 9 -42 17 31 3.75 128
   
 R 8 23 26 53 3.77 223
   
Superior Temporal Gyrus L 38 -45 20 -31 3.23 123
   
Precentral Gyrus L 4 -59 1 10 3.8 329
   
Postcentral Gyrus L 1 -60 -23 33 3.53 152
   
Inferior Parietal Lobule R 40 56 -52 22 3.69 447
   
 R 39 45 -77 31 3.42 183
   
Posterior Cingulate R 31 9 -30 40 3.6 257
   
Fusiform Gyrus L 19 -33 -80 -14 4.57 1281
   
Lingual Gyrus L 18 -14 -66 -7 3.56 155
   
Cuneus R 18 10 -92 18 3.56 235
   
Cerebellum L  -29 -75 -52 3.8 2154
   
 R  32 -66 -42 3.53 819
 - 137 -
   
Met/Met > Val/Met   
   
no significant differences   
   
Val/Met > Met/Met   
   
Middle Frontal Gyrus L 10 -52 50 10 3.7 102
   
Medial Frontal Gyrus R 8 7 26 52 3.4 205
   
 R 6 10 -22 60 3.43 122
   
Middle Temporal Gyrus L 37 -57 -76 -7 3.49 196
   
Inferior Parietal Lobule R 40 45 -50 54 3.67 262
   
Cerebellum L  -27 -76 -50 3.42 193
   
Val/Met > Val/Val   
   
Medial Frontal Gyrus R 6 13 -22 59 3.64 281
   
Precentral Gyrus L 4 -18 -28 55 3.45 103
   
Val/Val > Val/Met   
   
Inferior Frontal Gyrus L 11 -21 50 -19 4.55 1287
   
Middle Frontal Gyrus L 8 -22 28 44 3.4 169
   
 R 9 46 30 47 3.67 124
   
Superior Frontal Gyrus R 10 23 46 18 3.67 283
   
Fusiform Gyrus L 19 -23 -63 -6 3.42 177
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3 Discussion 
 
In this broader discussion, I will try to give an overview of the methodological 
problems of such kind of studies (chapter 3.1) and an impression of the field of 
research and the expectations that I have for its future (chapter 3.2).  
 
 
3.1 Methodological Considerations 
 
3.1.1 Problems with Genetic Studies in General 
 
One of the major problems of genetic studies of normal cognitive functions is effect 
size: Effects sizes are most of the times very small (it is already amazing if they reach 
the scale of 1%, if you think of the high number of variants and the often very indirect 
action of the genes). In consequence, to statistically prove such small effects, we 
need enormously large samples. Large samples give of course large power, because 
random effects are averaged out, but the danger to be caught by systematic bias 
rises: The effect size of a systematic bias is the same for a large sample as for a 
small sample, but it will rather get significant and be considered as a real effect in a 
large sample. The standard solution of this problem is to take two independent large 
samples. It seems very unlikely that in both samples the same effect gets statistically 
significant. Note that this is true for random effects, but not for systematic biases: 
Because they are systematic, they will show up not just in these two samples, but in 
every sample you would want to investigate. A better idea to get rid of systematic 
bias probably would be to choose different kinds of account and see if results 
converge. This is what we tried with our fMRI studies, attempting to control for 
behavioral effects and using different measures for memory performance, extracted 
from the fMRI signal. The fMRI signal is probably also one step nearer to the genes 
as the behaviour (it probably measures rather the underlying processes than just 
behavioral sum scores), which should increase the power of such an account. The 
problem arising there is one of interpretation: A difference in fMRI signal can mean 
many different things (partial volume effects, different degrees of anxiety of the 
scanning procedure, difference in coffee consumption and so on), so no one would 
conclude on genetic effects just from differences in the fMRI signal without behavioral 
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differences and/or further good reasons to assume that genetic differences could 
exist, like biochemical results of what gene products do in the context of the 
measured cognitive process.  
Another problem is that most of the variants are rare. The single nucleotid 
polymorphisms reviewed in this work are with one exception more frequent than 
about 25%. Rarer variants are of course difficult to find (see our PS1 study, 
Mondadori et al., 2006b): You need an even larger population to have at least 10-12 
carriers of a rare variant. For example, if there is a polymorphism with a frequency of 
10%, the probability to be a homozygous carrier is just 1%, so you would have to 
survey 1000 volunteers to get 10 homozygous carriers. In the study with the prion 
protein Met129Val polymorphism, we were quite lucky in this respect to get in total 
about 16 Val/Val carriers (frequency of Val/Val is around 12%, Palmer et al., 1991) 
and to have still 12 carriers after drop-outs and performance matching (from around 
350 volunteers genotyped that time, about half agreed to take part in fMRI studies). 
Of course the problem is also to get money if you wish to investigate a genetic variant 
that has a frequency of around 5%. This does not mean that investigating these rare 
variants would not be interesting: They may elucidate the influence of an altered 
protein on cognitive functions, which could maybe not be assessed otherwise, for 
example if the cognitive function can not be measured in animals.  
A severe problem are multiple comparisons. In principle, if you wanted to investigate 
the effects of a genetic variant, you would have to match for the whole rest of the 
genome and all environmental variables. Matching genes can be done more or less 
with animals (same genetic background) but not in humans, of course. In humans, if 
you want to control one gene while investigating another, you will lose half of your 
sample size in the best case. Of course some statistical tools like logistic regression 
try to solve this problem, but they do it only partly, since their results depend for 
example on the sequence of variables you feed into the procedure. One attempt to 
control genetic backgrounds in humans is to check for population stratification with 
the use of unrelated single nucleotid polymorphisms (see chapter 1.1.4) dispersed 
over the whole genome. If their distribution does not differ between groups, 
stratification is controlled on the whole genome-level (Pritchard and Rosenberg, 
1999). Of course this is a good idea but no guarantee that some other polymorphism 
may be in linkage disequilibrium to the investigated polymorphism and either impose 
their effect on the measured polymorphism, or obstruct a real effect (the 
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polymorphisms near to the investigated polymorphism are more likely to be 
correlated, since they are more likely to be inherited together; see the mixing process 
during meiosis, chapter 1.1.5). In our fMRI studies, we did the best we could, which is 
matching 3-4 other polymorphisms that have shown to influence memory. Up to a 
certain degree, this matches also nearby polymorphisms, because they are often 
inherited together. Of course this is not a big help since there could be many not yet 
discovered polymorphisms that could have been in linkage disequilibrium to our 
investigated polymorphisms.  
Another problem which is more important for genetic research than for research in 
‘general psychology’ (which deals with effects that are the same in all human beings) 
is selection bias. Our group did the best they could to look not only at a population of 
psychology- and medicine-students interested in memory experiments, but also a 
second population of persons reading a very common free newspaper (which was a 
necessary condition to see the ad). Of course this is already an exceptional part of 
the Swiss population, because interest in this kind of work is a sign of over-average 
intellectual abilities, which could be seen also in the professional categories and 
intelligence measures of this second population, which were as high as the 
intelligence measures of the students (except education-dependent measures like 
vocabulary tests or tests of general knowledge). This fact made it easier for us to do 
the experiments (average people would have had problems to get along with the 
instructions), but our results might underestimate the variability of memory in the 
general population. I suppose that this must not be a problem, because we measure 
the part of the variability conferred by a single polymorphism relative to the variability 
in our study population. Having homogeneous groups is possibly an additional 
control over genetic backgrounds and a part of other confounding variables. An 
interesting exception of a study which randomly selected inhabitants of a city by 
telephone directories and asked them to participate in a study (even if biases are 
likely because of selective willingness to participate) is the study of Rujescu and 
colleagues (2003).  
A further problem correlating with some problems already mentioned, is the quasi-
experimental design. Of course we have to measure individuals with the genotypes 
they were born with, so there are diverse kinds of moderating variables which could 
correlate with genetic features and variables we measure, but not in the way we 
suppose. For example, genes could influence emotions, which influence performance 
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or physiological variables (for example it is known that fear flattens the fMRI signal 
through maximal opening of arterioles during both experimental and basis condition). 
Or genotypes can seek specific learning environments (see also chapter 1) which 
can form their cognitive apparatus.  
 
 
3.1.2 Methodological Issues of the Actual fMRI Study 
 
fMRI (like other physiological measures, e.g. EEG) is a very powerful tool to 
investigate psychological functions like memory. It is very sensitive and yielded in our 
studies as in other studies reproducible activation patterns correlated with 
remembering (in the case of the prion study, recognition). Compared to a low-level 
baseline (comparing the first and last letter of a letter string), activations were much 
stronger in the left hemisphere than in the right hemisphere in practically all subjects. 
This baseline nicely subtracted out early visual activations and yielded activations 
where you would expect them (in the inferior frontal gyrus, BA 47 on both sides, in 
the dorsolateral frontal cortex BA 9, 8 and 6 left, the angular gyrus (BA 39) left; the 
middle temporal gyrus (BA 21) left, the basal ganglia on both sides and sometimes 
the posterior cingulate; see supplementary figure S2 of the paper). Choosing a 
higher-level baseline showed also the (“missing”) mediotemporal activations, rather 
parahippocampal than hippocampal, but sometimes also extending into the 
hippocampal formation (see Figure 24 as an example). 
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Figure 24: Activation in the whole sample (n=36) during recognizing the words 
learned 24 hours ago (only recollection), compared to the false positives as baseline; 
family-wise error corrected 
 
The stronger activation of the parahippocampal gyrus than the hippocampus (Figure 
24 is slightly misleading in that respect, which is the danger in single-slice figures; 
this is why I chose glass brains in the paper) is probably due to the single word 
learning task: Word association tasks (learning which words were on the same slide) 
challenge the hippocampus stronger. Often memory fMRI studies fail to show 
hippocampal activation, often due to inadequate baseline (see Stark and Squire, 
2001): The problem is not that the hippocampus is inactive during remembering, but 
that he is active if subjects are bored and remember things to be entertained 
(‘wandering mind’).  
The problem of using fMRI comparisons between subjects is that the signal is 
influenced by numerous factors other than the experimental manipulation (in our 
case, the genotype, which can be ‘manipulated’ only by selection), which strongly 
reduces the power as compared to comparisons within subjects. This is because 
many variables influence fMRI activation, which are controlled if conditions are 
compared within person, but which act as noise if conditions are compared between 
persons (for example brain anatomy or timings and form of the hemodynamic 
response function HRF). Good fMRI designs put all investigated conditions into the 
same time-series, which is of course not possible if comparing different genotypes.  
An important issue in doing fMRI studies with genetics is also to use well-
characterized tasks. In that respect, it is probably not a bad idea to take an 
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experiment that has been used several times already, because this facilitates the 
interpretation, especially if you do not see genotypic differences. The reason why we 
had to construct a new experiment was that the findings of Papassotiropoulos and 
colleagues (2005) had appeared in the word task and only in the 24 hours condition, 
so we had to construct an experiment involving a recall after a time-lag of 24 hours. 
To find optimal conditions and to test the experiment before applying it to the 
genotyped subjects, we tested already 28 subjects in pilot studies. Including a 24 
hours recall strongly increased the need for experimenters. To compensate dropouts, 
we had to scan 50 subjects, which means about 60 hours of scanning, and 23.5-25.5 
hours before scanning subjects had to learn the first word list, and half an hour 
before learning the second word list. This is why we needed up to 2 additional 
experimenters (blind for genotypes) per session to learn the word lists with the 
subjects. The work of these experimenters was quite critical, because one mistake 
would lead to one dropout. Another important reason for dropouts where subjects 
who repeated the words at home (and it was quite evident for them that they would 
have to remember the words from the first day on the second day, because all of 
them had already done an experiment from our collaboration partners involving a 24 
hours recall). It was wise to schedule the neuropsychological session before the main 
experiment, because we could probably lower the number of drop-outs by excluding 
weakly motivated subjects from the study before using expensive scanner-time. The 
problem with dropouts was that our pool of genotype subjects was shrinking with 
every dropout, and we could not afford to do additional genotyping. 
Another difficult issue to decide was the choice of a traditional block-design or an 
event-related design. One need was to maximize power, (which is especially difficult 
in a memory task where you can not make subjects learn 200 or more items) which 
would have spoken for a block design. However, assessing recognition with a block 
design has at least two disadvantages: One is that subjects may realise that there is 
a block-wise regularity in the sequence of the conditions (for example 4 learned 
items, 4 new items, 4 items baseline and so on), the other is that it is not possible to 
separate correctly recognized from falsely recognized items in the fMRI signal. An 
additional advantage of an event-related design is that we were able to differentiate 
recollective recognition (‘Remember’-answers, Tulving, 1985) from familiarity-based 
recognition (‘Know’-answers). Studies say that despite the signal-to-noise ratio is 
higher in a block design (Dale and Buckner, 1997) which practically means that you 
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need more items to get the same signal-to-noise ration in an event-related design), 
the event-related design extracts more information from the signal curve than the 
block-design (Mechelli et al., 2003).  
 
 
 
Figure 25: Comparison between block design and event-related design. The arrows 
designate stimulation (note that conditions are randomly or pseudorandomly mixed in 
event-related designs) 
 
 
There are two differences of fast event-related (fast event related means that the next 
stimulus is given before the end of the HRF; otherwise you would have to wait at 
least 15 seconds to present the next stimulus) designs as compared to block-designs 
to be taken into consideration: (A) You have to make sure that you sample your full 
HRF, and (B) have enough time to do your statistics.  
(A) Block designs assume that the signal is maximal for a large part of the duration of 
a block of about 20-24 seconds. If this assumption is correct, you do not have to 
worry much about the form of the HRF at its beginning or end, or about the timing of 
a measured slice with respect to the experimental variation (slice-timing correction is 
not necessary). In an event-related design, the form of the HRF has to be sampled, 
because otherwise you may miss maxima (which are rather narrow) and minima 
(which can be close to side-maxima). This means that you lose power, but even 
worse, you may measure artefacts of some regularity in the signal course (for 
example, if activation in condition B is always somewhat later than activation in 
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condition A; to account for this effect, we included time derivatives as effects of no 
interest, which shifts the beginning of all HRF’s of a certain condition by an optimal 
amount; Josephs, 1997). Besides, slice-timing correction is indispensable, because 
otherwise you measure artefacts again, because one slice is measured at different 
times in the course of signal decay. The sampling of the whole HRF can be 
reassured with two preventive measures: First, use a length of an item that is slightly 
shorter or longer than the repetition time or an integer number x the repetition time 
(we used 8.82 seconds mean inter stimulus interval at a repetition time of three 
seconds, which means that during a time-series of 50 stimuli, the HRF was sampled 
three times; repetition time (TR) is the time of acquisition of one image of an entire 
brain) and second, use jittering. Jittering is a systematic delaying or speeding of an 
item (which has the additional advantage that subjects have to be more attentive not 
to miss a beginning), with the extreme case of omitting one or even two items (null 
trials). Jittering has been shown to make a design more efficient (Burock et al., 1998; 
Dale, 1999).  
(B) Calculating the first-level fixed-effects model (for the within person contrasts, 
which are compared with other first-level contrasts in the group-analysis, which is 
normally done on the second level) is extremely time-consuming in an event-related 
design, because the vectors containing the time of stimulus-onsets are different from 
person to person. This means also that losing the behavioral data of a subject makes 
the imaging data worthless.   
 
 
3.1.3 How to do it better? Important Points for Genetic Research 
 
Knowledge-based search instead of screening: 
Nowadays it is possible to compare 500000 or even more polymorphisms in a 
genome-wide search. This makes it possible to search for “the best memory gene” 
with relatively moderate costs (though, one chip costs some 1000$). In that way, you 
can compare for example the blood of 500 good learners with the blood of 500 bad 
learners. If you are lucky, you might find one polymorphism with a huge difference in 
frequency (see chapter 1.3.6). Otherwise the account does not help you because of 
the problem of multiple comparisons (see chapter 3.1.1). In most of the cases it is not 
possible to say that a difference exists, and at the same time it is not possible to say 
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that it does not exist. Therefore, it would be ideal to look at few well-characterized 
genes and polymorphisms in a hypothesis-based manner. Our studies assessed a 
very low level of organization (i.e. the polymorphisms) and a very high level of 
organization (i.e. the fMRI signal and the behaviour), but we do not know enough of 
the biochemical, developmental and neurophysiological processes inbetween. 
Therefore it would be ideal if an interdisciplinary institute, specialised for example in 
serotonin-correlated processes, would have methodological specialists to follow a 
path from the gene up to behaviour and again down to the gene. This institute would 
need knock-out mice, cell-cultures, ideally a developmental assay (for example 
chicken) and brain imaging (e.g. EEG and fMRI) in healthy volunteers and patients, 
maybe before and after clinical interventions. Then these specialists could build gene 
clusters and try to find out how they interact among genes and with environmental 
factors.  
 
Work together:  
A result in genetics is worth more if it has been found not only in independent 
populations, but in populations with different genetic backgrounds. Why do Japanese 
people resist longer to prion diseases? Why is the distribution of cancers different in 
different cultures? It would also be very helpful to use the same standards if possible 
(of course this is difficult with language test, for example) to get comparable results. 
Then one could do metastudies with larger numbers of subjects. Data pools should 
be accessible for any researcher: For example, one could do volumetric studies with 
enough structural MRI scans of persons of each genotype, age and sex (of course 
you can not match for all polymorphisms).  
 
Involve more subjects: 
In some countries there are population-based studies of certain topics, for example 
special diseases. The problem arises that healthy people are less willing to take part 
in a study or to have themselves genotyped. But it would be of great help to have 
data from healthy subjects as well: For example it would be very interesting to have 
data from persons who have a high genetic risk for a disease but do not get the 
disease. How are they different? How do risk behaviours interact with genetic risks? 
One important factor to motivate people to take part of our experiments is to do public 
work and inform all those who are interested about what we are doing and why. 
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3.2 Conclusions and Expectations in this Field of Research 
 
While I tried to give an overview over some of the methodological problems in 
chapter 3.1, now I will try to speculate about the chances which this kind of research 
might hold.  
In chapter 1.3, I briefly reviewed genes that are thought to be involved in memory and 
shortly summarized some results of these studies. As pointed out in chapter 3.1, I 
think that the aim of this kind of research should not be primarily to screen, confirm or 
disprove the involvement of genes in higher cognitive functions, but to build a chain 
from the gene through all organizational levels up to the behaviour and to show how 
the gene might influence behaviour. This is of course a great deal of work, but these 
kinds of results would give a yield, not only for basic science, but also for potential 
therapeutics: It is not wise to try to influence processes which we do not understand.  
With respect to fMRI, this method should not be used as a hypothesis-generating, but 
as a hypothesis-testing tool. This is because fMRI is very sensitive, but sometimes 
not very discriminative. Below I will give an example of a case where it has been 
used very fruitfully in a genetic study (Heinz et al., 2004). But let me first summarize 
which of the studies cited in chapter 1.3 leave a better feeling of progress and which 
not. 
For the ‘clinical’ genes PS1 and APOE, it is a valuable attempt to improve early 
diagnostics, which could turn out to be very important once a causal therapy against 
Alzheimer’s has been developed. On the other hand, the gain of knowledge through 
our studies in these genes is relatively modest: The step from the gene to worse 
memory or increased fMRI activation is still too large to be understood. I would say 
something similar in the case of the prion protein gene Met129Val polymorphism: It 
might be really involved in memory, but what are the mechanisms? The numerous 
studies about the gene cited in chapter 1.3.7.5 give us a nice glimpse on what this 
protein could do, but it was probably too early to test the polymorphisms in humans, 
because no one knows what the polymorphism does on a cellular level. There is far 
more literature about the pathogenic mechanisms, but even they are hidden in the 
dark. To say it in different words, I’m sitting on quite promising results, but I am not 
able to give a hint of what they could mean, and probably no one is at this moment. 
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The situation is considerably better with the BDNF gene: There are not only concrete 
ideas about what this neurotrophin does, but it has also been characterized what the 
polymorphism does. This sets the stage for asking further questions (which should be 
assessed rather in animals than in humans) about how the different distribution of the 
protein influences brain structure and brain function. The ‘best’ gene mentioned in 
chapter 1.3 is probably the serotonin 2A receptor gene: I think that the involvement of 
this transmitter in memory has been shown convincingly, and the influence of the 
polymorphism has been shown on a cellular level. Memory seems to be quite 
sensitive to changes in serotonin transmission, not only between genotypes (de 
Quervain et al., 2003), but also upon slight changes in diet (Van der Veen et al., 
2006). Probably it is a good idea to investigate genes involved in neurophysiological 
processes, glutamatergic or Gamma-Amino-Butyric Acid (GABA)-ergic transmission. 
Because of its probable involvement in overnight memory consolidation, 
acetylcholine would also be very interesting. An especially promising case are genes 
involved in monoamine (dopamine, norepinephrine, serotonin) transmission, because 
they act in larger parts of the brain more or less in parallel and are very well 
characterized by pharmacological studies because of their implication in psychiatric 
diseases. Above I promised to introduce a study which I find an instructive example 
of interdisciplinary genetic research: 
In an earlier study, Lesch and colleagues (1996) showed that subjects with a 
shortened promoter of the serotonin-transporter (5-HTT), which leads to a diminished 
concentration of the transporter of about 50%, compared to the long variant of the 
transporter, score significantly higher on anxiety measures in personality inventories 
(the long/ long variant is found in about 31% of caucasians, the long/ short variant in 
51%, and the short/ short variant in 17%). Interestingly, one short allele already 
increased the neuroticism score as high as two short alleles (besides, the short allele 
also reduced agreeableness of the subjects slightly, but significantly, with a similar to 
the  “long/long > short/long = short/short” pattern observed in neuroticism). In a study 
with fear conditioning in humans, Garpenstrand and colleagues (2001) showed that 
carriers of the short allele learned an association between a neutral stimulus and an 
electric shock faster than homozygous long/long carriers (as measured by galvanic 
skin response). That this difference had to do with serotonin metabolism was further 
implicated by the fact that the effect was more pronounced in subjects who 
expressed little monoaminoxidase, an enzyme that splits serotonin and therefore 
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removes it from the synaptic cleft (like the serotonin transporter 5-HTT, which allows 
the presynaptic neuron to efficiently reuptake serotonin). Besides, a longer variant of 
the third exon of the dopamine D4 receptor slowed extinction of the fear response. In 
a longitudinal study, Caspi and colleagues (2003) could show that though the 
polymorphism is not proven to be associated with depression, it is associated with 
the response to stressful environments: Despite statistically equal number of stressful 
life events between genotypic groups, life events predicted (a) symptoms of 
depression (whether self-reported or by a nearby person), (b) a depression diagnosis 
and (c) suicide thoughts or attempt only in carriers of at least one short allele. Early 
depression (earlier than at an age of 20) was excluded from the analysis. 
 
 
 
Figure 26: Relation between 5-HTT genotype, life events and depressive symptoms 
(from Caspi et al., 2003). 
 
A further study showed a stronger amygdala activation upon fearful stimuli (Ekman 
faces) in carriers of at least one short allele of the 5-HTT transporter promoter 
polymorphism (Hariri et al., 2002; studies with depressed patients have shown the 
same amygdala overactivation, which improved after antidepressive medication; see 
Drevets et al., 2003). In a further fMRI study, Heinz and colleagues could show that 
aversive stimuli activated both amygdalae, stronger in carriers of the short allele than 
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in long/long-carriers (more pronouncedly in short/ short carriers), which was not the 
case for pleasant stimuli. More importantly, the coupling (coactivation) between the 
amygdala and the ventromedial prefrontal cortex on each side (BA 11 left, BA 10 
right) was much stronger for carriers of at least one short-allele than for homozygous 
long/ long carriers (see Figure 27).  
The authors discuss this finding in terms of a higher capacity for short allele carriers 
to regulate their emotional responses with their prefrontal cortex, which does not 
necessarily indicate greater vulnerability, but may lead to a problem in stressful 
situations, where this coupling might be too rigid and stabilize mood on a low level. 
While the interpretation seems to me a bit superficial (why exactly is coupling 
sometimes good, sometimes bad?), the finding is intriguing, since it could let the 
above findings converge and tell us why there is a faster fear conditioning in carriers 
of the short allele.  
 
 
 
Figure 27: Stronger amydala-prefrontal coupling in carryers of a short allele of the 
serotonin transporter gene promoter (from Heinz et al., 2004) 
 
What does this example show? First, using naturally occurring polymorphisms can 
allow us to investigate disorders directly in humans, for which we otherwise would 
have to use animal models, from which we never know if they are valid models for 
the disease (depression and schizophrenia are especially difficult to model). Second, 
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fMRI can help us a lot if we have a priori hypotheses of involved processes (in this 
case, the amygdala activation upon aversive stimuli): Now we have a model at hand 
which we can test in depressed subjects: Is the amygdala-prefrontal coupling really 
greater in people at high risk for depression than in people with lower risk for 
depression? Is it only part of the diathesis, or is it also a consequence of the stress? 
Is this coupling a trait, and if yes, does the trait predict depression after stressful 
events? Of course it would be important to characterize the psychological correlate of 
the coupling. Maybe it could elucidate the old controversy about what is first in 
depression- the emotion or the thought (probably this is the wrong question to ask).  
 
To say it in other words, ideally we should not set up to “do a genetic study”, but use 
genetic tools to elucidate concrete, well-characterized research questions, together 
with other tools.  
 
Another very important field for genetic tools (beside neurophysiology) is probably 
brain development (see e.g. Balaban, 2006). For example, from six genes implicated 
in developmental dyslexia, four are involved in the radial migration of neurons 
(reviewed by Ramus, 2006). What needs the brain to configure itself in a way that 
enables learning? Are Brodmann’s areae prespecified? What cues are needed for a 
circuit to develop? Of course this is rather research for biologists than for 
neuropsychologists. But there is enough to do for us between brain and cognition: 
Which concepts are useful in both? Which psychological function does a brain area 
execute (see chapter 1.2.3.1)? And if a biologist has made the observation that 
protein x influences strongly cell-type Y, which is found mainly in brain area A, and a 
specialist in genetics tells us that the gene X in humans has a common 
polymorphism that changes the activity of protein x, then we are ready to set up a 
design to test if the polymorphism in X really influences function a of brain area A, 
and our results potentially answer two kinds of questions, namely (1) if we discover a 
similar effect in humans than was found in animals and (2) we might be able to 
further characterize the functions of brain structure A. This is what I mean with 
concrete research questions and with interdisciplinary work. 
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